103RD GENERAL ASSEMBLY
State of Illinois
2023 and 2024
SB2612

 

Introduced 10/18/2023, by Sen. Willie Preston

 

SYNOPSIS AS INTRODUCED:
 
New Act
20 ILCS 2630/5.2
30 ILCS 105/5.1015 new
30 ILCS 105/5.1016 new
35 ILCS 1010/1-45
720 ILCS 570/102  from Ch. 56 1/2, par. 1102
720 ILCS 570/204  from Ch. 56 1/2, par. 1204

    Creates the Compassionate Use and Research of Entheogens Act. Establishes the Illinois Psilocybin Advisory Board within the Department of Public Health for the purpose of advising and making recommendations to the Department regarding the provision of psilocybin and psilocybin services. Provides that the Department shall begin receiving applications for the licensing of persons to manufacture or test psilocybin products, operate service centers, or facilitate psilocybin services. Contains licensure requirements and prohibitions. Provides that a licensee or licensee representative may manufacture, deliver, or possess a psilocybin product. Provides that the Department may obtain, relinquish, or dispose of psilocybin products to ensure compliance with and enforce the Act and rules adopted under the Act. Creates the Psilocybin Control and Regulation Fund and the Illinois Psilocybin Fund and makes conforming changes in the State Finance Act. Requires the Department of Agriculture, the Illinois Liquor Control Commission, and the Department of Revenue to perform specified duties. Contains provisions concerning rulemaking; taxes; fees; zoning; labeling; and penalties. Preempts home rule powers. Contains other provisions. Amends the Criminal Identification Act. Provides that specified records shall be expunged prior to (i) January 1, 2025 (rather than January 1, 2023) and (ii) January 1, 2027 (rather than January 1, 2025). Provides for expungement of specified records concerning the possession of psilocybin and psilocin. Amends the Illinois Controlled Substances Act. Removes psilocybin and psilocin from the list of Schedule I controlled substances. Amends the Illinois Independent Tax Tribunal Act of 2012. Provides that the Tax Tribunal shall have original jurisdiction over all determinations of the Department of Revenue reflected on specified notices issued under the Compassionate Use and Research of Entheogens Act. Effective immediately.


LRB103 34492 JAG 64324 b

 

 

A BILL FOR

 

SB2612LRB103 34492 JAG 64324 b

1    AN ACT concerning health.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 1. Short title. This Act may be cited as the
5Compassionate Use and Research of Entheogens Act.
 
6    Section 5. Findings. The General Assembly finds that:
7        (1) The War on Drugs has given rise to significant
8    financial and social costs, and the policies behind the
9    War on Drugs reflect neither a modern understanding of
10    substance use nor the actual risks or potential
11    therapeutic benefits of the substances that have been
12    criminalized.
13        (2) Moreover, criminalization has not deterred drug
14    use. Instead, it has made drug use less safe and has
15    created an unregulated, underground market in which
16    dosages are difficult to verify and dangerous adulterants,
17    such as fentanyl, are common.
18        (3) Lack of honest drug education has laid the
19    groundwork for decades of misinformation, stigma, and
20    cultural appropriation, which have all contributed to
21    increasing the dangers of drug use.
22        (4) Harm reduction tools, including drug-checking
23    kits, scales, and capsules, allow users to make safe and

 

 

SB2612- 2 -LRB103 34492 JAG 64324 b

1    more accurate, evidence-based decisions about their
2    personal use of these substances, and allowing the use of
3    such tools can increase public health and safety.
4        (5) Research is advancing to support the use of
5    psychedelic compounds, along with psychotherapy, to treat
6    mental health disorders, such as anxiety, depression,
7    post-traumatic stress disorder, and substance use
8    disorder.
9        (6) Voters of the city and county of Denver, Colorado
10    approved Ordinance 301 in May of 2019, making the personal
11    possession and use of the natural medicine psilocybin by
12    adults the lowest level of law enforcement priority in
13    Denver and to prohibit the city and county from spending
14    resources enforcing related penalties.
15        (7) Measures 109 and 110 in Oregon, which both passed
16    in November 2020, established a regulated psilocybin
17    therapy system in Oregon to provide people therapeutic
18    access to psilocybin and decriminalized the personal
19    possession of all drugs.
20        (8) Almost 20 countries around the world, including
21    Portugal, the Czech Republic, and Spain, have expressly or
22    effectively decriminalized the personal use of all
23    substances.
24        (9) The City of Oakland, California, and the City of
25    Santa Cruz, California have passed resolutions
26    decriminalizing or deprioritizing the enforcement of laws

 

 

SB2612- 3 -LRB103 34492 JAG 64324 b

1    regulating the possession, use, and propagation of
2    psychedelic plants and fungi. Since June 2019, the
3    following cities have also decriminalized the possession,
4    use, and propagation of psychedelic plants and fungi at
5    the local level: Ann Arbor, Michigan; Somerville,
6    Massachusetts; and Cambridge, Massachusetts. In 2020,
7    Washington, D.C., passed Initiative 81 to decriminalize
8    and deprioritize the enforcement of laws regulating the
9    possession and use of psychedelic plants and fungi with
10    76% voter approval.
11        (10) The State of Colorado passed Proposition 122 in
12    November of 2022, decriminalizing the possession of
13    psychedelic plants and fungi and eventually allowing
14    state-licensed treatment centers to administer the
15    compounds of psychedelic plants and fungi under the
16    supervision of trained staff.
17        (11) To transition away from criminalization models
18    while protecting people who use or may use drugs and
19    reduce negative environmental or cultural impacts, it is
20    necessary to review the full legal context in which these
21    changes to the law are made. It is also necessary to
22    incorporate evidence-based policy, consult with experts,
23    and maintain open discourse based in harm reduction,
24    reciprocity, and human rights during the process of
25    developing alternative regulatory systems.
26        (12) Criminalizing psychedelic plants and fungi has

 

 

SB2612- 4 -LRB103 34492 JAG 64324 b

1    denied people access to accurate education and harm
2    reduction information related to the use of psychedelic
3    compounds and limited the development of appropriate
4    training for first responders and multi-responders,
5    including law enforcement, emergency medical services, and
6    fire services.
7        (13) Illinoisans deserve more tools to address mental
8    health issues, including approaches using psychedelic
9    plants and fungi that are grounded in treatment, recovery,
10    cultural competency, and wellness rather than
11    criminalization, suffering, and punishment.
12        (14) This Act will allow for the noncommercial,
13    personal use and sharing of specified controlled
14    substances, including for the purpose of group counseling,
15    community-based healing, or other related services.
16        (15) These changes in law will not displace any
17    restrictions on driving or operating a vehicle while
18    impaired, an employer's ability to restrict the use of
19    controlled substances by its employees, or the legal
20    standard for negligence.
21        (16) Peyote is specifically excluded from the list of
22    substances to be decriminalized, including any
23    cultivation, harvest, extraction, tincture, or other
24    product manufactured or derived therefrom, because of the
25    nearly endangered status of the peyote plant and the
26    special significance peyote holds in Native American

 

 

SB2612- 5 -LRB103 34492 JAG 64324 b

1    spirituality. Furthermore, this Act does not amend or
2    repeal paragraph (12) of subsection (d) of Section 204 of
3    the Illinois Controlled Substances Act, which identifies
4    peyote and its derivatives as a Schedule I drug.
5        (17) The State of Illinois fully respects and supports
6    the continued Native American possession and use of peyote
7    under federal law, 42 U.S.C. 1996a, understanding that
8    Native Americans in the United States were persecuted and
9    prosecuted for their ceremonial practices, including the
10    use of peyote, for more than a century, and had to fight
11    numerous legal and political battles to achieve the
12    current protected status. The enactment of this
13    legislation does not intend to explicitly or implicitly
14    undermine that status.
15        (18) Research conducted by domestic and international
16    medical institutions indicates that psilocybin is
17    efficacious and safe for the treatment of a variety of
18    mental health conditions, including, but not limited to,
19    addiction, depression, anxiety disorders, headache
20    disorders, and end-of-life psychological distress.
21        (19) The United States Food and Drug Administration
22    has:
23            (A) determined that preliminary clinical evidence
24        indicates that psilocybin may demonstrate substantial
25        improvement over available therapies for
26        treatment-resistant depression; and

 

 

SB2612- 6 -LRB103 34492 JAG 64324 b

1            (B) granted a "Breakthrough Therapy" designation
2        for a treatment that uses psilocybin as a therapy for
3        such depression.
4        (20) During a 2-year program development period, the
5    Department should:
6            (A) examine, publish, and distribute to the public
7        available medical, psychological, and scientific
8        studies, research, and other information relating to
9        the safety and efficacy of psilocybin in treating
10        mental health conditions; and
11            (B) adopt rules and regulations for the eventual
12        implementation of a comprehensive regulatory framework
13        that will allow persons 18 years of age and older in
14        this State to be provided psilocybin services.
15        (21) An advisory board should be established within
16    the Department for the purpose of advising and making
17    recommendations to the Department.
 
18    Section 10. Purposes.
19    (a) The purpose of this Act is to establish a new,
20compassionate, and effective approach to entheogens by:
21        (1) Adopting a public health and harm reduction
22    approach to natural medicines by removing criminal
23    penalties for the possession of some entheogens for
24    personal use by adults who are 18 years of age or older.
25        (2) Developing and promoting public education related

 

 

SB2612- 7 -LRB103 34492 JAG 64324 b

1    to the use of entheogens and appropriate training for
2    first responders.
3        (3) Reducing the prevalence of behavioral health
4    disorders among adults in this State to improve the
5    physical, mental, and social well-being of all people in
6    this State.
7        (4) Promoting health and healing by reducing focus on
8    criminal punishments for persons who suffer from mental
9    health issues by establishing regulated access to natural
10    medicines through a humane, cost-effective, and
11    responsible approach.
12        (5) Developing a long-term strategic plan for ensuring
13    that psilocybin services will become and remain a safe,
14    accessible, and affordable option for all persons 18 years
15    of age and older in this State for whom psilocybin may be
16    appropriate.
17        (6) Protecting the safety, welfare, health, and peace
18    of the people of this State by prioritizing this State's
19    limited law enforcement resources in the most effective,
20    consistent, and rational way.
21        (7) After a 2-year program development period:
22            (A) permitting persons licensed, controlled, and
23        regulated by this State to legally manufacture
24        psilocybin products and provide psilocybin services to
25        persons 18 years of age and older, subject to the
26        provisions of this Act;

 

 

SB2612- 8 -LRB103 34492 JAG 64324 b

1            (B) establishing a comprehensive regulatory
2        framework concerning psilocybin products and
3        psilocybin services under State law; and
4            (C) preparing proposed rules for the addition of
5        botanical forms of dimethyltryptamine, ibogaine
6        (except ibogaine from iboga), and mescaline (except
7        mescaline from peyote) to substances regulated under
8        this Act on or before June 1, 2027.
9    (b) The People of the State of Illinois intend that the
10provisions of this Act, together with other provisions of
11State law, will prevent:
12        (1) the distribution of psilocybin products to other
13    persons who are not permitted to possess psilocybin
14    products under the provisions of this Act and rules
15    adopted under this Act, including, but not limited to,
16    persons under 18 years of age; and
17        (2) the diversion of psilocybin products from this
18    State to other states.
 
19    Section 15. Construction. This Act may not be construed
20to:
21    (1) Require a government medical assistance program or
22private health insurer to reimburse a person for costs
23associated with the use of psilocybin products.
24    (2) Amend or affect State or federal law pertaining to
25employment matters.

 

 

SB2612- 9 -LRB103 34492 JAG 64324 b

1    (3) Amend or affect State or federal law pertaining to
2landlord-tenant matters.
3    (4) Prohibit a recipient of a federal grant or an
4applicant for a federal grant from prohibiting the
5manufacture, delivery, possession, or use of psilocybin
6products to the extent necessary to satisfy federal
7requirements for the grant.
8    (5) Prohibit a party to a federal contract or a person
9applying to be a party to a federal contract from prohibiting
10the manufacture, delivery, possession, or use of psilocybin
11products to the extent necessary to comply with the terms and
12conditions of the contract or to satisfy federal requirements
13for the contract.
14    (6) Require a person to violate a federal law.
15    (7) Exempt a person from a federal law or obstruct the
16enforcement of a federal law.
17    (8) Amend or affect State law to the extent that a person
18does not manufacture, deliver, or possess psilocybin products
19in accordance with the provisions of this Act and rules
20adopted under this Act.
 
21    Section 20. Definitions. In this Act:
22    "2-year program development period" means the period
23beginning on January 1, 2025 and ending no later than December
2431, 2026.
25    "Administration session" means a session held under the

 

 

SB2612- 10 -LRB103 34492 JAG 64324 b

1supervision of a facilitator at which a client consumes and
2experiences the effects of a psilocybin product under the
3supervision of a facilitator.
4    "Advisory Board" or "Board" means the Illinois Psilocybin
5Advisory Board established under Section 25.
6    "Client" means an individual who consumes a psilocybin
7product in an administration session in this State.
8    "Department" means the Department of Public Health.
9    "Entheogen" means the following substances in any form,
10regardless of whether the substance is regulated under the
11federal Controlled Substances Act or the Illinois Controlled
12Substances Act:
13        (1) Dimethyltryptamine.
14        (2) Ibogaine, except ibogaine from iboga.
15        (3) Mescaline, except mescaline from peyote.
16        (4) Psilocybin.
17        (5) Psilocin.
18    "Facilitator" means an individual who facilitates the
19provision of a psilocybin service in this State.
20    "Integration session" means a meeting between a client and
21a facilitator that may occur after the client completes an
22administration session.
23    "Legal entity" means a corporation, limited liability
24company, limited partnership, or other legal entity that is
25registered with the office of the Secretary of State or with a
26comparable office of another jurisdiction.

 

 

SB2612- 11 -LRB103 34492 JAG 64324 b

1    "Licensee" means a person who holds a license issued under
2Section 85, 100, 115, or 325.
3    "Licensee representative" means an owner, director,
4officer, manager, employee, agent, or other representative of
5a licensee, to the extent that the person acts in a
6representative capacity.
7    "Manufacture" means the manufacture, planting,
8cultivation, growing, harvesting, production, preparation,
9propagation, compounding, conversion, or processing of a
10psilocybin product, directly or indirectly, by extraction from
11substances of natural origin, independently by means of
12chemical synthesis or by a combination of extraction and
13chemical synthesis. "Manufacture" includes any packaging or
14repackaging of the psilocybin product or labeling or
15relabeling of its container.
16    "Premises" includes the following areas of a location
17licensed under this Act:
18        (1) All public and private enclosed areas at the
19    location that are used in the business operated at the
20    location, including offices, kitchens, restrooms, and
21    storerooms.
22        (2) All areas outside of a building that the
23    Department has specifically licensed for the manufacturing
24    of psilocybin products or the operation of a service
25    center.
26        (3) For a location that the Department has

 

 

SB2612- 12 -LRB103 34492 JAG 64324 b

1    specifically licensed for the operation of a service
2    center outside of a building, that portion of the location
3    used to operate the service center and provide a
4    psilocybin service to a client.
5    "Premises" does not include a primary residence, unless a
6primary residence is necessary for the provision of a
7psilocybin service to a recipient who is a hospice patient or
8who is unable to travel to a service center due to a chronic,
9life-threatening illness.
10    "Preparation session" means a meeting between a client and
11a facilitator that must occur before the client participates
12in an administration session.
13    "Psilocybin" means psilocybin or psilocin.
14    "Psilocybin product" means:
15        (1) psilocybin-producing fungi; or
16        (2) mixtures or substances containing a detectable
17    amount of psilocybin.
18    "Psilocybin product" does not include a psilocybin
19service.
20    "Psilocybin product manufacturer" means a person who
21manufactures a psilocybin product in this State.
22    "Psilocybin service" means a service provided to a client
23before, during, or after the client's consumption of a
24psilocybin product, including any of the following:
25        (1) A preparation session.
26        (2) An administration session.

 

 

SB2612- 13 -LRB103 34492 JAG 64324 b

1        (3) An integration session.
2    "Service center" means an establishment at which:
3        (1) an administration session is held;
4        (2) a psilocybin product is purchased; or
5        (2) other psilocybin services may be provided.
6    "Service center operator" means a person who operates a
7service center in this State.
 
8    Section 25. Illinois Psilocybin Advisory Board; members;
9terms; meetings; compensation.
10    (a) The Illinois Psilocybin Advisory Board is established
11within the Department for the purpose of advising and making
12recommendations to the Department. The Illinois Psilocybin
13Advisory Board shall consist of the following members:
14        (1) The members appointed by the Governor as specified
15    under subsection (b).
16        (2) The Director of Public Health or the Director's
17    designee.
18        (3) A designee of the State Board of Health Policy.
19    (b) The Governor shall appoint the following individuals
20to the Advisory Board:
21        (1) Any 4 of the following:
22            (A) A State employee who has technical expertise
23        in the field of public health.
24            (B) A local health officer.
25            (C) An individual who is a member of or who

 

 

SB2612- 14 -LRB103 34492 JAG 64324 b

1        represents a federally recognized Indian tribe in this
2        State.
3            (D) An individual who is a member of or who
4        represents an advisory body regarding addiction and
5        mental health planning within the Department or the
6        Department of Human Services.
7            (E) An individual who is a member of or who
8        represents a body regarding health equity policy
9        within the Department or the Department of Human
10        Services.
11            (F) An individual who is a member of or who
12        represents a body regarding palliative care and
13        quality of life within the Department or the
14        Department of Human Services.
15            (G) An individual who represents individuals who
16        provide public health services directly to the public.
17        (2) A psychologist licensed to practice in Illinois
18    who has professional experience engaging in the diagnosis
19    or treatment of a mental, emotional, or behavioral
20    condition.
21        (3) A psychiatrist licensed to practice in Illinois
22    who has professional experience engaging in the diagnosis
23    or treatment of a mental, emotional, or behavioral
24    condition.
25        (4) A therapist licensed to practice in Illinois who
26    has professional experience engaging in the diagnosis or

 

 

SB2612- 15 -LRB103 34492 JAG 64324 b

1    treatment of a mental, emotional, or behavioral condition.
2        (5) A physician licensed to practice in Illinois who
3    holds a degree of Doctor of Medicine.
4        (6) A naturopathic physician.
5        (7) An expert in the field of public health who has a
6    background in academia.
7        (8) A Veterans Affairs service-connected disabled
8    veteran.
9        (9) Any 3 of the following:
10            (A) A person who has professional experience
11        conducting scientific research regarding the use of
12        psychedelic compounds in clinical therapy.
13            (B) A person who has experience in the field of
14        mycology.
15            (C) A person who has experience in the field of
16        ethnobotany.
17            (D) A person who has experience in the field of
18        psychopharmacology.
19            (E) A person who has experience in the field of
20        psilocybin harm reduction.
21        (10) A person representing the Illinois Liquor Control
22    Commission, a person who has experience working with a
23    system developed and maintained by a State body under the
24    Cannabis Regulation and Tax Act for tracking the transfer
25    of cannabis or cannabis products, or a person who is both.
26        (11) The following:

 

 

SB2612- 16 -LRB103 34492 JAG 64324 b

1            (A) During the 2-year program development period:
2                (i) one of the chief petitioners of this Act;
3            and
4                (ii) one or 2 at-large members.
5            (B) After the 2-year program development period,
6        one, 2, or 3 at-large members.
7    (c) The term of office for an Advisory Board member
8appointed under this Section is 4 years, but a member serves at
9the pleasure of the Governor. Before the expiration of the
10term of a member, the Governor shall appoint a successor whose
11term begins on January 1 of the following calendar year.
12Members may be eligible for reappointment. If there is a
13vacancy for any reason, the Governor shall make an appointment
14to become immediately effective for the unexpired term.
15    (d) Members of the Advisory Board described in paragraphs
16(2) and (3) of subsection (a) are nonvoting ex officio members
17of the Advisory Board.
18    (e) A majority of the voting members of the Advisory Board
19constitutes a quorum for the transaction of business.
20    (f) Official action by the Advisory Board requires the
21approval of a majority of the voting members of the board.
22    (g) The Advisory Board shall elect one of its voting
23members to serve as chairperson.
24    (h) During the 2-year program development period, the
25Advisory Board shall meet at least once every 2 calendar
26months at a time and place determined by the chairperson, or a

 

 

SB2612- 17 -LRB103 34492 JAG 64324 b

1majority of the voting members of the Advisory Board. After
2the 2-year program development period, the Advisory Board
3shall meet at least once every calendar quarter at a time and
4place determined by the chairperson or a majority of the
5voting members of the Advisory Board. The Advisory Board may
6also meet at other times and places specified by the call of
7the chairperson or of a majority of the voting members of the
8board.
9    (i) The Advisory Board may adopt rules necessary for the
10operation of the board.
11    (j) The Advisory Board may establish committees or
12subcommittees necessary for the operation of the board.
13    (k) Members of the Advisory Board are entitled to
14compensation and expenses.
 
15    Section 30. Duties of the Illinois Psilocybin Advisory
16Board.
17    (a) The Illinois Psilocybin Advisory Board shall perform
18the following duties:
19        (1) Provide advice to the Department with respect to
20    the administration of this Act as it relates to accurate
21    public health approaches regarding use, effect, and risk
22    reduction of entheogens and the content and scope of
23    educational campaigns related to entheogens.
24        (2) Make recommendations to the Department on
25    available medical, psychological, and scientific studies,

 

 

SB2612- 18 -LRB103 34492 JAG 64324 b

1    research, and other information relating to the safety and
2    efficacy of psilocybin in treating mental health
3    conditions, including, but not limited to, addiction,
4    depression, anxiety and trauma disorders, headache
5    disorders, and end-of-life psychological distress.
6        (3) Study and review the Oregon Psilocybin Services
7    Act (Measure 109), the Colorado Natural Medicine Health
8    Act of 2022 (Proposition 122), and relevant legislative
9    initiatives in other states in an effort to determine
10    successes and pitfalls that may be applied to the
11    rulemaking process in Illinois.
12        (4) Review scientific and cultural literature
13    concerning ibogaine (except ibogaine from iboga),
14    mescaline (except mescaline from peyote), and botanical
15    forms of dimethlyltryptamine and make recommendations to
16    the Department concerning whether these substances may be
17    included in this Act or a similar appropriate regulatory
18    framework based on medical, psychological, and scientific
19    studies, research, and other information related to the
20    safety and efficacy of each compound to avoid an
21    unregulated de facto market for other natural plants and
22    fungi.
23        (5) Make recommendations to the Department on the
24    requirements, specifications, and guidelines for providing
25    psilocybin services to a client, including the following:
26            (A) The requirements, specifications, and

 

 

SB2612- 19 -LRB103 34492 JAG 64324 b

1        guidelines for holding and verifying the completion of
2        a preparation session, an administration session, and
3        an integration session.
4            (B) The contents of the client information form
5        that a client must complete and sign before the client
6        participates in an administration session, giving
7        particular consideration to the following:
8                (i) The information that should be solicited
9            from the client to determine whether the client
10            should participate in the administration session,
11            including information that may identify risk
12            factors and contraindications.
13                (ii) The information that should be solicited
14            from the client to assist the service center
15            operator and the facilitator in meeting any public
16            health and safety standards and industry best
17            practices during the administration session.
18                (iii) The health and safety warnings and other
19            disclosures that should be made to the client
20            before the client participates in the
21            administration session.
22        (6) Make recommendations to the Department on public
23    health and safety standards and industry best practices
24    for each type of licensee under this Act.
25        (7) Make recommendations to the Department on the
26    formulation of a code of professional conduct for

 

 

SB2612- 20 -LRB103 34492 JAG 64324 b

1    facilitators, giving particular consideration to a code of
2    ethics, cultural responsibility, and outlining a clear
3    process for reporting complaints of unethical conduct by
4    facilitators or service center employees.
5        (8) Make recommendations to the Department on the
6    education, experience, and training that facilitators must
7    achieve, giving particular consideration to the following
8    and including whether such education, experience, and
9    training should be available through online resources:
10            (A) Facilitation skills that are affirming,
11        nonjudgmental, nondirective, trauma-informed, and
12        rooted in informed consent.
13            (B) Support skills for clients during an
14        administration session, including specialized skills
15        for the following:
16                (i) Client safety.
17                (ii) Clients who may have a mental health
18            condition.
19                (iii) Appropriate boundaries, heightened
20            transference in expanded states of consciousness,
21            and special precautions related to the use of
22            touch in psilocybin sessions.
23                (iv) Crisis assessment and appropriate
24            referral for those who need ongoing support if
25            challenging mental health issues emerge in
26            psilocybin sessions

 

 

SB2612- 21 -LRB103 34492 JAG 64324 b

1            (C) The environment in which psilocybin services
2        should occur.
3            (D) Social and cultural considerations.
4            (E) Affordable, equitable, ethical, and culturally
5        responsible access to entheogens and requirements to
6        ensure that the regulated entheogen access program is
7        equitable and inclusive.
8        (9) Make recommendations to the Department on the
9    examinations that facilitators must pass.
10        (10) Make recommendations to the Department on public
11    health and safety standards and industry best practices
12    for holding and completing an administration session,
13    including the following:
14            (A) Best practices surrounding group
15        administration.
16            (B) How clients can safely access common or
17        outside areas on the premises at which the
18        administration session is held.
19            (C) The circumstances under which an
20        administration session is considered complete.
21            (D) The transportation needs of the client after
22        the completion of the administration session.
23        (11) Develop a long-term strategic plan for ensuring
24    that psilocybin services will become and remain a safe,
25    accessible, and affordable therapeutic option for all
26    persons 18 years of age and older in this State for whom

 

 

SB2612- 22 -LRB103 34492 JAG 64324 b

1    psilocybin may be appropriate.
2        (12) Monitor and study federal laws, regulations, and
3    policies regarding psilocybin.
4        (13) On an ongoing basis, review and evaluate existing
5    research studies and real-world data related to entheogens
6    and make recommendations to the General Assembly and
7    relevant State agencies as to whether entheogens and
8    associated services should be covered under any Illinois
9    State health insurance or other insurance program as a
10    cost-effective intervention for various mental health
11    conditions, including, but not limited to, end of life
12    anxiety, substance use disorder, alcoholism, depressive
13    disorders, neurological disorders, post-traumatic stress
14    disorder, and other painful conditions, including, but not
15    limited to, cluster headaches, migraines, cancer, and
16    phantom limbs.
17        (14) On an ongoing basis, review and evaluate
18    sustainability issues related to natural entheogens and
19    their impact on indigenous cultures and document existing
20    reciprocity efforts and continuing support measures that
21    are needed as part of the Advisory Board's annual report.
22        (15) Publish an annual report describing the Advisory
23    Board's activities, including, but not limited to, any
24    recommendations and advice for the Department or the
25    General Assembly.
26    (b) The Department shall provide technical, logistical,

 

 

SB2612- 23 -LRB103 34492 JAG 64324 b

1and other support to the Advisory Board, as requested by the
2Advisory Board, to assist the Advisory Board with its duties
3and obligations.
 
4    Section 35. Department of Public Health's general powers
5and duties; rules.
6    (a) The Department has the duties, functions, and powers
7specified in this Act and the powers necessary or proper to
8enable the Department to carry out the Department's duties,
9functions, and powers under this Act. The jurisdiction,
10supervision, duties, functions, and powers of the Department
11extend to any person who produces, processes, transports,
12delivers, sells, or purchases a psilocybin product in this
13State or who provides a psilocybin service in this State. The
14Department may sue and be sued.
15    (b) The duties, functions, and powers of the Department
16specified in this Act include the following:
17        (1) To examine, publish, and distribute to the public
18    available medical, psychological, and scientific studies,
19    research, and other information relating to the safety and
20    efficacy of psilocybin in treating mental health
21    conditions, including, but not limited to, addiction,
22    depression, anxiety disorders, headache disorders, and
23    end-of-life psychological distress.
24        (2) After the 2-year program development period, the
25    following:

 

 

SB2612- 24 -LRB103 34492 JAG 64324 b

1            (A) To regulate the manufacturing, transportation,
2        delivery, sale, and purchase of psilocybin products
3        and the provision of psilocybin services in this State
4        in accordance with the provisions of this Act.
5            (B) To issue, renew, suspend, revoke, or refuse to
6        issue or renew licenses for the manufacturing or sale
7        of psilocybin products, the provision of psilocybin
8        services, or other licenses related to the consumption
9        of psilocybin products, and to permit, at the
10        Department's discretion, the transfer of a license
11        between persons.
12            (C) To regulate the use of psilocybin products and
13        psilocybin services for other purposes as deemed
14        necessary or appropriate by the Department.
15        (3) To adopt, amend, or repeal rules as necessary to
16    carry out the intent and provisions of this Act, including
17    rules that the Department considers necessary to protect
18    the public health and safety.
19        (4) To exercise all powers incidental, convenient, or
20    necessary to enable the Department to administer or carry
21    out the provisions of this Act or any other law of this
22    State that charges the Department with a duty, function,
23    or power related to psilocybin products or psilocybin
24    services. Powers described in this paragraph include, but
25    are not limited to, the following:
26            (A) Issuing subpoenas.

 

 

SB2612- 25 -LRB103 34492 JAG 64324 b

1            (B) Compelling the attendance of witnesses.
2            (C) Administering oaths.
3            (D) Certifying official acts.
4            (E) Taking depositions as provided by law.
5            (F) Compelling the production of books, payrolls,
6        accounts, papers, records, documents, or testimony.
7            (G) Establishing fees in addition to the
8        application, licensing, and renewal fees described in
9        Sections 85, 100, 115, and 325 of this Act, provided
10        that any fee established by the Department is
11        reasonably calculated to not exceed the cost of the
12        activity for which the fee is charged.
13        (5) To adopt rules prohibiting advertisement of
14    psilocybin products to the public.
15        (6) To adopt rules regulating and prohibiting
16    advertisement of psilocybin services and prohibiting
17    advertisements for those services that:
18            (A) That is appealing to minors.
19            (B) That promotes excessive use.
20            (C) That promotes illegal activity.
21            (D) That violates the code of professional conduct
22        for facilitators formulated by the Department.
23            (E) That otherwise presents a significant risk to
24        public health and safety as determined by the
25        Department.
26    (c) The Department may not require that a psilocybin

 

 

SB2612- 26 -LRB103 34492 JAG 64324 b

1product be manufactured by means of chemical synthesis.
2    (d) The Department may not require a client to be
3diagnosed with or have any particular medical condition as a
4prerequisite to being provided psilocybin services.
5    (e) Fees collected pursuant to this Section shall be
6deposited into the Psilocybin Control and Regulation Fund
7established under Section 205.
 
8    Section 40. Authority to purchase, possess, seize,
9transfer to a licensee, or dispose of psilocybin products.
10Subject to any applicable provision of Illinois law, the
11Department may purchase, possess, seize, transfer to a
12licensee, or dispose of psilocybin products as is necessary
13for the Department to ensure compliance with and enforce the
14provisions of this Act and any rule adopted under this Act.
 
15    Section 45. 2-year program development period; dates.
16    (a) Unless the General Assembly provides otherwise, the
17Department may not issue any licenses under this Act during
18the 2-year program development period.
19    (b) On or before February 28, 2025, the Governor shall
20appoint the individuals specified in subsection (b) of Section
2125 to the Advisory Board.
22    (c) On or before March 31, 2025, the Advisory Board shall
23hold its first meeting at a time and place specified by the
24Governor.

 

 

SB2612- 27 -LRB103 34492 JAG 64324 b

1    (d) On or before June 30, 2025, and on a regular basis
2after that date, the Advisory Board shall submit its findings
3and recommendations to the Department on available medical,
4psychological, and scientific studies, research, and other
5information relating to the safety and efficacy of psilocybin
6and other entheogens in treating mental health conditions,
7including, but not limited to, addiction, depression, anxiety
8disorders, headache disorders, and end-of-life psychological
9distress.
10    (e) On or before June 30, 2026, the Advisory Board shall
11submit its findings and recommendations concerning the
12following to the Department:
13        (1) Rules and regulations for the implementation of
14    this Act.
15        (2) A long-term strategic plan for ensuring that
16    psilocybin services will become and remain a safe,
17    accessible, and affordable therapeutic option for all
18    persons 18 years of age and older in this State for whom
19    psilocybin may be appropriate.
20        (3) With respect to federal laws, regulations, and
21    policies regarding psilocybin and other entheogens.
22    (f) On or before July 31, 2025, and on a regular basis
23after that date, the Department shall publish and distribute
24to the public available medical, psychological, and scientific
25studies, research, and other information relating to the
26safety and efficacy of psilocybin and other entheogens in

 

 

SB2612- 28 -LRB103 34492 JAG 64324 b

1treating mental health conditions, including, but not limited
2to, addiction, depression, anxiety disorders, headache
3disorders, and end-of-life psychological distress.
4    (g) On or before December 31, 2026, the Department shall
5prescribe forms and adopt such rules as the Department deems
6necessary for the implementation of this Act.
 
7    Section 50. Licensing.
8    (a) On or before January 2, 2026, the Department shall
9begin receiving applications for the licensing of persons to
10perform the following:
11        (1) Manufacture psilocybin products.
12        (2) Operate a service center.
13        (3) Facilitate psilocybin services.
14        (4) Test psilocybin products.
15    (b) Except as provided in subsection (c), an applicant for
16a license or renewal of a license issued under this Act shall
17apply to the Department in the form required by the Department
18by rule, showing the name and address of the applicant, the
19location of the facility that is to be operated under the
20license, and other pertinent information required by the
21Department. The Department may not issue or renew a license
22until the applicant has complied with the provisions of this
23Act and rules adopted under this Act.
24    (c) The Department may reject any application that is not
25submitted in the form required by the Department by rule. The

 

 

SB2612- 29 -LRB103 34492 JAG 64324 b

1Department shall give applicants an opportunity to be heard if
2an application is rejected. A hearing under this subsection is
3not subject to the requirements for contested case proceedings
4under applicable Illinois law.
5    (d) Except as provided in subsection (c), a revocation of
6or a refusal to issue or renew a license issued under this Act
7is subject to the requirements for contested case proceedings
8under applicable Illinois law.
9    (e) An applicant for a facilitator license or renewal of a
10facilitator license issued under Section 115 need not show the
11location of any premises.
12    (f) The Department may not license an applicant under the
13provisions of this Act if the applicant is under 18 years of
14age.
15    (g) The Department may refuse to issue a license or may
16issue a restricted license to an applicant under the
17provisions of this Act if the Department finds that the
18applicant meets any of the following conditions:
19        (1) Has failed to complete any of the education or
20    training required by the provisions of this Act or rules
21    adopted under this Act.
22        (2) Has failed to complete any of the examination
23    required by the provisions of this Act or rules adopted
24    under this Act.
25        (3) Is in the habit of using alcoholic beverages,
26    habit-forming drugs, or controlled substances to excess as

 

 

SB2612- 30 -LRB103 34492 JAG 64324 b

1    determined by the Department.
2        (4) Has made false statements to the Department.
3        (5) Is incompetent or physically unable to carry on
4    the management of the establishment proposed to be
5    licensed as determined by the Department.
6        (6) Has been convicted of violating a federal law,
7    State law, or local ordinance if the conviction is
8    substantially related to the fitness and ability of the
9    applicant to lawfully carry out activities under the
10    license.
11        (7) Is not of good repute and moral character as
12    determined by the Department.
13        (8) Does not have a good record of compliance with
14    this Act or any rule adopted under this Act.
15        (9) Is not the legitimate owner of the premises
16    proposed to be licensed or has not disclosed that any
17    other person has an ownership interest in the premises
18    proposed to be licensed.
19        (10) Has not demonstrated financial responsibility
20    sufficient to adequately meet the requirements of the
21    premises proposed to be licensed.
22        (11) Is unable to understand the laws of this State
23    relating to psilocybin products, psilocybin services, or
24    the rules adopted under this Act.
25    (h) Notwithstanding paragraph (6) of subsection (g), in
26determining whether to issue a license or a restricted license

 

 

SB2612- 31 -LRB103 34492 JAG 64324 b

1to an applicant, the Department may not consider the prior
2conviction of the applicant or any owner, director, officer,
3manager, employee, agent, or other representative of the
4applicant for the following:
5        (1) The manufacture of psilocybin or the manufacture
6    of cannabis, as defined under Section 1-10 of the Cannabis
7    Regulation and Tax Act, or cannabis product if any of the
8    following apply:
9            (A) The date of the conviction is 2 or more years
10        before the date of the application.
11            (B) The person has not been convicted more than
12        once for the manufacture of psilocybin.
13        (2) The possession of a controlled substance, as
14    defined in the Illinois Controlled Substances Act, if any
15    of the following apply:
16            (A) The date of the conviction is 2 or more years
17        before the date of the application.
18            (B) The person has not been convicted more than
19        once for the possession of a controlled substance.
 
20    Section 55. Authority to require fingerprints of
21applicants and other individuals. For the purpose of
22requesting a State or nationwide criminal records check, the
23Department may require the fingerprints of any individual
24listed on an application submitted under Section 50. The
25powers conferred on the Department under this Section include

 

 

SB2612- 32 -LRB103 34492 JAG 64324 b

1the power to require the fingerprints of the following
2persons:
3        (1) If the applicant is a limited partnership, each
4    general partner of the limited partnership.
5        (2) If the applicant is a manager-managed limited
6    liability company, each manager of the limited liability
7    company.
8        (3) If the applicant is a member-managed limited
9    liability company, each voting member of the limited
10    liability company.
11        (4) If the applicant is a corporation, each director
12    and officer of the corporation.
13        (5) Any individual who holds a financial interest of
14    10% or more in the person applying for the license.
 
15    Section 60. Properties of license. A license issued under
16this Act is all of the following:
17        (1) A personal privilege.
18        (2) Renewable in the manner provided under Section 50,
19    except for a cause that would be grounds for refusal to
20    issue the license under Section 50.
21        (3) Subject to revocation or suspension as provided in
22    Section 185.
23        (4) Except for a license issued to a facilitator under
24    Section 115, transferable from the premises for which the
25    license was originally issued to another premises subject

 

 

SB2612- 33 -LRB103 34492 JAG 64324 b

1    to the provisions of this Act, applicable rules adopted
2    under this Act, and applicable local ordinances.
3        (5) Subject to expiration upon the death of the
4    licensee, if the license was issued to an individual
5    except as provided under subsection (q) of Section 165.
6        (6) Not considered property.
7        (7) Not alienable.
8        (8) Not subject to attachment or execution.
9        (9) Not subject to descent by the laws of testate or
10    intestate succession.
 
11    Section 65. Duties of the Department with respect to
12issuing licenses.
13    (a) The Department shall approve or deny an application to
14be licensed under this Act. Upon receiving an application
15under Section 50, the Department may not unreasonably delay
16processing, approving, or denying the application or, if the
17application is approved, issuing the license.
18    (b) The licenses described in this Act must be issued by
19the Department, subject to the provisions of this Act and
20rules adopted under this Act.
21    (c) The Department may not licensee premises that do not
22have defined boundaries. Premises do not need to be enclosed
23by a wall, fence, or other structure, but the Department may
24require premises to be enclosed as a condition of issuing or
25renewing a license. The Department may not license mobile

 

 

SB2612- 34 -LRB103 34492 JAG 64324 b

1premises.
 
2    Section 70. Duty to request land use compatibility
3statement.
4    (a) Prior to receiving a license under Section 85 or 100,
5an applicant shall request a land use compatibility statement
6from the city or county that authorizes the land use. The land
7use compatibility statement must demonstrate that the
8requested license is for a land use that is allowable as a
9permitted or conditional use within the given zoning
10designation where the land is located. The Department may not
11issue a license if the land use compatibility statement shows
12that the proposed land use is prohibited in the applicable
13zone.
14    (b) Except as otherwise provided in this Section, a city
15or county that receives a request for a land use compatibility
16statement under this Section must act on that request within
1721 days after either of the following:
18        (1) Receipt of the request, if the land use is
19    allowable as an outright permitted use.
20        (2) Final local permit approval, if the land use is
21    allowable as a conditional use.
22    A city or county that receives a request for a land use
23compatibility statement under this Section is not required to
24act on that request during the period that the Department
25discontinues licensing those premises pursuant to subsection

 

 

SB2612- 35 -LRB103 34492 JAG 64324 b

1(d) of Section 480.
 
2    Section 75. Lawful manufacture, delivery, and possession
3of psilocybin products. A licensee or licensee representative
4may manufacture, deliver, or possess a psilocybin product
5subject to the provisions of this Act and rules adopted under
6this Act. The manufacture, delivery, or possession of a
7psilocybin product by a licensee or a licensee representative
8in compliance with this Act and rules adopted under this Act
9does not constitute a criminal or civil offense under the laws
10of this State.
 
11    Section 80. Restriction on financial interests in multiple
12licensees.
13    (a) An individual may not have a financial interest in
14either of the following:
15        (1) More than one psilocybin product manufacturer.
16        (2) More than 5 service center operators.
17    (b) Subject to subsection (a), a
person may hold multiple
18service center operator licenses under Section 100 and may
19hold both a manufacturer license under Section 85 and a
20service center operator license under Section 100 at the same
21or different premises.
 
22    Section 85. License to manufacture psilocybin products.
23    (a) The manufacture of psilocybin products is subject to

 

 

SB2612- 36 -LRB103 34492 JAG 64324 b

1regulation by the Department.
2    (b) A psilocybin product manufacturer must have a
3manufacturer license issued by the Department for the premises
4at which the psilocybin products are manufactured. To hold a
5manufacturer license issued under this Section, a psilocybin
6product manufacturer must comply with the following:
7        (1) Apply for a license in the manner described in
8    Section 50.
9        (2) Provide proof that the applicant is 18 years of
10    age or older.
11        (3) Until January 1, 2028 comply with the following:
12            (A) If the direct owner of the business operating
13        or to be operated under the license is a legal entity,
14        provide proof that more than 50% of the shares,
15        membership interests, partnership interests, or other
16        ownership interests of the legal entity are held,
17        directly or indirectly, by one or more individuals who
18        have been residents of this State for 2 or more years.
19            (B) If the direct owner of the business operating
20        or to be operated under the license is a partnership
21        that is not a legal entity, provide proof that more
22        than 50% of the partnership interests of the
23        partnership are held, directly or indirectly, by one
24        or more individuals who have been residents of this
25        State for 2 or more years.
26            (C) If the direct owner of the business operating

 

 

SB2612- 37 -LRB103 34492 JAG 64324 b

1        or to be operated under the license is an individual,
2        provide proof that the individual has been a resident
3        of this State for 2 or more years.
4        (4) Meet the requirements of any rule adopted by the
5    Department under subsections (c) and (d).
6    (c) If the applicant is not the owner of the premises at
7which the psilocybin is to be manufactured, the applicant
8shall submit to the Department signed informed consent from
9the owner of the premises to manufacture psilocybin at the
10premises. The Department may adopt rules regarding the
11informed consent described in this subsection.
12    (d) The Department shall adopt rules that comply with the
13following:
14        (1) Require a psilocybin product manufacturer to
15    annually renew a license issued under this Section.
16        (2) Establish application, licensure, and renewal of
17    licensure fees for psilocybin product manufacturers.
18        (3) Require psilocybin products manufactured by
19    psilocybin product manufacturers to be tested in
20    accordance with Section 320.
21    (e) Fees adopted under paragraph (2) of subsection (d) may
22not exceed, together with other fees collected under this Act,
23the cost of administering this Act and shall be deposited into
24the Psilocybin Control and Regulation Fund established under
25Section 205.
 

 

 

SB2612- 38 -LRB103 34492 JAG 64324 b

1    Section 90. Psilocybin product manufacturers;
2endorsements.
3    (a) The Department shall adopt rules that designate
4different types of manufacturing activities. A psilocybin
5product manufacturer may only engage in a type of
6manufacturing activity if the psilocybin product manufacturer
7has received an endorsement from the Department for that type
8of manufacturing activity.
9    (b) An applicant must request an endorsement upon
10submission of an initial application but may also request an
11endorsement at any time following licensure.
12    (c) Only one application and license fee is required
13regardless of how many endorsements an applicant or licensee
14requests or at what time the request is made.
15    (d) A psilocybin product manufacturer licensee may hold
16multiple endorsements.
17    (e) The Department may deny a psilocybin product
18manufacturer's request for an endorsement or revoke an
19existing endorsement if the psilocybin product manufacturer
20cannot or does not meet the requirements for the endorsement
21that is requested. If the Department denies or revokes
22approval, the psilocybin product manufacturer has a right to a
23hearing under relevant procedures specified in the Illinois
24Administrative Procedure Act.
 
25    Section 95. Psilocybin product quantities; rules. The

 

 

SB2612- 39 -LRB103 34492 JAG 64324 b

1Department shall adopt rules restricting the quantities of
2psilocybin products at premises for which a license has been
3issued under Section 85. In adopting rules under this Section,
4the Department shall take into consideration the demand for
5psilocybin services in this State, the number of psilocybin
6product manufacturers applying for a license under Section 85,
7the number of psilocybin product manufacturers that hold a
8license issued under Section 85, and whether the availability
9of psilocybin products in this State is commensurate with the
10demand for psilocybin services.
 
11    Section 100. License to operate a service center.
12    (a) The operation of a service center is subject to
13regulation by the Department.
14    (b) Service centers are to be regulated under the
15provisions of this Act and not the provisions of any other Act.
16    (c) A service center operator must have a service center
17operator license issued by the Department for the premises at
18which psilocybin services are provided. To hold a service
19center operator license under this Section, a service center
20operator must comply with the following:
21        (1) Apply for a license in the manner described in
22    Section 50.
23        (2) Provide proof that the applicant is 18 years of
24    age or older.
25        (3) Until January 1, 2028, comply with the following:

 

 

SB2612- 40 -LRB103 34492 JAG 64324 b

1            (A) If the direct owner of the business operating
2        or to be operated under the license is a legal entity,
3        provide proof that more than 50% of the shares,
4        membership interests, partnership interests, or other
5        ownership interests of the legal entity are held,
6        directly or indirectly, by one or more individuals who
7        have been residents of this State for 2 or more years.
8            (B) If the direct owner of the business operating
9        or to be operated under the license is a partnership
10        that is not a legal entity, provide proof that more
11        than 50% of the partnership interests of the
12        partnership are held, directly or indirectly, by one
13        or more individuals who have been residents of this
14        State for 2 or more years.
15            (C) If the direct owner of the business operating
16        or to be operated under the license is an individual,
17        provide proof that the individual has been a resident
18        of this State for 2 or more years.
19        (4) Must ensure that the service center is located in
20    an area that is not within the limits of an area zoned
21    exclusively for residential use.
22        (5) Except as provided in Section 105, must ensure
23    that the service center is not located within 1,000 feet
24    of a public, private, or parochial school.
25        (6) Must meet the requirements of any rule adopted by
26    the Department under paragraph (7).

 

 

SB2612- 41 -LRB103 34492 JAG 64324 b

1        (7) The Department shall adopt rules that comply with
2    the following:
3            (A) Require a service center operator to annually
4        renew a license issued under this Section.
5            (B) Establish application, licensure, and renewal
6        of licensure fees for service center operators.
7            (C) Require psilocybin products sold by a service
8        center operator to be tested in accordance with
9        Section 320.
10            (D) Require a service center operator to meet any
11        public health and safety standards and industry best
12        practices established by the Department by rule.
13        (8) Fees adopted under subparagraph (B) of paragraph
14    (7) may not exceed, together with other fees collected
15    under this Act, the cost of administering this Act and
16    shall be deposited into the Psilocybin Control and
17    Regulation Fund established under Section 205.
 
18    Section 105. Proximity of service center to schools.
19Notwithstanding paragraph (5) of subsection (c) of Section
20100, a service center may be located within 1,000 feet of a
21school if either of the following apply:
22        (1) The service center is not located within 500 feet
23    of:
24            (A) a public elementary or secondary school for
25        which attendance is compulsory under applicable

 

 

SB2612- 42 -LRB103 34492 JAG 64324 b

1        provisions of the School Code; or
2            (B) a private or parochial elementary or secondary
3        school.
4        (2) The Department determines that there is a physical
5    or geographic barrier capable of preventing children from
6    traversing to the premises of the service center.
 
7    Section 110. Establishment of schools after issuance of
8license.
9    (a) If a school described under paragraph (5) of
10subsection (c) of Section 100 that has not previously been
11attended by children is established within 1,000 feet of
12premises for which a license has been issued under Section
13100, the service center operator located at that premises may
14remain at that location unless the Department revokes the
15license of the service center operator under Section 180.
16    (b) The Department may adopt rules establishing the
17circumstances under which the Department may require a service
18center operator that holds a license issued under Section 100
19to use an age verification scanner or any other equipment used
20to verify a person's age for the purpose of ensuring that the
21service center operator does not sell psilocybin products to a
22person under 18 years of age. Information obtained under this
23subsection may not be retained after verifying a person's age
24and may not be used for any purpose other than verifying a
25person's age.
 

 

 

SB2612- 43 -LRB103 34492 JAG 64324 b

1    Section 115. License to facilitate psilocybin services.
2    (a) The facilitation of psilocybin services is subject to
3regulation by the Department.
4    (b) A facilitator must have a facilitator license issued
5by the Department. To hold a facilitator license issued under
6this Section, a facilitator must comply with the following:
7        (1) Apply for a license in the manner described in
8    Section 50.
9        (2) Provide proof that the applicant is 18 years of
10    age or older.
11        (3) Until January 1, 2028, provide proof that the
12    applicant has been a resident of this State for 2 or more
13    years.
14        (4) Have a high school diploma or equivalent
15    education.
16        (5) Submit evidence of completion of education and
17    training prescribed and approved by the Department.
18        (6) Have passed an examination approved, administered,
19    or recognized by the Department.
20        (7) Meet the requirements of any rule adopted by the
21    Department under subsection (d).
22    (c) The Department may not require a facilitator to have a
23degree from a university, college, postsecondary institution,
24or other institution of higher education.
25    (d) The Department shall adopt rules that comply with the

 

 

SB2612- 44 -LRB103 34492 JAG 64324 b

1following:
2        (1) Require a facilitator to annually renew a license
3    issued under this Section.
4        (2) Establish application, licensure, and renewal of
5    licensure fees for facilitators.
6        (3) Require a facilitator to meet any public health
7    and safety standards and industry best practices
8    established by the Department by rule.
9    (e) Fees adopted under paragraph (2) of subsection (d) may
10not exceed, together with other fees collected under this Act,
11the cost of administering this Act and shall be deposited into
12the Psilocybin Control and Regulation Fund established under
13Section 205.
14    (f) A facilitator may be, but need not be, an employee,
15manager, director, officer, partner, member, shareholder, or
16direct or indirect owner of one or more service center
17operators.
18    (g) A license issued to a facilitator under this Section
19is not limited to any one or more premises.
 
20    Section 120. License examinations; rules. The Department
21shall offer an examination for applicants for licenses to
22facilitate psilocybin services at least twice a year. An
23applicant who fails any part of the examination may retake the
24failed section in accordance with rules adopted by the
25Department.
 

 

 

SB2612- 45 -LRB103 34492 JAG 64324 b

1    Section 125. Age verification. The Department may adopt
2rules establishing the circumstances under which the
3Department may require a facilitator that holds a license
4issued under Section 115 to use an age verification scanner or
5any other equipment used to verify a person's age for the
6purpose of ensuring that the facilitator does not provide
7psilocybin services to a person under 18 years of age.
8Information obtained under this Section may not be retained
9after verifying a person's age and may not be used for any
10purpose other than verifying a person's age.
 
11    Section 130. Psilocybin services. The Department shall
12adopt by rule the requirements, specifications, and guidelines
13for the following:
14        (1) Providing psilocybin services to a client.
15        (2) Holding and verifying the completion of a
16    preparation session.
17        (3) Having a client complete, sign, and deliver a
18    client information form to a service center operator and a
19    facilitator.
20        (4) Holding and verifying the completion of an
21    administration session.
22        (5) Holding and verifying the completion of an
23    integration session.
 

 

 

SB2612- 46 -LRB103 34492 JAG 64324 b

1    Section 135. Preparation session.
2    (a) Before a client participates in an administration
3session, the client must attend a preparation session with a
4facilitator.
5    (b) A preparation session may be, but need not be, held at
6a service center.
7    (c) If a preparation session is completed in accordance
8with all applicable requirements, specifications, and
9guidelines, as determined by the Department, the facilitator
10must certify, in a form and manner prescribed by the
11Department, that the client completed the preparation session.
 
12    Section 140. Client information form.
13    (a) Before a client participates in an administration
14session, the following must occur:
15        (1) The client must complete and sign a client
16    information form in a form and manner prescribed by the
17    Department.
18        (2) A copy of the completed and signed client
19    information form must be delivered to the service center
20    operator that operates the service center at which the
21    administration session is to be held and to the
22    facilitator that will supervise the administration
23    session.
24    (b) The client information form must comply with the
25following:

 

 

SB2612- 47 -LRB103 34492 JAG 64324 b

1        (1) Solicit from the client such information as may be
2    necessary (i) to enable a service center operator and a
3    facilitator to determine whether the client should
4    participate in an administration session, including
5    information that may identify risk factors and
6    contraindications, and (ii) to assist the service center
7    operator and the facilitator in meeting any public health
8    and safety standards and industry best practices during
9    the administration session.
10        (2) Contain such health and safety warnings and other
11    disclosures to the client as the Department may require.
 
12    Section 145. Administration session.
13    (a) After a client completes a preparation session and
14completes and signs a client information form, the client may
15participate in an administration session.
16    (b) An administration session must be held under the
17supervision of a licensed facilitator.
18    (c) If an administration session is completed in
19accordance with all applicable requirements, specifications,
20and guidelines, as determined by the Department, the
21facilitator must certify, in a form and manner prescribed by
22the Department, that the client completed the administration
23session.
 
24    Section 150. Integration session.

 

 

SB2612- 48 -LRB103 34492 JAG 64324 b

1    (a) After a client completes an administration session,
2the facilitator who supervised the administration session must
3offer the client an opportunity to participate in an
4integration session. The client may, but need not, participate
5in an integration session.
6    (b) An integration session may be, but need not be, held at
7a service center.
8    (c) If an integration session is completed in accordance
9with all applicable requirements, specifications, and
10guidelines, as determined by the Department, the facilitator
11must certify, in a form and manner prescribed by the
12Department, that the client completed the integration session.
 
13    Section 155. Reliance on client information form.
14    (a) If a client information form is offered as evidence in
15any administrative or criminal prosecution of a licensee or
16licensee representative for sale or service of a psilocybin
17product to a client, the licensee or licensee representative
18is not guilty of any offense prohibiting a person from selling
19or serving a psilocybin product to a client unless it is
20demonstrated that a reasonable person would have determined
21that the responses provided by the client on the client
22information form were incorrect or altered.
23    (b) A licensee or licensee representative shall be
24entitled to rely upon all statements, declarations, and
25representations made by a client in a client information form

 

 

SB2612- 49 -LRB103 34492 JAG 64324 b

1unless it is demonstrated that either:
2        (1) a reasonable person would have determined that one
3    or more of the statements, declarations, or
4    representations made by the client in the client
5    information form were incorrect or altered; or
6        (2) the licensee or licensee representative violated a
7    provision of this Act or a rule adopted under this Act
8    relative to the client information form.
9    (c) Except as provided in subsection (b), no licensee or
10licensee representative shall incur legal liability by virtue
11of any untrue statement, declaration, or representation so
12relied upon in good faith by the licensee or licensee
13representative.
14    (d) The Department shall adopt rules for recordkeeping,
15privacy, and confidentiality requirements of service centers.
16However, the recordkeeping shall not result in disclosure to
17the public or any governmental agency of any participant's
18personally identifiable information.
 
19    Section 160. Refusal to provide psilocybin services to a
20client.
21    (a) Subject to applicable State law, a licensee or
22licensee representative may refuse to provide psilocybin
23services to a potential client for any or no reason.
24    (b) Except as provided in subsection (c), and subject to
25applicable State law, a licensee or licensee representative

 

 

SB2612- 50 -LRB103 34492 JAG 64324 b

1may cease providing psilocybin services to a client for any or
2no reason.
3    (c) A service center operator and a facilitator may not
4cease providing psilocybin services to a client during an
5administration session after the client has consumed a
6psilocybin product, except as authorized by the Department by
7rule or as necessary in an emergency.
 
8    Section 165. Department powers and duties relating to
9facilitators.
10    (a) The Department shall perform the following:
11        (1) Determine the qualifications, training, education,
12    and fitness of applicants for licenses to facilitate
13    psilocybin services, giving particular consideration to
14    the following:
15            (A) Facilitation skills that are affirming,
16        nonjudgmental, culturally competent, trauma informed,
17        rooted in informed consent, and nondirective.
18            (B) Support skills for clients during an
19        administration session, including specialized skills
20        for the following:
21                (i) Client safety.
22                (ii) Clients who may have a mental health
23            condition.
24             (C) The environment in which psilocybin services
25        should occur.

 

 

SB2612- 51 -LRB103 34492 JAG 64324 b

1             (D) Social and cultural considerations.
2        (2) Formulate a code of professional conduct for
3    facilitators, giving particular consideration to a code of
4    ethics.
5        (3) Establish standards of practice and professional
6    responsibility for individuals licensed by the Department
7    to facilitate psilocybin services.
8        (4) Select licensing examinations for licenses to
9    facilitate psilocybin services.
10        (5) Provide for waivers of examinations, as
11    appropriate.
12        (6) Appoint representatives to conduct or supervise
13    examinations of applicants for licenses to facilitate
14    psilocybin services.
15    (b) The Department shall adopt by rule minimum standards
16of education and training requirements for facilitators.
17    (c) The Department shall approve courses for facilitators.
18To obtain approval of a course, the provider of a course must
19submit an outline of instruction to the Department. The
20outline must include the proposed courses, total hours of
21instruction, hours of lectures in theory, and the hours of
22instruction in application of practical skills.
23    (d) The Department may, after 72 hours' notice, make an
24examination of the books of a licensee for the purpose of
25determining compliance with this Act and rules adopted under
26this Act.

 

 

SB2612- 52 -LRB103 34492 JAG 64324 b

1    (e) The Department may at any time make an examination of
2premises for which a license has been issued under this Act for
3the purpose of determining compliance with this Act and rules
4adopted under this Act.
5    (f) The Department may not require the books of a licensee
6to be maintained on the premises of the licensee.
7    (g) If a licensee holds more than one license issued under
8this Act for the same premises, the Department may require the
9premises to be segregated into separate areas for conducting
10the activities permitted under each license as is necessary to
11protect the public health and safety.
12    (h) As is necessary to protect the public health and
13safety, the Department may require a licensee to maintain
14general liability insurance in an amount that the Department
15determines is reasonably affordable and available for the
16purpose of protecting the licensee against damages resulting
17from a cause of action related to activities undertaken
18pursuant to the license held by the licensee.
19    (i) The Department shall perform the following:
20        (1) Develop and maintain a system for tracking the
21    transfer of psilocybin products between premises for which
22    licenses have been issued under this Act. The purposes of
23    the system include, but are not limited to, the following:
24            (A) Preventing the diversion of psilocybin
25        products to other states.
26            (B) Preventing persons from substituting or

 

 

SB2612- 53 -LRB103 34492 JAG 64324 b

1        tampering with psilocybin products.
2            (C) Ensuring an accurate accounting of the
3        production, processing, and sale of psilocybin
4        products.
5            (D) Ensuring that laboratory testing results are
6        accurately reported.
7            (E) Ensuring compliance with this Act, rules
8        adopted under this Act, and any other law of this State
9        that charges the Department with a duty, function, or
10        power related to psilocybin.
11        (2) Enter into an agreement with the Illinois Liquor
12    Control Commission under which the Illinois Liquor Control
13    Commission shall permit the Department to use any system
14    developed and maintained by the Illinois Liquor Control
15    Commission to track the transfer of psilocybin products
16    between premises for which licenses have been issued under
17    this Act.
18    (j) The system developed under paragraph (1) of subsection
19(i) must be capable of tracking, at a minimum, the following:
20        (1) The manufacturing of psilocybin products.
21        (2) The sale of psilocybin products by a service
22    center operator to a client.
23        (3) The sale and purchase of psilocybin products
24    between licensees, as permitted by this Act.
25        (4) The transfer of psilocybin products between
26    premises for which licenses have been issued under this

 

 

SB2612- 54 -LRB103 34492 JAG 64324 b

1    Act.
2        (5) Any other information that the Department
3    determines is reasonably necessary to accomplish the
4    duties, functions, and powers of the Department under this
5    Act.
6    (k) Notwithstanding Section 470, before making any other
7distribution from the Illinois Psilocybin Fund established
8under Section 470, the Department of Revenue shall first
9distribute moneys quarterly from the Fund to the Illinois
10Liquor Control Commission for deposit into the Cannabis
11Regulation Fund for purposes of paying any costs incurred by
12the Illinois Liquor Control Commission under paragraph (2) of
13subsection (i). For purposes of estimating the amount of
14moneys necessary to pay any costs incurred under this Section,
15the Illinois Liquor Control Commission shall establish a
16formulary based on expected costs for each licensee that is
17tracked under this Section. The Illinois Liquor Control
18Commission shall provide to the Department of Revenue and the
19Illinois Liquor Control Commission on Government Forecasting
20and Accountability before each quarter the estimated amount of
21moneys necessary to pay costs expected to be incurred under
22this Section and the formulary.
23    (l) Except as otherwise provided by law, the Department
24has any power, and may perform any function, necessary for the
25Department to prevent the diversion of psilocybin products
26from licensees to a source that is not operating legally under

 

 

SB2612- 55 -LRB103 34492 JAG 64324 b

1the laws of this State.
2    (m) In addition to any other disciplinary action available
3to the Department under this Act, the Department may
4immediately restrict, suspend, or refuse to renew a license
5issued under this Act if circumstances create probable cause
6for the Department to conclude that a licensee has purchased
7or received a psilocybin product from an unlicensed source or
8that a licensee has sold, stored, or transferred a psilocybin
9product in a manner that is not permitted by the licensee's
10license.
11    (n) The Department may require a licensee or applicant for
12a license under this Act to submit, in a form and manner
13prescribed by the Department, to the Department a sworn
14statement showing the following:
15        (1) The name and address of each person who has a
16    financial interest in the business operating or to be
17    operated under the license.
18        (2) The nature and extent of the financial interest of
19    each person who has a financial interest in the business
20    operating or to be operated under the license.
21        (3) The Department may refuse to issue, or may
22    suspend, revoke, or refuse to renew, a license issued
23    under this Act if the Department determines that a person
24    who has a financial interest in the business operating or
25    to be operated under the license committed or failed to
26    commit an act that would constitute grounds for the

 

 

SB2612- 56 -LRB103 34492 JAG 64324 b

1    Department to refuse to issue, or to suspend, revoke, or
2    refuse to renew, the license if the person is the licensee
3    or applicant for the license.
4    (o) Notwithstanding the lapse, suspension, or revocation
5of a license issued under this Act, the Department may perform
6the following:
7        (1) Proceed with any investigation of, or any action
8    or disciplinary proceeding against, the person who held
9    the license.
10        (2) Revise or render void an order suspending or
11    revoking the license.
12        (3) In cases involving the proposed denial of a
13    license applied for under this Act, the applicant for
14    licensure may not withdraw the applicant's application.
15    (p) Notwithstanding the lapse, suspension or revocation of
16a permit issued under Section 190, the Department may perform
17the following:
18        (1) Proceed with any investigation of, or any action
19    or disciplinary proceeding against, the person who held
20    the permit.
21        (2) Revise or render void an order suspending or
22    revoking the permit.
23        (3) In cases involving the proposed denial of a permit
24    applied for under Section 190, the applicant may not
25    withdraw the applicant's application.
26    (q) The Department may, by rule or order, provide for the

 

 

SB2612- 57 -LRB103 34492 JAG 64324 b

1manner and conditions under which the following occur:
2        (1) Psilocybin products left by a deceased, insolvent,
3    or bankrupt person or licensee, or subject to a security
4    interest, may be foreclosed, sold under execution, or
5    otherwise disposed of.
6        (2) The business of a deceased, insolvent, or bankrupt
7    licensee may be operated for a reasonable period following
8    the death, insolvency, or bankruptcy.
9        (3) A secured party may continue to operate at
10    premises for which a license has been issued under this
11    Act for a reasonable period after default on the
12    indebtedness by the debtor.
 
13    Section 170. Conduct of licensees; prohibitions.
14    (a) A psilocybin product manufacturer that holds a license
15under Section 85 may not manufacture psilocybin products
16outdoors.
17    (b) A psilocybin product manufacturer that holds a license
18under Section 85 may deliver psilocybin products only to or on
19premises for which a license has been issued under Section 85
20or Section 100 and may receive psilocybin products only from a
21psilocybin product manufacturer that holds a license under
22Section 85.
23    (c) A service center operator that holds a license under
24Section 100 may deliver psilocybin products only to or on
25premises for which a license has been issued under Section 100

 

 

SB2612- 58 -LRB103 34492 JAG 64324 b

1and may receive psilocybin products only from a psilocybin
2product manufacturer that holds a license under Section 85 or
3a service center operator that holds a license under Section
4100.
5    (d) The sale of psilocybin products to a client by a
6service center operator that holds a license issued under
7Section 100 must be restricted to the premises for which the
8license has been issued.
9    (e) The Department may by order waive the requirements of
10subsections (b) and (c) to ensure compliance with this Act or a
11rule adopted under this Act. An order issued under this
12subsection does not constitute a waiver of any other
13requirement of this Act or any other rule adopted under this
14Act.
15    (f) A licensee or licensee representative may not sell or
16deliver a psilocybin product to a person under 18 years of age.
17    (g) Subject to subsection (h), a licensee or licensee
18representative, before selling or providing a psilocybin
19product to another person, must require the person to produce
20one of the following pieces of identification:
21        (1) The person's passport.
22        (2) The person's driver's license, issued by the State
23    of Illinois or another state of the United States.
24        (3) An identification card issued by the State of
25    Illinois.
26        (4) A United States military identification card.

 

 

SB2612- 59 -LRB103 34492 JAG 64324 b

1        (5) An identification card issued by a federally
2    recognized Indian tribe.
3        (6) Any other identification card issued by a state or
4    territory of the United States that bears a picture of the
5    person, the name of the person, the person's date of
6    birth, and a physical description of the person.
7    (h) The Department may adopt rules exempting a licensee or
8licensee representative from the provisions of subsection (g).
9    (i) A client may not be required to procure for the purpose
10of acquiring or purchasing a psilocybin product a piece of
11identification other than a piece of identification described
12in subsection (g).
13    (j) A service center operator, a facilitator, or any
14employee of a service center operator or facilitator may not
15disclose any information that may be used to identify a client
16or any communication made by a client during the course of
17providing psilocybin services or selling psilocybin products
18to the client, except for the following:
19        (1) When the client or a person authorized to act on
20    behalf of the client gives consent to the disclosure.
21        (2) When the client initiates legal action or makes a
22    complaint against the service center operator, the
23    facilitator, or the employee.
24        (3) When the communication reveals the intent to
25    commit a crime harmful to the client or others.
26        (4) When the communication reveals that a minor may

 

 

SB2612- 60 -LRB103 34492 JAG 64324 b

1    have been a victim of a crime or physical, sexual, or
2    emotional abuse or neglect.
3        (5) When responding to an inquiry by the Department
4    made during the course of an investigation into the
5    conduct of the service center operator, the facilitator,
6    or the employee under this Act.
7    (k) A client may purchase a psilocybin product only at a
8service center.
9    (l) A licensee may not employ a person under 18 years of
10age at premises for which a license has been issued under this
11Act.
12    (m) During an inspection of premises for which a license
13has been issued under this Act, the Department may require
14proof that a person performing work at the premises is 18 years
15of age or older. If the person does not provide the Department
16with acceptable proof of age upon request, the Department may
17require the person to immediately cease any activity and leave
18the premises until the Department receives acceptable proof of
19age. This subsection does not apply to a person temporarily at
20the premises to make a service, maintenance, or repair call or
21for other purposes independent of the premises operations.
22    (n) If a person performing work has not provided proof of
23age requested by the Department under subsection (m), the
24Department may request that the licensee provide proof that
25the person is 18 years of age or older. Failure of the licensee
26to respond to a request made under this subsection by

 

 

SB2612- 61 -LRB103 34492 JAG 64324 b

1providing acceptable proof of age for a person is prima facie
2evidence that the licensee has allowed the person to perform
3work at the premises for which a license has been issued under
4this Act in violation of the minimum age requirement.
5    (o) A licensee may not use or allow the use of a mark or
6label on the container of a psilocybin product that is kept for
7sale if the mark or label does not precisely and clearly
8indicate the nature of the container's contents or if the mark
9or label in any way might deceive a person about the nature,
10composition, quantity, age, or quality of the container's
11contents.
12    (p) The Department may prohibit a licensee from selling
13any psilocybin product that, in the Department's judgment, is
14deceptively labeled or contains injurious or adulterated
15ingredients.
 
16    Section 175. Psilocybin product prohibitions.
17    (a) A psilocybin product may not be sold or offered for
18sale within this State unless the psilocybin product complies
19with the minimum standards under the laws of this State.
20    (b) The Department may prohibit the sale of a psilocybin
21product by a service center operator for a reasonable period
22of time, not exceeding 90 days, for the purpose of determining
23whether the psilocybin product complies with the minimum
24standards prescribed by the laws of this State.
25    (c) A person may not make false representations or

 

 

SB2612- 62 -LRB103 34492 JAG 64324 b

1statements to the Department in order to induce or prevent
2action by the Department.
3    (d) A licensee may not maintain a noisy, lewd, unsafe, or
4unsanitary establishment or supply impure or otherwise
5deleterious psilocybin products.
6    (e) A licensee may not misrepresent to a person or to the
7public any psilocybin products.
 
8    Section 180. Purpose of licenses issued under this Act. A
9license issued under this Act serves the purpose of exempting
10the person who holds the license from the criminal laws of this
11State for possession, delivery, or manufacture of psilocybin
12products if the person complies with all State laws and rules
13applicable to the licensee.
 
14    Section 185. Disciplining licensees.
15    (a) The Department may revoke, suspend, or restrict a
16license issued under this Act or require a licensee or
17licensee representative to undergo training if the Department
18finds or has reasonable grounds to believe any of the
19following to be true:
20        (1) That the licensee or licensee representative:
21            (A) has violated a provision of this Act or a rule
22        adopted under this Act, including any code of
23        professional conduct or code of ethics;
24            (B) has made any false representation or statement

 

 

SB2612- 63 -LRB103 34492 JAG 64324 b

1        to the Department in order to induce or prevent action
2        by the Department;
3            (C) is insolvent or incompetent or physically
4        unable to carry on the management of the establishment
5        of the licensee;
6            (D) is in the habit of using alcoholic liquor,
7        habit-forming drugs, cannabis, psilocybin products, or
8        controlled substances to excess;
9            (E) has misrepresented to a person or the public
10        any psilocybin products sold by the licensee or
11        licensee representative; or
12            (F) since the issuance of the license has been
13        convicted of a felony, of violating any State or local
14        psilocybin products law, or of any misdemeanor or
15        violation of any municipal ordinance committed on the
16        premises for which the license has been issued.
17        (2) That there is any other reason that, in the
18    opinion of the Department, based on public convenience or
19    necessity, warrants revoking, suspending, or restricting
20    the license.
21    (b) An individual who performs work for, or on behalf of, a
22licensee must have a valid permit issued by the Department
23under Section 190 if the individual participates in any of the
24following:
25        (1) The provision of psilocybin services at the
26    premises for which the license has been issued.

 

 

SB2612- 64 -LRB103 34492 JAG 64324 b

1        (2) The possession, manufacturing, securing, or
2    selling of psilocybin products at the premises for which
3    the license has been issued.
4        (3) The recording of the possession, manufacturing,
5    securing, or selling of psilocybin products at the
6    premises for which the license has been issued.
7        (4) The verification of any document containing
8    fingerprints required under Section 55.
9    (c) A licensee must verify that an individual has a valid
10permit issued under Section 190 before allowing the individual
11to perform any work described in subsection (b) at the
12premises for which the license has been issued.
 
13    Section 190. Issuing and renewing permits; fees; rules.
14    (a) The Department shall issue permits to qualified
15applicants to perform work described in Section 185. The
16Department shall adopt rules establishing the following:
17        (1) The qualifications for performing work described
18    in Section 185.
19        (2) The term of a permit issued under this Section.
20        (3) Procedures for applying for and renewing a permit
21    issued under this Section.
22        (4) Reasonable application, issuance, and renewal fees
23    for a permit issued under this Section.
24    (b) The Department may require an individual applying for
25a permit under this Section to successfully complete a course,

 

 

SB2612- 65 -LRB103 34492 JAG 64324 b

1made available by or through the Department, through which the
2individual receives training on the following:
3        (1) Checking identification.
4        (2) Detecting intoxication.
5        (3) Handling psilocybin products.
6        (4) If applicable, the manufacturing of psilocybin
7    products.
8        (5) The content of this Act and rules adopted under
9    this Act.
10        (6) Any matter deemed necessary by the Department to
11    protect the public health and safety.
12    (c) The Department or other provider of a course may
13charge a reasonable fee for the course described under
14subsection (b).
15    (d) The Department may not require an individual to
16successfully complete a course described under subsection (b)
17more than once, except for the following:
18        (1) As part of a final order suspending a permit
19    issued under this Section, the Department may require a
20    permit holder to successfully complete the course as a
21    condition of lifting the suspension.
22        (2) As part of a final order revoking a permit issued
23    under this Section, the Department shall require an
24    individual to successfully complete the course prior to
25    applying for a new permit.
26    (e) The Department shall conduct a criminal records check

 

 

SB2612- 66 -LRB103 34492 JAG 64324 b

1on an individual applying for a permit under this Section.
2    (f) Subject to applicable provisions of Illinois law, the
3Department may suspend, revoke, or refuse to issue or renew a
4permit if the individual who is applying for or who holds the
5permit meets any of the following:
6        (1) Is convicted of a felony, or is convicted of an
7    offense under this Act, except that the Department may not
8    consider a conviction for an offense under this Act if the
9    date of the conviction is 2 or more years before the date
10    of the application or renewal.
11        (2) Violates any provision of this Act or any rule
12    adopted under this Act.
13        (3) Makes a false statement to the Department.
14    (g) A permit issued under this Section is a personal
15privilege and permits work described under Section 185 only
16for the individual who holds the permit.
 
17    Section 195. Authority to require fingerprints of
18individuals listed on application. For the purpose of
19requesting a State or nationwide criminal records check, the
20Department may require the fingerprints of any individual
21listed on an application submitted under Section 190.
 
22    Section 200. Whistleblower protection for employees. It is
23an unlawful employment practice for a licensee to discharge,
24demote, suspend, or in any manner discriminate or retaliate

 

 

SB2612- 67 -LRB103 34492 JAG 64324 b

1against an employee of the licensee with regard to promotion,
2compensation, or other terms, conditions, or privileges of
3employment on the basis that the employee has in good faith
4reported information to the Department that the employee
5believes is evidence of a violation of this Act or a rule
6adopted under this Act.
 
7    Section 205. Psilocybin Control and Regulation Fund. The
8Psilocybin Control and Regulation Fund is established as a
9special fund in the State treasury. Interest earned by the
10Psilocybin Control and Regulation Fund shall be credited to
11the Fund. Moneys in the Fund are continuously appropriated to
12the Department to administer and enforce this Act and to
13develop and implement programs for education, harm reduction,
14social equity, and unarmed crisis prevention services.
 
15    Section 210. Prohibited conduct.
16    (a) Except as authorized by the Department by rule, or as
17necessary in an emergency, a person under 18 years of age may
18not enter or attempt to enter any portion of premises posted or
19otherwise identified as being prohibited to the use of persons
20under 18 years of age.
21    (b) A person who violates subsection (a) commits a Class B
22misdemeanor.
23    (c) The prohibitions of this Section do not apply to a
24person under 18 years of age who is acting under the direction

 

 

SB2612- 68 -LRB103 34492 JAG 64324 b

1of the Department or under the direction of a State or local
2law enforcement agency for the purpose of investigating the
3possible violation of a law prohibiting the sale of a
4psilocybin product to a person who is under 18 years of age.
5    (d) The prohibitions of this Section do not apply to a
6person under 18 years of age who is acting under the direction
7of a licensee for the purpose of investigating possible
8violations by employees of the licensee of laws prohibiting
9sales of psilocybin products to persons who are under 18 years
10of age.
11    (e) A person under 18 years of age is not in violation of,
12and is immune from prosecution under, this Section if either
13of the following occurred:
14        (1) The person contacted emergency medical services or
15    a law enforcement agency in order to obtain medical
16    assistance for another person who was in need of medical
17    assistance because that person consumed a psilocybin
18    product and the evidence of the violation was obtained as
19    a result of the person having contacted emergency medical
20    services or a law enforcement agency.
21        (2) The person was in need of medical assistance
22    because the person consumed a psilocybin product and the
23    evidence of the violation was obtained as a result of the
24    person having sought or obtained the medical assistance.
25    (f) Subsection (e) does not exclude the use of evidence
26obtained as a result of a person having sought medical

 

 

SB2612- 69 -LRB103 34492 JAG 64324 b

1assistance in proceedings for crimes or offenses other than a
2violation of this Section.
 
3    Section 215. Identification that falsely indicates age.
4    (a) A person may not produce any piece of identification
5that falsely indicates the person's age.
6    (b) Violation of this Section is a Class A misdemeanor.
7    (c) If a piece of identification is offered as evidence in
8any administrative or criminal prosecution of a licensee or
9licensee representative for sale or service of a psilocybin
10product to a person under 18 years of age, the licensee or
11licensee representative is not guilty of any offense
12prohibiting a person from selling or serving a psilocybin
13product to a person under 18 years of age unless it is
14demonstrated that a reasonable person would have determined
15that the identification exhibited by the person under 18 years
16of age was altered or that the identification exhibited by the
17person under 18 years of age did not accurately describe the
18person to whom the psilocybin product was sold or served.
 
19    Section 220. Prohibition against giving psilocybin
20products to a person who is visibly intoxicated; penalty.
21    (a) A person may not sell, give, or otherwise make
22available a psilocybin product to a person who is visibly
23intoxicated.
24    (b) Violation of this Section is a Class A misdemeanor.
 

 

 

SB2612- 70 -LRB103 34492 JAG 64324 b

1    Section 225. Prohibition against giving psilocybin product
2as prize; penalty.
3    (a) A psilocybin product may not be given as a prize,
4premium, or consideration for a lottery, contest, game of
5chance, game of skill, or competition of any kind.
6    (b) Violation of this Section is a Class A misdemeanor.
 
7    Section 230. Civil enforcement. In addition to any other
8liability or penalty provided by law, the Department may
9impose for each violation of a provision of this Act or a rule
10adopted under this Act a civil penalty that does not exceed
11$5,000 for each violation. Moneys collected under this Section
12shall be deposited into the Psilocybin Control and Regulation
13Fund established under Section 205.
 
14    Section 235. Criminal enforcement.
15    (a) The law enforcement officers of this State may enforce
16this Act and assist the Department in detecting violations of
17this Act and apprehending offenders. A law enforcement officer
18who has notice, knowledge, or reasonable grounds for suspicion
19of a violation of this Act shall immediately notify the
20State's Attorney who has jurisdiction over the violation and
21furnish the State's Attorney who has jurisdiction over the
22violation with the name and address of any witnesses to the
23violation or other information related to the violation.

 

 

SB2612- 71 -LRB103 34492 JAG 64324 b

1    (b) A county court, State's Attorney, or municipal
2authority, immediately upon the conviction of a licensee of a
3violation of this Act or of a violation of any other law of
4this State or ordinance of a city or county located in this
5State, an element of which is the possession, delivery, or
6manufacture of a psilocybin product, shall notify the
7Department of the conviction.
8    (c) Violation of a rule adopted under paragraph (3) of
9subsection (b) of Section 35 is a Class C misdemeanor.
 
10    Section 245. Home rule; licensure. The authority to
11require a license for the manufacturing or sale of psilocybin
12products in this State or for the provision of psilocybin
13services in this State is an exclusive power and function of
14the State. A home rule unit may not license the manufacture,
15sale, or provision of psilocybin products. This Section is a
16denial and limitation of home rule powers and functions under
17subsection (h) of Section 6 of Article VII of the Illinois
18Constitution.
 
19    Section 250. Local time, place, and manner regulations.
20    (a) For purposes of this Section, "reasonable regulation"
21includes the following:
22        (1) Reasonable conditions on the manner in which a
23    psilocybin product manufacturer that holds a license
24    issued under Section 85 may manufacture psilocybin

 

 

SB2612- 72 -LRB103 34492 JAG 64324 b

1    products.
2        (2) Reasonable conditions on the manner in which a
3    service center operator that holds a license issued under
4    Section 100 may provide psilocybin services.
5        (3) Reasonable limitations on the hours during which
6    premises for which a license has been issued under this
7    Act may operate.
8        (4) Reasonable requirements related to the public's
9    access to premises for which a license has been issued
10    under this Act.
11        (5) Reasonable limitations on where premises for which
12    a license may be issued under this Act may be located.
13    (b) Notwithstanding the provisions of any law to the
14contrary, the governing body of a city or county may adopt an
15ordinance that imposes a reasonable regulation on the
16operation of businesses located at premises for which a
17license has been issued under this Act if the premises are
18located in an area subject to the jurisdiction of the city or
19county, except that the governing body of a city or county may
20not adopt an ordinance that prohibits premises for which a
21license has been issued under Section 100 from being located
22within a distance that is greater than 1,000 feet of another
23premises for which a license has been issued under Section
24100.
 
25    Section 255. Local tax or fee prohibited.

 

 

SB2612- 73 -LRB103 34492 JAG 64324 b

1    (a) The authority to impose a tax or fee on the
2manufacturing, sale, or provision of psilocybin products in
3this State or on the provision of psilocybin services in this
4State is an exclusive power and function of the State. A home
5rule unit may not impose a tax or fee on the manufacture, sale,
6or provision of psilocybin products. This Section is a denial
7and limitation of home rule powers and functions under
8subsection (h) of Section 6 of Article VII of the Illinois
9Constitution.
10    (b) A county, municipality, or unit of local government
11may not adopt or enact ordinances imposing a tax or fee on the
12manufacturing or sale of psilocybin products in this State or
13on the provision of psilocybin services in this State.
 
14    Section 260. Repeal of city or county ordinances that
15prohibit certain establishments.
16    (a) The governing body of a city or county may repeal an
17ordinance that prohibits the establishment of any one or more
18of the following in the area subject to the jurisdiction of the
19city or in the unincorporated area subject to the jurisdiction
20of the county:
21        (1) Psilocybin product manufacturers that hold a
22    license issued under Section 85.
23        (2) Service center operators that hold a license
24    issued under Section 100.
25        (3) Any combination of the entities described in

 

 

SB2612- 74 -LRB103 34492 JAG 64324 b

1    paragraphs (1) and (2).
2    (b) If the governing body of a city or county repeals an
3ordinance under this Section, the governing body must provide
4the text of the ordinance to the Department, in a form and
5manner prescribed by the Department, if the ordinance concerns
6premises for which a license has been issued under this Act.
 
7    Section 265. Duty of Illinois Liquor Control Commission to
8assist. The Illinois Liquor Control Commission shall assist
9and cooperate with the Department and the Department of
10Agriculture to the extent necessary for the Department and the
11Department of Agriculture to carry out the duties of the
12Department and the Department of Agriculture under this Act.
 
13    Section 270. Department of Agriculture to assist.
14    (a) The Department of Agriculture shall assist and
15cooperate with the Department to the extent necessary for the
16Department to carry out the duties of the Department under
17this Act.
18    (b) The Department of Agriculture may possess, test, and
19dispose of psilocybin products.
 
20    Section 275. Prohibition against refusing to perform
21certain duties.
22    (a) The Department, the Department of Agriculture, and the
23Illinois Liquor Control Commission may not refuse to perform

 

 

SB2612- 75 -LRB103 34492 JAG 64324 b

1any duty under this Act on the basis that manufacturing,
2distributing, dispensing, possessing, or using psilocybin
3products is prohibited by federal law.
4    (b) The Department may not revoke, refuse to issue, or
5renew a license or permit under this Act on the basis that
6manufacturing, distributing, dispensing, possessing, or using
7psilocybin products is prohibited by federal law.
 
8    Section 280. Immunity for State agencies, officers, and
9employees in performance of duties. A person may not sue the
10Department, the Department of Agriculture, the Illinois Liquor
11Control Commission, a member of the Illinois Liquor Control
12Commission, or any employee of the Department, Department of
13Agriculture, or Illinois Liquor Control Commission for
14performing or omitting to perform any duty, function, or power
15of the Department, the Department of Agriculture, or the
16Illinois Liquor Control Commission set forth in this Act or in
17any other law of this State requiring the Department, the
18Department of Agriculture, or the Illinois Liquor Control
19Commission to perform a duty, function, or power related to
20psilocybin products.
 
21    Section 285. Authority to purchase, possess, seize, or
22dispose of psilocybin products. Subject to any applicable
23provision of Illinois law, any State officer, board,
24commission, corporation, institution, department, or other

 

 

SB2612- 76 -LRB103 34492 JAG 64324 b

1State body, and any local officer, board, commission,
2institution, department, or other local government body, that
3is authorized by the laws of this State to perform a duty,
4function, or power with respect to a psilocybin product may
5purchase, possess, seize, or dispose of the psilocybin product
6as the State officer, board, commission, corporation,
7institution, department, or other State body or the local
8officer, board, commission, institution, department, or other
9local government body considers necessary to ensure compliance
10with and enforce the applicable State law or any rule adopted
11under the applicable State law.
 
12    Section 290. Suspension of a license or permit without
13notice. In the case of an invasion, disaster, insurrection,
14riot, or imminent danger of invasion, disaster, insurrection,
15or riot, the Governor may, for the duration of the invasion,
16disaster, insurrection, riot, or imminent danger, immediately
17and without notice, suspend, in the area involved, any license
18or permit issued under this Act.
 
19    Section 295. Psilocybin-producing fungi as a crop.
20    (a) In this Section, "psilocybin-producing fungi" means:
21        (1) A crop for the purposes of farm use.
22        (2) A crop for purposes of a farm or farming practice.
23        (3) A product of farm use.
24        (4) The product of an agricultural activity.

 

 

SB2612- 77 -LRB103 34492 JAG 64324 b

1    (b) Notwithstanding the provisions of any law to the
2contrary, the following are not permitted uses on land
3designated for exclusive farm use:
4        (1) A new dwelling used in conjunction with a
5    psilocybin-producing fungi crop.
6        (2) A farm stand used in conjunction with a
7    psilocybin-producing fungi crop.
8    (c) The operation of a service center may be carried on in
9conjunction with a psilocybin-producing fungi crop.
10    (d) A county may allow the manufacture of psilocybin
11products as a farm use on land zoned for farm or forest use in
12the same manner as the manufacture of psilocybin products is
13allowed in exclusive farm use zones under this Section or any
14other applicable State law.
15    (e) This Section applies to psilocybin product
16manufacturers that hold a license under Section 85.
 
17    Section 300. Regulation of psilocybin products as food or
18other commodity.
19    (a) Notwithstanding the authority granted to the
20Department of Agriculture under the provisions of any law to
21the contrary, the Department of Agriculture may not exercise
22authority over a psilocybin product or a licensee except as
23provided in this Act.
24    (b) In exercising its authority under this Act, the
25Department of Agriculture may not:

 

 

SB2612- 78 -LRB103 34492 JAG 64324 b

1        (1) establish standards for psilocybin products as a
2    food additive; or
3        (2) consider psilocybin products to be an adulterant
4    unless the concentration of a psilocybin product exceeds
5    acceptable levels established by the Department by rule.
 
6    Section 305. Enforceability of contracts. A contract is
7not unenforceable on the basis that manufacturing,
8distributing, dispensing, possessing, or using psilocybin
9products is prohibited by federal law.
 
10    Section 310. Department hotline for verification of
11license. The Department shall maintain a telephone hotline for
12the following persons to inquire if an address is the location
13of premises for which a license has been issued under this Act
14or is the location of premises for which an application for
15licensure has been submitted under Section 50:
16        (1) A person designated by a city or a county.
17        (2) A person designated by the Office of Water
18    Resources of the Department of Natural Resources.
19        (3) A person designated by the board of trustees of
20    any public water district.
 
21    Section 315. Information related to licensure that is
22exempt from disclosure.
23    (a) Subject to subsection (b), information is exempt from

 

 

SB2612- 79 -LRB103 34492 JAG 64324 b

1public disclosure under the Freedom of Information Act if the
2information is any of the following:
3        (1) Personally identifiable information.
4        (2) The address of premises for which a license has
5    been issued or for which an applicant has proposed
6    licensure under Section 85, 100, or 325.
7        (3) Related to the security plan or the operational
8    plan for premises for which a license has been issued or
9    for which an applicant has proposed licensure under
10    Section 85, 100, or 325.
11        (4) Related to any record that the Department
12    determines contains proprietary information of a licensee.
13    (b) The exemption from public disclosure as provided by
14this Section does not apply to the following:
15        (1) The name of an individual listed on an application
16    if the individual is a direct owner of the business
17    operating or to be operated under the license.
18        (2) A request for information if the request is made
19    by a law enforcement agency.
20    (c) For purposes of paragraph (1) of subsection (b), an
21individual is not a direct owner of the business operating or
22to be operated under the license if the individual is either of
23the following:
24        (1) The direct owner of the business operating or to
25    be operated under the license is a legal entity.
26        (2) Merely a general partner, limited partner, member,

 

 

SB2612- 80 -LRB103 34492 JAG 64324 b

1    shareholder, or other direct or indirect owner of the
2    legal entity.
 
3    Section 320. Testing standards and processes; rules.
4    (a) As is necessary to protect the public health and
5safety, and in consultation with the Illinois Liquor Control
6Commission and the Department of Agriculture, the Department
7shall adopt rules that achieve the following:
8        (1) Establish standards for testing psilocybin
9    products.
10        (2) Identify appropriate tests for psilocybin
11    products, depending on the type of psilocybin product and
12    the manner in which the psilocybin product was
13    manufactured, that are necessary to protect the public
14    health and safety, which may include, but are not limited
15    to, tests for the following:
16            (A) Microbiological contaminants.
17            (B) Pesticides.
18            (C) Other contaminants.
19            (D) Solvents or residual solvents.
20            (E) Psilocybin concentration.
21            (F) Psilocin concentration.
22            (G) Total tryptamine concentration
23        (3) Establish procedures for determining batch sizes
24    and for sampling psilocybin products.
25        (4) Establish different minimum standards for

 

 

SB2612- 81 -LRB103 34492 JAG 64324 b

1    different varieties of psilocybin products.
2    (b) In addition to the testing requirements established
3under subsection (a), the Department may require psilocybin
4products to be tested in accordance with any applicable law of
5this State, or any applicable rule adopted under a law of this
6State, related to the production and processing of food
7products or commodities.
8    (c) In adopting rules under this Act, the Department may
9require a psilocybin product manufacturer that holds a license
10under Section 85 to test psilocybin products before selling or
11transferring the psilocybin products.
12    (d) The Department may conduct random testing of
13psilocybin products for the purpose of determining whether a
14licensee subject to testing under subsection (c) is in
15compliance with this Section.
16    (e) In adopting rules to implement this Section, the
17Department may not require a psilocybin product to undergo the
18same test more than once unless the psilocybin product is
19processed into a different type of psilocybin product or the
20condition of the psilocybin product has fundamentally changed.
21    (f) The testing of psilocybin products as required by this
22Section must be conducted by a laboratory licensed by the
23Department under Section 325 and accredited by the Department
24under Section 340.
25    (g) In adopting rules under subsection (a), the Department
26shall consider the cost of a potential testing procedure and

 

 

SB2612- 82 -LRB103 34492 JAG 64324 b

1how that cost will affect the cost to the ultimate client and
2may not adopt rules that are more restrictive than is
3reasonably necessary to protect the public health and safety.
 
4    Section 325. Laboratory licensure; qualifications; fees;
5rules.
6    (a) A laboratory that conducts testing of psilocybin
7products as required by Section 320 must have a license to
8operate at the premises at which the psilocybin products are
9tested.
10    (b) For purposes of this Section, the Department shall
11adopt rules establishing the following:
12        (1) Qualifications to be licensed under this Section,
13    including that an applicant for licensure under this
14    Section must be accredited by the Department as described
15    in Section 340.
16        (2) Processes for applying for and renewing a license
17    under this Section.
18        (3) Fees for applying for, receiving, and renewing a
19    license under this Section.
20        (4) Procedures for the following:
21            (A) Tracking psilocybin products to be tested.
22            (B) Documenting and reporting test results.
23            (C) Disposing of samples of psilocybin products
24        that have been tested.
25    (c) A license issued under this Section must be renewed

 

 

SB2612- 83 -LRB103 34492 JAG 64324 b

1annually.
2    (d) The Department may inspect premises licensed under
3this Section to ensure compliance with Sections 320 through
4360 and rules adopted under those Sections.
5    (e) Subject to applicable provisions of Illinois law, the
6Department may refuse to issue or renew, or may suspend or
7revoke, a license issued under this Section for violation of a
8provision of this Act or a rule adopted under a provision of
9this Act.
10    (f) Fees adopted under paragraph (3) of subsection (b)
11must be reasonably calculated to pay the expenses incurred by
12the Department under this Act.
13    (g) Fees collected under this Section shall be deposited
14into the Psilocybin Control and Regulation Fund established
15under Section 205 and are continuously appropriated to the
16Department for the purpose of carrying out the duties,
17functions, and powers of the Department under this Act.
 
18    Section 330. Authority to require fingerprints of
19applicants and other individuals. For the purpose of
20requesting a State or nationwide criminal records check under
21this Act, the Department may require the fingerprints of any
22individual listed on an application submitted under Section
23325. The powers conferred on the Department under this Section
24include the power to require the fingerprints of the following
25persons:

 

 

SB2612- 84 -LRB103 34492 JAG 64324 b

1        (1) If the applicant is a limited partnership, each
2    general partner of the limited partnership.
3        (2) If the applicant is a manager-managed limited
4    liability company, each manager of the limited liability
5    company.
6        (3) If the applicant is a member-managed limited
7    liability company, each voting member of the limited
8    liability company.
9        (4) If the applicant is a corporation, each director
10    and officer of the corporation.
11        (5) Any individual who holds a financial interest of
12    10% or more in the person applying for the license.
 
13    Section 335. Statement of applicant for laboratory
14licensure. The Department may require a licensee or applicant
15for a license under Section 325 to submit, in a form and manner
16prescribed by the Department, to the Department a sworn
17statement showing the following:
18        (1) The name and address of each person who has a
19    financial interest in the business operating or to be
20    operated under the license.
21        (2) The nature and extent of the financial interest of
22    each person who has a financial interest in the business
23    operating or to be operated under the license.
24        (3) The Department may refuse to issue, or may
25    suspend, revoke, or refuse to renew, a license issued

 

 

SB2612- 85 -LRB103 34492 JAG 64324 b

1    under Section 325 if the Department determines that a
2    person who has a financial interest in the business
3    operating or to be operated under the license committed or
4    failed to commit an act that would constitute grounds for
5    the Department to refuse to issue, or to suspend, revoke
6    or refuse to renew, the license if the person were the
7    licensee or applicant for the license.
 
8    Section 340. Laboratory accreditation.
9    (a) A laboratory that conducts testing of a psilocybin
10product as required by Section 325 must be accredited and meet
11other qualifications as established by the Department under
12this Section.
13    (b) In addition to other qualifications required pursuant
14to applicable law, the Department shall require an applicant
15for accreditation for purposes related to the testing of
16psilocybin products to the following:
17        (1) Complete an application.
18        (2) Undergo an onsite inspection.
19        (3) Meet other applicable requirements,
20    specifications, and guidelines for testing psilocybin
21    products, as determined to be appropriate by the
22    Department by rule.
23    (c) The Department may inspect premises licensed under
24Section 325 to ensure compliance with Sections 320 through 360
25and rules adopted under those Sections.

 

 

SB2612- 86 -LRB103 34492 JAG 64324 b

1    (d) Subject to applicable provisions of Illinois law, the
2Department may refuse to issue or renew, or may suspend or
3revoke, a laboratory's accreditation granted under this
4Section for violation of a provision of this Act or a rule
5adopted under this Act.
6    (e) In establishing fees under this Section for
7laboratories that test psilocybin products, the Department
8shall establish fees that are reasonably calculated to pay the
9expenses incurred by the Department under this Section in
10accrediting laboratories that test psilocybin products.
 
11    Section 345. Authority to discipline licensees. Subject to
12applicable provisions of Illinois law, if an applicant or
13licensee violates a provision of Sections 320 through 360 or a
14rule adopted under those Sections, the Department may refuse
15to issue or renew, or may suspend or revoke, a license issued
16under Section 85, 100, 115, or 325.
 
17    Section 350. Authority of the Department over certain
18persons; license actions.
19    (a) Notwithstanding the lapse, suspension, or revocation
20of a license issued under Section 325, the Department may do
21either of the following:
22        (1) Proceed with any investigation of, or any action
23    or disciplinary proceeding against, the person who held
24    the license.

 

 

SB2612- 87 -LRB103 34492 JAG 64324 b

1        (2) Revise or render void an order suspending or
2    revoking the license.
3    (b) In cases involving the proposed denial of a license
4applied for under this Act, the applicant for licensure may
5not withdraw the applicant's application.
 
6    Section 355. Civil penalty for certain violations.
7    (a) In addition to any other liability or penalty provided
8by law, the Department may impose for each violation of a
9provision of Sections 320 through 360 or a rule adopted under
10those Sections a civil penalty that does not exceed $500 for
11each day that the violation occurs.
12    (b) The Department shall impose civil penalties under this
13Section in the manner provided by applicable Illinois law.
14    (c) Moneys collected under this Section shall be deposited
15into the Psilocybin Control and Regulation Fund established
16under Section 205 and are continuously appropriated to the
17Department for the purpose of carrying out the duties,
18functions, and powers of the Department under this Act.
 
19    Section 360. Exemption from criminal liability. A person
20who holds a license under Section 325, and an employee of or
21other person who performs work for a person who holds a license
22under Section 325, is exempt from the criminal laws of this
23State for possession, delivery, or manufacture of psilocybin,
24aiding and abetting another in the possession, delivery, or

 

 

SB2612- 88 -LRB103 34492 JAG 64324 b

1manufacture of psilocybin, or any other criminal offense in
2which possession, delivery, or manufacture of psilocybin is an
3element, while performing activities related to testing as
4described in Sections 320 through 360.
 
5    Section 365. Labeling requirements; rules.
6    (a) As is necessary to protect the public health and
7safety, and in consultation with the Department of Agriculture
8and the Illinois Liquor Control Commission, the Department
9shall adopt rules establishing standards for the labeling of
10psilocybin products, including, but not limited to, the
11following:
12        (1) Ensuring that psilocybin products have labeling
13    that communicates the following:
14            (A) Health and safety warnings.
15            (B) If applicable, activation time.
16            (C) Potency.
17            (D) If applicable, serving size and the number of
18        servings included in a psilocybin product.
19            (E) Content of the psilocybin product.
20        (2) Labeling that is in accordance with applicable
21    State food labeling requirements for the same type of food
22    product or potable liquid when the food product or potable
23    liquid does not contain psilocybin.
24    (b) In adopting rules under this Act, the Department shall
25require all psilocybin products sold or transferred by a

 

 

SB2612- 89 -LRB103 34492 JAG 64324 b

1service center that holds a license issued under Section 100
2to be labeled in accordance with subsection (a) and rules
3adopted under subsection (a).
4    (c) In adopting rules under subsection (a), the
5Department:
6        (1) may establish different labeling standards for
7    different varieties and types of psilocybin products;
8        (2) shall consider the cost of a potential requirement
9    and how that cost will affect the cost to the ultimate
10    client; and
11        (3) may not adopt rules that are more restrictive than
12    is reasonably necessary to protect the public health and
13    safety.
 
14    Section 370. Preapproval of labels.
15    (a) The Department may by rule require a licensee to
16submit a label intended for use on a psilocybin product for
17preapproval by the Department before the licensee may sell or
18transfer a psilocybin product bearing the label. The
19Department shall determine whether a label submitted under
20this Section complies with Section 365 and any rule adopted
21under Section 365.
22    (b) The Department may impose a fee for submitting a label
23for preapproval under this Section that is reasonably
24calculated to not exceed the cost of administering this
25Section.
 

 

 

SB2612- 90 -LRB103 34492 JAG 64324 b

1    Section 375. Packaging requirements; rules.
2    (a) As is necessary to protect the public health and
3safety, and in consultation with the Department of Agriculture
4and the Illinois Liquor Control Commission, the Department
5shall adopt rules establishing standards for the packaging of
6psilocybin products, including, but not limited to, ensuring
7that psilocybin products are not marketed in a manner that is
8either untruthful or misleading, or otherwise creates a
9significant risk of harm to public health and safety.
10    (b) In adopting rules under this Act, the Department shall
11require all psilocybin products sold or transferred by a
12service center that holds a license issued under Section 100
13to be packaged in accordance with subsection (a) and rules
14adopted under subsection (a).
15    (c) In adopting rules under subsection (a), the
16Department:
17        (1) may establish different packaging standards for
18    different varieties and types of psilocybin products;
19        (2) may consider the effect on the environment of
20    requiring certain packaging;
21        (3) shall consider the cost of a potential requirement
22    and how that cost will affect the cost to the ultimate
23    client; and
24        (4) may not adopt rules that are more restrictive than
25    is reasonably necessary to protect the public health and

 

 

SB2612- 91 -LRB103 34492 JAG 64324 b

1    safety.
 
2    Section 380. Preapproval of packaging.
3    (a) The Department may by rule require a licensee to
4submit packaging intended for a psilocybin product for
5preapproval by the Department before the licensee may sell or
6transfer a psilocybin product packaged in the packaging. The
7Department shall determine whether packaging submitted under
8this Section complies with Section 375 and any rule adopted
9under Section 375.
10    (b) The Department may impose a fee for submitting
11packaging for preapproval under this Section that is
12reasonably calculated to not exceed the cost of administering
13this Section.
 
14    Section 385. Dosage requirements; rules.
15    (a) The Department shall adopt rules establishing the
16following:
17        (1) The maximum concentration of psilocybin that is
18    permitted in a single serving of a psilocybin product.
19        (2) The number of servings that are permitted in a
20    psilocybin product package.
21    (b) In adopting rules under this Act, the Department shall
22require all psilocybin products sold or transferred by a
23service center that holds a license under Section 100 to meet
24the concentration standards and packaging standards adopted by

 

 

SB2612- 92 -LRB103 34492 JAG 64324 b

1rule pursuant to this Section.
 
2    Section 390. Inspections. To ensure compliance with
3Sections 365 through 400 and any rule adopted under those
4Sections, the Department may inspect the premises of a person
5that holds a license under Section 85 or 100.
 
6    Section 395. Discipline of licensees. Subject to
7applicable provisions of law, if an applicant or licensee
8violates a provision of Sections 365 through 400 or a rule
9adopted under those Sections, the Department may refuse to
10issue or renew, or may suspend or revoke, a license issued
11under Section 85, 100, or 115.
 
12    Section 400. Civil penalties.
13    (a) In addition to any other liability or penalty provided
14by law, the Department may impose for each violation of a
15provision of Sections 365 through 400 or a rule adopted under
16those Sections, a civil penalty that does not exceed $500 for
17each day that the violation occurs.
18    (b) The Department shall impose civil penalties under this
19Section in the manner provided under applicable Illinois law.
20    (c) Moneys collected under this Section shall be deposited
21into the Psilocybin Control and Regulation Fund established
22under Section 205 and are continuously appropriated to the
23Department for the purpose of carrying out the duties,

 

 

SB2612- 93 -LRB103 34492 JAG 64324 b

1functions, and powers of the Department under this Act.
 
2    Section 405. Definitions. In this Section through Section
3475:
4    "Retail sale" means any transfer, exchange, gift, or
5barter of a psilocybin product by any person to a client.
6    "Retail sales price" means the price paid for a psilocybin
7product, excluding tax, to a service center operator by or on
8behalf of a client.
 
9    Section 410. Tax on retail sale of psilocybin products.
10    (a) A tax is hereby imposed upon the retail sale of
11psilocybin products in this State. The tax imposed by this
12Section is a direct tax on the client for which payment upon
13retail sale is required. The tax shall be collected at the
14point of sale of a psilocybin product by a service center
15operator at the time at which the retail sale occurs.
16    (b) The tax imposed under this Section shall be imposed at
17the rate of 15% of the retail sales price of psilocybin
18products.
19    (c) If the tax imposed under this Section does not equal an
20amount calculable to a whole cent, the tax shall be equal to
21the next higher whole cent.
22    (d) Except as otherwise provided by the Department of
23Revenue by rule, the amount of the tax shall be separately
24stated on an invoice, receipt, or other similar document that

 

 

SB2612- 94 -LRB103 34492 JAG 64324 b

1the service center operator provides to the client at the time
2at which the retail sale occurs.
3    (e) A person may not knowingly sell, purchase, install,
4transfer, or possess electronic devices or software programs
5for the purposes of the following:
6        (1) Hiding or removing records of retail sales of
7    psilocybin products.
8        (2) Falsifying records of retail sales of psilocybin
9    products.
10    (f) A service center operator may not discount a
11psilocybin product or offer a psilocybin product for free if
12the retail sale of the psilocybin product is made in
13conjunction with the retail sale of any other item or service.
14    (g) Subsection (f) does not affect any provision of this
15Act or any rule adopted by the Department pursuant to this Act
16that is related to the retail sale of psilocybin products.
17    (h) The Department shall regularly review the rate of tax
18under subsection (b) and make recommendations to the General
19Assembly regarding appropriate adjustments to the rate that
20will further the following purposes:
21        (1) Providing the Department with moneys sufficient to
22    administer and enforce this Act.
23        (2) Not providing the Department with moneys that
24    exceed, together with fees collected under this Act, the
25    cost of administering and enforcing this Act.
 

 

 

SB2612- 95 -LRB103 34492 JAG 64324 b

1    Section 415. Collection of tax.
2    (a) Except as otherwise provided in Sections 405 through
3475, the tax imposed upon a client under Section 410 shall be
4collected at the point of sale and remitted by each service
5center operator that engages in the retail sale of psilocybin
6products. The tax is considered a tax upon the service center
7operator that is required to collect the tax and the service
8center operator is considered a taxpayer.
9    (b) The service center operator shall file a return to the
10Department of Revenue on or before the last day of January,
11April, July, and October of each year for the previous
12calendar quarter.
13    (c) The service center operator shall pay the tax to the
14Department of Revenue in the form and manner prescribed by the
15Department of Revenue, but not later than with each quarterly
16return, without regard to an extension granted under
17subsection (e).
18    (d) Service center operators shall file the returns
19required under this Section regardless of whether any tax is
20owed.
21    (e) For good cause, the Department of Revenue may extend
22the time for filing a return under this Section. The extension
23may be granted at any time if a written request is filed with
24the Department of Revenue during or prior to the period for
25which the extension may be granted. The Department of Revenue
26may not grant an extension of more than 30 days.

 

 

SB2612- 96 -LRB103 34492 JAG 64324 b

1    (f) Interest shall be added at a rate established by the
2Department of Revenue from the time the return was originally
3required to be filed to the time of payment.
4    (g) If a service center operator fails to file a return or
5pay the tax as required by this Section, the Department of
6Revenue shall impose a penalty in the manner provided under
7applicable Illinois law.
8    (h) Except as provided in subsections (i) and (j), the
9period prescribed for the Department of Revenue to allow or
10make a refund of any overpayment of tax paid under Sections 405
11through 475 is as provided under applicable Illinois law.
12    (i) The Department of Revenue shall first apply any
13overpayment of tax by a service center operator to any
14psilocybin tax that is owed by the service center operator.
15    If after any offset against any delinquent amount the
16overpayment of tax remains greater than $1,000, the remaining
17refund shall be applied as a credit against the next
18subsequent calendar quarter as an estimated payment.
19    (j) The Department of Revenue may not make a refund of or
20credit any overpayment of tax under Sections 405 through 475
21that was credited to the account of a service center operator
22under subsection (i) if the return for that tax period is not
23filed within 3 years after the due date of that return.
 
24    Section 420. Psilocybin revenue estimate.
25    (a) Not later than 30 days before the beginning of each

 

 

SB2612- 97 -LRB103 34492 JAG 64324 b

1calendar quarter, the Department of Revenue shall forecast and
2prepare an estimate of the revenue that will be received
3during the remainder of the current biennium and subsequent 3
4biennia pursuant to the tax imposed under Section 410. The
5estimate may be made on the basis of all pertinent information
6available to the Department of Revenue. Upon making the
7estimate, the Department of Revenue shall report the estimate
8to the Commission on Government Forecasting and Accountability
9and the Comptroller.
10    (b) The Department shall provide the Department of Revenue
11with any information necessary for the Department of Revenue
12to perform its duties under this Section.
 
13    Section 425. Enforcement.
14    (a) Every person who collects any amount under Section 415
15shall hold the same in trust for the State of Illinois and for
16the payment thereof to the Department of Revenue in the manner
17and at the time provided in Section 415.
18    (b) If a service center operator fails to remit any amount
19collected, the Department of Revenue may enforce collection in
20the manner provided in Article 11 of the Illinois Income Tax
21Act.
22    (c) In the case of a service center operator that is
23assessed pursuant to relevant provisions of Illinois law, the
24Department of Revenue may issue a notice of liability to any
25officer, employee, or member of the service center operator

 

 

SB2612- 98 -LRB103 34492 JAG 64324 b

1within 3 years after the time of assessment. Within 30 days
2after the date the notice of liability is mailed to the
3officer, employee, or member, the officer, employee, or member
4shall pay the assessment, plus penalties and interest, or
5advise the Department of Revenue in writing of objections to
6the liability and, if desired, request a conference. A
7conference shall be governed by the provisions of Illinois law
8pertaining to a conference requested from a notice of
9deficiency.
10    After a conference or, if no conference is requested, a
11determination of the issues considering the written
12objections, the Department of Revenue shall mail the officer,
13employee, or member a conference letter affirming, canceling,
14or adjusting the notice of liability. Within 90 days after the
15date the conference letter is mailed to the officer, employee,
16or member, the officer, employee, or member shall pay the
17assessment, plus penalties and interest, or appeal to the tax
18court in the manner provided for an appeal from a notice of
19assessment.
20    If the Department of Revenue does not receive payment or
21written objection to the notice of liability within 30 days
22after the notice of liability was mailed, the notice of
23liability becomes final. In that event, the officer, employee
24or member may appeal the notice of liability to the tax court
25within 90 days after it became final in the manner provided for
26an appeal from a notice of assessment.

 

 

SB2612- 99 -LRB103 34492 JAG 64324 b

1    (d) In the case of a failure to file a return by the due
2date, the Department of Revenue, in addition to any action
3under State law, may send a notice of determination and
4assessment to any officer, employee, or member any time within
53 years after the assessment. The time of assessment against
6the officer, employee, or member is 30 days after the date the
7notice of determination and assessment is mailed. Within 30
8days after the date the notice of determination and assessment
9is mailed to the officer, employee, or member, the officer,
10employee, or member shall pay the assessment, plus penalties
11and interest, or advise the Department of Revenue in writing
12of objections to the assessment and, if desired, request a
13conference. A conference shall be governed by the provisions
14of Illinois law pertaining to a conference requested from a
15notice of deficiency.
16    After a conference or, if no conference is requested, a
17determination of the issues considering the written
18objections, the Department of Revenue shall mail the officer,
19employee, or member a conference letter affirming, canceling,
20or adjusting the notice of determination and assessment.
21Within 90 days after the date the conference letter is mailed
22to the officer, employee, or member, the officer, employee, or
23member shall pay the assessment, plus penalties and interest,
24or appeal in the manner provided for an appeal from a notice of
25assessment.
26    If the Department of Revenue does not receive payment or

 

 

SB2612- 100 -LRB103 34492 JAG 64324 b

1written objection to the notice of determination and
2assessment within 30 days after the notice of determination
3and assessment was mailed, the notice of determination and
4assessment becomes final. In that event, the officer,
5employee, or member may appeal the notice of determination and
6assessment to the tax court within 90 days after it became
7final in the manner provided for an appeal from a notice of
8assessment.
9    (e) More than one officer or employee of a corporation may
10be held jointly and severally liable for payment of taxes.
11    Notwithstanding the confidentiality provisions of Section
12465, if more than one officer or employee of a corporation may
13be held jointly and severally liable for payment of taxes, the
14Department of Revenue may require any or all of the officers,
15members, or employees who may be held liable to appear before
16the Department of Revenue for a joint determination of
17liability. The Department of Revenue shall notify each
18officer, member, or employee of the time and place set for the
19determination of liability.
20    Each person notified of a joint determination under this
21subsection shall appear and present such information as is
22necessary to establish that person's liability or nonliability
23for payment of taxes to the Department of Revenue. If a person
24who was notified fails to appear, the Department of Revenue
25shall make its determination on the basis of all the
26information and evidence presented. The Department of

 

 

SB2612- 101 -LRB103 34492 JAG 64324 b

1Revenue's determination is binding on all persons notified and
2required to appear under this subsection.
3    If an appeal is taken to the Illinois Independent Tax
4Tribunal pursuant to Section 465 by any person determined to
5be liable for unpaid taxes under this subsection, each person
6required to appear before the Department of Revenue under this
7subsection shall be impleaded by the plaintiff. The Department
8of Revenue may implead any officer, employee, or member who
9may be held jointly and severally liable for the payment of
10taxes. Each person impleaded under this paragraph shall be
11made a party to the action before the Illinois Independent Tax
12Tribunal and shall make available to the Illinois Independent
13Tax Tribunal the information that was presented before the
14Department of Revenue, as well as other information that may
15be presented to the Illinois Independent Tax Tribunal. The
16Illinois Independent Tax Tribunal may determine that one or
17more persons impleaded under this paragraph are liable for
18unpaid taxes without regard to any earlier determination by
19the Department of Revenue that an impleaded person was not
20liable for unpaid taxes. If a person required to appear before
21the Illinois Independent Tax Tribunal under this subsection
22fails or refuses to appear or bring such information in part or
23in whole, or is outside the jurisdiction of the Illinois
24Independent Tax Tribunal, the Illinois Independent Tax
25Tribunal shall make its determination on the basis of all the
26evidence introduced. Notwithstanding Section 465, the evidence

 

 

SB2612- 102 -LRB103 34492 JAG 64324 b

1constitutes a public record and shall be available to the
2parties and the Illinois Independent Tax Tribunal. The
3determination of the Illinois Independent Tax Tribunal is
4binding on all persons made parties to the action under this
5subsection.
6    (f) This Section may not be construed to preclude a
7determination by the Department of Revenue or the Illinois
8Independent Tax Tribunal that more than one officer, employee,
9or member are jointly and severally liable for unpaid taxes.
 
10    Section 430. Duty to keep receipts, invoices, and other
11records.
12    (a) A service center operator shall keep receipts,
13invoices, and other pertinent records related to retail sales
14of psilocybin products in the form required by the Department
15of Revenue. Each record shall be preserved for 5 years after
16the time to which the record relates or for as long as the
17service center operator retains the psilocybin products to
18which the record relates, whichever is later. During the
19retention period and at any time prior to the destruction of
20records, the Department of Revenue may give written notice to
21the service center operator not to destroy records described
22in the notice without written permission of the Department of
23Revenue. Notwithstanding any other provision of law, the
24Department of Revenue shall preserve reports and returns filed
25with the Department of Revenue for at least 5 years.

 

 

SB2612- 103 -LRB103 34492 JAG 64324 b

1    (b) The Department of Revenue or its authorized
2representative, upon oral or written demand, may make
3examinations of the books, papers, records, and equipment of
4persons making retail sales of psilocybin products and any
5other investigations as the Department of Revenue deems
6necessary to carry out the provisions of Sections 405 through
7475.
 
8    Section 435. Authority to require production of books,
9papers, accounts, and other information.
10    (a) The Department of Revenue has the authority, by order
11or subpoena to be served with the same force and effect and in
12the same manner as a subpoena is served in a civil action in
13the circuit court or the Illinois Independent Tax Tribunal, to
14require the production at any time and place the Department of
15Revenue designates of any books, papers, accounts, or other
16information necessary to carry out Sections 405 through 475.
17The Department of Revenue may require the attendance of any
18person having knowledge in the premises and may take testimony
19and require proof material for the information with power to
20administer oaths to the person.
21    (b) If a person fails to comply with a subpoena or order of
22the Department of Revenue or to produce or permit the
23examination or inspection of any books, papers, records, and
24equipment pertinent to an investigation or inquiry under
25Sections 405 through 475, or to testify to any matter

 

 

SB2612- 104 -LRB103 34492 JAG 64324 b

1regarding which the person is lawfully interrogated, the
2Department of Revenue may apply to the Illinois Independent
3Tax Tribunal or to the circuit court of the county in which the
4person resides or where the person is for an order to the
5person to attend and testify or otherwise to comply with the
6demand or request of the Department of Revenue. The Department
7of Revenue shall apply to the court by ex parte motion, upon
8which the court shall make an order requiring the person
9against whom the motion is directed to comply with the request
10or demand of the Department of Revenue within 10 days after the
11service of the order, or within the additional time granted by
12the court, or to justify the failure within that time. The
13order shall be served upon the person to whom it is directed in
14the manner required by this State for service of process,
15which service is required to confer jurisdiction upon the
16court. Failure to obey any order issued by the court under this
17Section is contempt of court. The remedy provided by this
18Section is in addition to other remedies, civil or criminal,
19existing under the tax laws or other laws of this State.
 
20    Section 440. Disclosure of information.
21    (a) Notwithstanding the confidentiality provisions of
22Section 465, the Department of Revenue may disclose
23information received under applicable Illinois law and
24Sections 405 through 475 to the Department to carry out the
25provisions of this Act.

 

 

SB2612- 105 -LRB103 34492 JAG 64324 b

1    (b) The Department may disclose information obtained
2pursuant to this Act to the Department of Revenue for the
3purpose of carrying out the provisions of this Act.
 
4    Section 445. Right to appeal determination of tax
5liability. Except as otherwise provided in this Act, a person
6aggrieved by an act or determination of the Department of
7Revenue or its authorized agent under applicable Illinois law
8and Sections 405 through 475 may appeal, within 90 days after
9the act or determination, to the Illinois Independent Tax
10Tribunal in the manner provided under applicable Illinois law.
11These appeal rights are the exclusive remedy available to
12determine the person's liability for the tax imposed under
13Sections 405 through 475.
 
14    Section 450. Duty to return excess tax collected.
15    (a) When an amount represented by a service center
16operator at retail to a client as constituting the tax imposed
17under Sections 405 through 475 of this Act is computed upon an
18amount that is not taxable or is in excess of the taxable
19amount and is actually paid by the client to the service center
20operator, the excess tax paid shall be returned by the service
21center operator to the client upon written notification by the
22Department of Revenue or the client.
23    The written notification must contain information
24necessary to determine the validity of the client's claim.

 

 

SB2612- 106 -LRB103 34492 JAG 64324 b

1    (b) If the service center operator does not return the
2excess tax within 60 days after mailing of the written
3notification required under subsection (a), the client may
4appeal to the Department of Revenue for a refund of the amount
5of the excess tax in the manner and within the time allowed
6under rules adopted by the Department of Revenue.
7    (c) If excess tax is returned to the client by the
8Department of Revenue, the Department of Revenue may issue a
9notice of deficiency for the excess tax to the service center
10operator in the manner provided under applicable Illinois law.
 
11    Section 455. Retention of portions of tax to pay for
12expenses incurred. For the purpose of compensating service
13center operators for expenses incurred in collecting the tax
14imposed under Section 410, each service center operator is
15permitted to deduct and retain 2% of the amount of taxes that
16are collected by the service center operator from all retail
17sales of psilocybin products conducted by the service center
18operator.
 
19    Section 460. Duties and powers of the Department of
20Revenue.
21    (a) The Department of Revenue shall administer and enforce
22Sections 405 through 475. The Department of Revenue is
23authorized to establish rules and procedures for the
24implementation and enforcement of Sections 405 through 475

 

 

SB2612- 107 -LRB103 34492 JAG 64324 b

1that are consistent with Sections 405 through 475 and that the
2Department of Revenue considers necessary and appropriate to
3administer and enforce Sections 405 through 475.
4    (b) The Department shall enter into an agreement with the
5Department of Revenue for the purpose of administering and
6enforcing those provisions of Sections 405 through 475, and
7rules or procedures established for the purpose of
8implementing and enforcing Sections 405 through 475, that the
9Department and the Department of Revenue determine are
10necessary for the effective and efficient administration,
11implementation, and enforcement of Sections 405 through 475.
 
12    Section 465. Applicability of tax laws. Except as
13otherwise provided in Sections 405 through 475 or where the
14context requires otherwise, the provisions of applicable
15Illinois law as to the audit and examination of returns,
16periods of limitation, determination of and notices of
17deficiencies, assessments, collections, liens, delinquencies,
18claims for refund and refunds, conferences, appeals to the
19Illinois Independent Tax Tribunal or the Department of
20Revenue, stays of collection pending appeal, confidentiality
21of returns and the penalties relative thereto, and the
22procedures relating thereto, apply to the determinations of
23taxes, penalties, and interest under Sections 405 through 475.
 
24    Section 470. Illinois Psilocybin Fund. The Illinois

 

 

SB2612- 108 -LRB103 34492 JAG 64324 b

1Psilocybin Fund is created as a special fund in the State
2treasury. The Fund shall consist of moneys transferred to the
3Fund under Section 475. The Department of Revenue shall
4certify quarterly the amount of moneys available in the
5Illinois Psilocybin Fund. The Department of Revenue shall
6transfer quarterly the moneys in the Illinois Psilocybin Fund
7to the Psilocybin Control and Regulation Fund.
 
8    Section 475. Illinois Psilocybin Fund; payment of
9expenses. All moneys received by the Department of Revenue
10under Sections 405 through this Section shall be deposited
11into the Illinois Psilocybin Fund. The Department of Revenue
12may pay expenses for the administration and enforcement of
13Sections 405 through this Section out of moneys received from
14the tax imposed under Section 410. Amounts necessary to pay
15administrative and enforcement expenses are continuously
16appropriated to the Department of Revenue from the Illinois
17Psilocybin Fund.
 
18    Section 480. Adoption of ordinances.
19    (a) The governing body of a city or county may adopt
20ordinances to be referred to the electors of the city or county
21as described in subsection (b) that prohibit or allow the
22establishment of any one or more of the following in the area
23subject to the jurisdiction of the city or in the
24unincorporated area subject to the jurisdiction of the county:

 

 

SB2612- 109 -LRB103 34492 JAG 64324 b

1        (1) Psilocybin product manufacturers that hold a
2    license issued under Section 85.
3        (2) Service center operators that hold a license
4    issued under 100.
5        (3) Any combination of the entities described in
6    paragraphs (1) and (2).
7    (b) If the governing body of a city or county adopts an
8ordinance under this Section, the governing body shall submit
9the measure of the ordinance to the electors of the city or
10county for approval at the next statewide general election.
11    (c) If the governing body of a city or county adopts an
12ordinance under this Section, the governing body must provide
13the text of the ordinance to the Department.
14    (d) Upon receiving notice of a prohibition under
15subsection (c), the Department shall discontinue licensing
16those premises to which the prohibition applies until the date
17of the next statewide general election.
18    (e) If an allowance is approved at the next statewide
19general election under subsection (b), the Department shall
20begin licensing the premises to which the allowance applies on
21the first business day of the January immediately following
22the date of the next statewide general election.
23    (f) Notwithstanding any other provision of law, a city or
24county that adopts an ordinance under this Section that
25prohibits the establishment of an entity described in
26subsection (a) may not impose a tax or fee on the manufacturing

 

 

SB2612- 110 -LRB103 34492 JAG 64324 b

1or sale of psilocybin products.
 
2    Section 485. Incorporation by reference. All of the
3provisions of Sections 4, 5, 5a, 5b, 5c, 5d, 5e, 5f, 5g, 5h,
45i, 5j, 6, 6a, 6b, 6c, 8, 9, 10, 11, 11a, and 12 of the
5Retailers' Occupation Tax Act, and all applicable provisions
6of the Uniform Penalty and Interest Act that are not
7inconsistent with this Act, apply to clients, legal entities,
8licensees, licensee representatives, psilocybin product
9manufacturers, service centers, service center operators, and
10facilitators to the same extent as if those provisions were
11included in this Act. References in the incorporated Sections
12of the Retailers' Occupation Tax Act to retailers, to sellers,
13or to persons engaged in the business of selling tangible
14personal property mean distributors when used in this Act.
15References in the incorporated Sections to sales of tangible
16personal property mean sales of tobacco products when used in
17this Act.
 
18    Section 490. Registration under the Retailers' Occupation
19Tax Act. A retailer maintaining a place of business in this
20State, if required to register under the Retailers' Occupation
21Tax Act, need not obtain an additional Certificate of
22Registration under this Act, but shall be deemed to be
23sufficiently registered by virtue of his being registered
24under the Retailers' Occupation Tax Act. Every retailer

 

 

SB2612- 111 -LRB103 34492 JAG 64324 b

1maintaining a place of business in this State, if not required
2to register under the Retailers' Occupation Tax Act, shall
3apply to the Department of Revenue (upon a form prescribed and
4furnished by the Department of Revenue) for a Certificate of
5Registration under this Act. In completing such application,
6the applicant shall furnish such information as the Department
7of Revenue may reasonably require. Upon approval of an
8application for Certificate of Registration, the Department of
9Revenue shall issue, without charge, a Certificate of
10Registration to the applicant. Such Certificate of
11Registration shall be displayed at the address which the
12applicant states in his or her application to be the principal
13place of business or location from which he or she will act as
14a retailer in this State. If the applicant will act as a
15retailer in this State from other places of business or
16locations, he shall list the addresses of such additional
17places of business or locations in this application for
18Certificate of Registration, and the Department of Revenue
19shall issue a Sub-Certificate of Registration to the applicant
20for each such additional place of business or location. Each
21Sub-Certificate of Registration shall be conspicuously
22displayed at the place for which it is issued. Such
23Sub-Certificate of Registration shall bear the same
24registration number as that appearing upon the Certificate of
25Registration to which such Sub-Certificates relate. Where a
26retailer operates more than one place of business which is

 

 

SB2612- 112 -LRB103 34492 JAG 64324 b

1subject to registration under this Section and such businesses
2are substantially different in character or are engaged in
3under different trade names or are engaged in under other
4substantially dissimilar circumstances (so that it is more
5practicable, from an accounting, auditing, or bookkeeping
6standpoint, for such businesses to be separately registered),
7the Department of Revenue may require or permit such person to
8apply for and obtain a separate Certificate of Registration
9for each such business or for any of such businesses instead of
10registering such person, as to all such businesses, under a
11single Certificate of Registration supplemented by related
12Sub-Certificates of Registration. No Certificate of
13Registration shall be issued to any person who is in default to
14the State of Illinois for moneys due hereunder.
15    The Department of Revenue may, in its discretion, upon
16application, authorize the collection of the tax herein
17imposed by any retailer not maintaining a place of business
18within this State, who, to the satisfaction of the Department
19of Revenue, furnishes adequate security to insure collection
20and payment of the tax. Such retailer shall be issued, without
21charge, a permit to collect such tax. When so authorized, it
22shall be the duty of such retailer to collect the tax upon all
23tangible personal property sold to his knowledge for use
24within this State, in the same manner and subject to the same
25requirements, including the furnishing of a receipt to the
26purchaser (if demanded by the purchaser), as a retailer

 

 

SB2612- 113 -LRB103 34492 JAG 64324 b

1maintaining a place of business within this State. The receipt
2given to the purchaser shall be sufficient to relieve him or
3her from further liability for the tax to which such receipt
4may refer. Such permit may be revoked by the Department as
5provided herein.
 
6    Section 497. Severability. The provisions of this Act are
7severable under Section 1.31 of the Statute on Statutes.
 
8    Section 500. The Criminal Identification Act is amended by
9changing Section 5.2 as follows:
 
10    (20 ILCS 2630/5.2)
11    (Text of Section before amendment by P.A. 103-35)
12    Sec. 5.2. Expungement, sealing, and immediate sealing.
13    (a) General Provisions.
14        (1) Definitions. In this Act, words and phrases have
15    the meanings set forth in this subsection, except when a
16    particular context clearly requires a different meaning.
17            (A) The following terms shall have the meanings
18        ascribed to them in the following Sections of the
19        Unified Code of Corrections:
20                Business Offense, Section 5-1-2.
21                Charge, Section 5-1-3.
22                Court, Section 5-1-6.
23                Defendant, Section 5-1-7.

 

 

SB2612- 114 -LRB103 34492 JAG 64324 b

1                Felony, Section 5-1-9.
2                Imprisonment, Section 5-1-10.
3                Judgment, Section 5-1-12.
4                Misdemeanor, Section 5-1-14.
5                Offense, Section 5-1-15.
6                Parole, Section 5-1-16.
7                Petty Offense, Section 5-1-17.
8                Probation, Section 5-1-18.
9                Sentence, Section 5-1-19.
10                Supervision, Section 5-1-21.
11                Victim, Section 5-1-22.
12            (B) As used in this Section, "charge not initiated
13        by arrest" means a charge (as defined by Section 5-1-3
14        of the Unified Code of Corrections) brought against a
15        defendant where the defendant is not arrested prior to
16        or as a direct result of the charge.
17            (C) "Conviction" means a judgment of conviction or
18        sentence entered upon a plea of guilty or upon a
19        verdict or finding of guilty of an offense, rendered
20        by a legally constituted jury or by a court of
21        competent jurisdiction authorized to try the case
22        without a jury. An order of supervision successfully
23        completed by the petitioner is not a conviction. An
24        order of qualified probation (as defined in subsection
25        (a)(1)(J)) successfully completed by the petitioner is
26        not a conviction. An order of supervision or an order

 

 

SB2612- 115 -LRB103 34492 JAG 64324 b

1        of qualified probation that is terminated
2        unsatisfactorily is a conviction, unless the
3        unsatisfactory termination is reversed, vacated, or
4        modified and the judgment of conviction, if any, is
5        reversed or vacated.
6            (D) "Criminal offense" means a petty offense,
7        business offense, misdemeanor, felony, or municipal
8        ordinance violation (as defined in subsection
9        (a)(1)(H)). As used in this Section, a minor traffic
10        offense (as defined in subsection (a)(1)(G)) shall not
11        be considered a criminal offense.
12            (E) "Expunge" means to physically destroy the
13        records or return them to the petitioner and to
14        obliterate the petitioner's name from any official
15        index or public record, or both. Nothing in this Act
16        shall require the physical destruction of the circuit
17        court file, but such records relating to arrests or
18        charges, or both, ordered expunged shall be impounded
19        as required by subsections (d)(9)(A)(ii) and
20        (d)(9)(B)(ii).
21            (F) As used in this Section, "last sentence" means
22        the sentence, order of supervision, or order of
23        qualified probation (as defined by subsection
24        (a)(1)(J)), for a criminal offense (as defined by
25        subsection (a)(1)(D)) that terminates last in time in
26        any jurisdiction, regardless of whether the petitioner

 

 

SB2612- 116 -LRB103 34492 JAG 64324 b

1        has included the criminal offense for which the
2        sentence or order of supervision or qualified
3        probation was imposed in his or her petition. If
4        multiple sentences, orders of supervision, or orders
5        of qualified probation terminate on the same day and
6        are last in time, they shall be collectively
7        considered the "last sentence" regardless of whether
8        they were ordered to run concurrently.
9            (G) "Minor traffic offense" means a petty offense,
10        business offense, or Class C misdemeanor under the
11        Illinois Vehicle Code or a similar provision of a
12        municipal or local ordinance.
13            (G-5) "Minor Cannabis Offense" means a violation
14        of Section 4 or 5 of the Cannabis Control Act
15        concerning not more than 30 grams of any substance
16        containing cannabis, provided the violation did not
17        include a penalty enhancement under Section 7 of the
18        Cannabis Control Act and is not associated with an
19        arrest, conviction or other disposition for a violent
20        crime as defined in subsection (c) of Section 3 of the
21        Rights of Crime Victims and Witnesses Act.
22            (H) "Municipal ordinance violation" means an
23        offense defined by a municipal or local ordinance that
24        is criminal in nature and with which the petitioner
25        was charged or for which the petitioner was arrested
26        and released without charging.

 

 

SB2612- 117 -LRB103 34492 JAG 64324 b

1            (I) "Petitioner" means an adult or a minor
2        prosecuted as an adult who has applied for relief
3        under this Section.
4            (J) "Qualified probation" means an order of
5        probation under Section 10 of the Cannabis Control
6        Act, Section 410 of the Illinois Controlled Substances
7        Act, Section 70 of the Methamphetamine Control and
8        Community Protection Act, Section 5-6-3.3 or 5-6-3.4
9        of the Unified Code of Corrections, Section
10        12-4.3(b)(1) and (2) of the Criminal Code of 1961 (as
11        those provisions existed before their deletion by
12        Public Act 89-313), Section 10-102 of the Illinois
13        Alcoholism and Other Drug Dependency Act, Section
14        40-10 of the Substance Use Disorder Act, or Section 10
15        of the Steroid Control Act. For the purpose of this
16        Section, "successful completion" of an order of
17        qualified probation under Section 10-102 of the
18        Illinois Alcoholism and Other Drug Dependency Act and
19        Section 40-10 of the Substance Use Disorder Act means
20        that the probation was terminated satisfactorily and
21        the judgment of conviction was vacated.
22            (K) "Seal" means to physically and electronically
23        maintain the records, unless the records would
24        otherwise be destroyed due to age, but to make the
25        records unavailable without a court order, subject to
26        the exceptions in Sections 12 and 13 of this Act. The

 

 

SB2612- 118 -LRB103 34492 JAG 64324 b

1        petitioner's name shall also be obliterated from the
2        official index required to be kept by the circuit
3        court clerk under Section 16 of the Clerks of Courts
4        Act, but any index issued by the circuit court clerk
5        before the entry of the order to seal shall not be
6        affected.
7            (L) "Sexual offense committed against a minor"
8        includes, but is not limited to, the offenses of
9        indecent solicitation of a child or criminal sexual
10        abuse when the victim of such offense is under 18 years
11        of age.
12            (M) "Terminate" as it relates to a sentence or
13        order of supervision or qualified probation includes
14        either satisfactory or unsatisfactory termination of
15        the sentence, unless otherwise specified in this
16        Section. A sentence is terminated notwithstanding any
17        outstanding financial legal obligation.
18        (2) Minor Traffic Offenses. Orders of supervision or
19    convictions for minor traffic offenses shall not affect a
20    petitioner's eligibility to expunge or seal records
21    pursuant to this Section.
22        (2.5) Commencing 180 days after July 29, 2016 (the
23    effective date of Public Act 99-697), the law enforcement
24    agency issuing the citation shall automatically expunge,
25    on or before January 1 and July 1 of each year, the law
26    enforcement records of a person found to have committed a

 

 

SB2612- 119 -LRB103 34492 JAG 64324 b

1    civil law violation of subsection (a) of Section 4 of the
2    Cannabis Control Act or subsection (c) of Section 3.5 of
3    the Drug Paraphernalia Control Act in the law enforcement
4    agency's possession or control and which contains the
5    final satisfactory disposition which pertain to the person
6    issued a citation for that offense. The law enforcement
7    agency shall provide by rule the process for access,
8    review, and to confirm the automatic expungement by the
9    law enforcement agency issuing the citation. Commencing
10    180 days after July 29, 2016 (the effective date of Public
11    Act 99-697), the clerk of the circuit court shall expunge,
12    upon order of the court, or in the absence of a court order
13    on or before January 1 and July 1 of each year, the court
14    records of a person found in the circuit court to have
15    committed a civil law violation of subsection (a) of
16    Section 4 of the Cannabis Control Act or subsection (c) of
17    Section 3.5 of the Drug Paraphernalia Control Act in the
18    clerk's possession or control and which contains the final
19    satisfactory disposition which pertain to the person
20    issued a citation for any of those offenses.
21            (2.6) Commencing 180 days after the effective date
22    of this amendatory Act of the 103rd General Assembly, the
23    law enforcement agency issuing the citation shall
24    automatically expunge, on or before January 1 and July 1
25    of each year, the law enforcement records of a person
26    found to have committed a violation of subsection (e) of

 

 

SB2612- 120 -LRB103 34492 JAG 64324 b

1    Section 401 of the Illinois Controlled Substances Act by
2    possessing psilocybin and psilocin or of subsection (a) of
3    Section 3.5 of the Drug Paraphernalia Control Act by
4    possessing paraphernalia used in relation to psilocybin
5    and psilocin in the law enforcement agency's possession or
6    control and which contains the final satisfactory
7    disposition which pertain to the person issued a citation
8    for that offense. The law enforcement agency shall provide
9    by rule the process for access, review, and to confirm the
10    automatic expungement by the law enforcement agency
11    issuing the citation. Commencing 180 days after the
12    effective date of this amendatory Act of the 103rd General
13    Assembly, the clerk of the circuit court shall expunge,
14    upon order of the court, or in the absence of a court order
15    on or before January 1 and July 1 of each year, the court
16    records of a person found in the circuit court to have
17    committed a violation of subsection (e) of Section 401 of
18    the Illinois Controlled Substances Act by possessing
19    psilocybin and psilocin or of subsection (a) of Section
20    3.5 of the Drug Paraphernalia Control Act by possessing
21    paraphernalia used in relation to psilocybin and psilocin
22    in the clerk's possession or control and which contains
23    the final satisfactory disposition which pertain to the
24    person issued a citation for any of those offenses.
25        (3) Exclusions. Except as otherwise provided in
26    subsections (b)(5), (b)(6), (b)(8), (e), (e-5), and (e-6)

 

 

SB2612- 121 -LRB103 34492 JAG 64324 b

1    of this Section, the court shall not order:
2            (A) the sealing or expungement of the records of
3        arrests or charges not initiated by arrest that result
4        in an order of supervision for or conviction of: (i)
5        any sexual offense committed against a minor; (ii)
6        Section 11-501 of the Illinois Vehicle Code or a
7        similar provision of a local ordinance; or (iii)
8        Section 11-503 of the Illinois Vehicle Code or a
9        similar provision of a local ordinance, unless the
10        arrest or charge is for a misdemeanor violation of
11        subsection (a) of Section 11-503 or a similar
12        provision of a local ordinance, that occurred prior to
13        the offender reaching the age of 25 years and the
14        offender has no other conviction for violating Section
15        11-501 or 11-503 of the Illinois Vehicle Code or a
16        similar provision of a local ordinance.
17            (B) the sealing or expungement of records of minor
18        traffic offenses (as defined in subsection (a)(1)(G)),
19        unless the petitioner was arrested and released
20        without charging.
21            (C) the sealing of the records of arrests or
22        charges not initiated by arrest which result in an
23        order of supervision or a conviction for the following
24        offenses:
25                (i) offenses included in Article 11 of the
26            Criminal Code of 1961 or the Criminal Code of 2012

 

 

SB2612- 122 -LRB103 34492 JAG 64324 b

1            or a similar provision of a local ordinance,
2            except Section 11-14 and a misdemeanor violation
3            of Section 11-30 of the Criminal Code of 1961 or
4            the Criminal Code of 2012, or a similar provision
5            of a local ordinance;
6                (ii) Section 11-1.50, 12-3.4, 12-15, 12-30,
7            26-5, or 48-1 of the Criminal Code of 1961 or the
8            Criminal Code of 2012, or a similar provision of a
9            local ordinance;
10                (iii) Section 12-3.1 or 12-3.2 of the Criminal
11            Code of 1961 or the Criminal Code of 2012, or
12            Section 125 of the Stalking No Contact Order Act,
13            or Section 219 of the Civil No Contact Order Act,
14            or a similar provision of a local ordinance;
15                (iv) Class A misdemeanors or felony offenses
16            under the Humane Care for Animals Act; or
17                (v) any offense or attempted offense that
18            would subject a person to registration under the
19            Sex Offender Registration Act.
20            (D) (blank).
21    (b) Expungement.
22        (1) A petitioner may petition the circuit court to
23    expunge the records of his or her arrests and charges not
24    initiated by arrest when each arrest or charge not
25    initiated by arrest sought to be expunged resulted in: (i)
26    acquittal, dismissal, or the petitioner's release without

 

 

SB2612- 123 -LRB103 34492 JAG 64324 b

1    charging, unless excluded by subsection (a)(3)(B); (ii) a
2    conviction which was vacated or reversed, unless excluded
3    by subsection (a)(3)(B); (iii) an order of supervision and
4    such supervision was successfully completed by the
5    petitioner, unless excluded by subsection (a)(3)(A) or
6    (a)(3)(B); or (iv) an order of qualified probation (as
7    defined in subsection (a)(1)(J)) and such probation was
8    successfully completed by the petitioner.
9        (1.5) When a petitioner seeks to have a record of
10    arrest expunged under this Section, and the offender has
11    been convicted of a criminal offense, the State's Attorney
12    may object to the expungement on the grounds that the
13    records contain specific relevant information aside from
14    the mere fact of the arrest.
15        (2) Time frame for filing a petition to expunge.
16            (A) When the arrest or charge not initiated by
17        arrest sought to be expunged resulted in an acquittal,
18        dismissal, the petitioner's release without charging,
19        or the reversal or vacation of a conviction, there is
20        no waiting period to petition for the expungement of
21        such records.
22            (B) When the arrest or charge not initiated by
23        arrest sought to be expunged resulted in an order of
24        supervision, successfully completed by the petitioner,
25        the following time frames will apply:
26                (i) Those arrests or charges that resulted in

 

 

SB2612- 124 -LRB103 34492 JAG 64324 b

1            orders of supervision under Section 3-707, 3-708,
2            3-710, or 5-401.3 of the Illinois Vehicle Code or
3            a similar provision of a local ordinance, or under
4            Section 11-1.50, 12-3.2, or 12-15 of the Criminal
5            Code of 1961 or the Criminal Code of 2012, or a
6            similar provision of a local ordinance, shall not
7            be eligible for expungement until 5 years have
8            passed following the satisfactory termination of
9            the supervision.
10                (i-5) Those arrests or charges that resulted
11            in orders of supervision for a misdemeanor
12            violation of subsection (a) of Section 11-503 of
13            the Illinois Vehicle Code or a similar provision
14            of a local ordinance, that occurred prior to the
15            offender reaching the age of 25 years and the
16            offender has no other conviction for violating
17            Section 11-501 or 11-503 of the Illinois Vehicle
18            Code or a similar provision of a local ordinance
19            shall not be eligible for expungement until the
20            petitioner has reached the age of 25 years.
21                (ii) Those arrests or charges that resulted in
22            orders of supervision for any other offenses shall
23            not be eligible for expungement until 2 years have
24            passed following the satisfactory termination of
25            the supervision.
26            (C) When the arrest or charge not initiated by

 

 

SB2612- 125 -LRB103 34492 JAG 64324 b

1        arrest sought to be expunged resulted in an order of
2        qualified probation, successfully completed by the
3        petitioner, such records shall not be eligible for
4        expungement until 5 years have passed following the
5        satisfactory termination of the probation.
6        (3) Those records maintained by the Illinois State
7    Police for persons arrested prior to their 17th birthday
8    shall be expunged as provided in Section 5-915 of the
9    Juvenile Court Act of 1987.
10        (4) Whenever a person has been arrested for or
11    convicted of any offense, in the name of a person whose
12    identity he or she has stolen or otherwise come into
13    possession of, the aggrieved person from whom the identity
14    was stolen or otherwise obtained without authorization,
15    upon learning of the person having been arrested using his
16    or her identity, may, upon verified petition to the chief
17    judge of the circuit wherein the arrest was made, have a
18    court order entered nunc pro tunc by the Chief Judge to
19    correct the arrest record, conviction record, if any, and
20    all official records of the arresting authority, the
21    Illinois State Police, other criminal justice agencies,
22    the prosecutor, and the trial court concerning such
23    arrest, if any, by removing his or her name from all such
24    records in connection with the arrest and conviction, if
25    any, and by inserting in the records the name of the
26    offender, if known or ascertainable, in lieu of the

 

 

SB2612- 126 -LRB103 34492 JAG 64324 b

1    aggrieved's name. The records of the circuit court clerk
2    shall be sealed until further order of the court upon good
3    cause shown and the name of the aggrieved person
4    obliterated on the official index required to be kept by
5    the circuit court clerk under Section 16 of the Clerks of
6    Courts Act, but the order shall not affect any index
7    issued by the circuit court clerk before the entry of the
8    order. Nothing in this Section shall limit the Illinois
9    State Police or other criminal justice agencies or
10    prosecutors from listing under an offender's name the
11    false names he or she has used.
12        (5) Whenever a person has been convicted of criminal
13    sexual assault, aggravated criminal sexual assault,
14    predatory criminal sexual assault of a child, criminal
15    sexual abuse, or aggravated criminal sexual abuse, the
16    victim of that offense may request that the State's
17    Attorney of the county in which the conviction occurred
18    file a verified petition with the presiding trial judge at
19    the petitioner's trial to have a court order entered to
20    seal the records of the circuit court clerk in connection
21    with the proceedings of the trial court concerning that
22    offense. However, the records of the arresting authority
23    and the Illinois State Police concerning the offense shall
24    not be sealed. The court, upon good cause shown, shall
25    make the records of the circuit court clerk in connection
26    with the proceedings of the trial court concerning the

 

 

SB2612- 127 -LRB103 34492 JAG 64324 b

1    offense available for public inspection.
2        (6) If a conviction has been set aside on direct
3    review or on collateral attack and the court determines by
4    clear and convincing evidence that the petitioner was
5    factually innocent of the charge, the court that finds the
6    petitioner factually innocent of the charge shall enter an
7    expungement order for the conviction for which the
8    petitioner has been determined to be innocent as provided
9    in subsection (b) of Section 5-5-4 of the Unified Code of
10    Corrections.
11        (7) Nothing in this Section shall prevent the Illinois
12    State Police from maintaining all records of any person
13    who is admitted to probation upon terms and conditions and
14    who fulfills those terms and conditions pursuant to
15    Section 10 of the Cannabis Control Act, Section 410 of the
16    Illinois Controlled Substances Act, Section 70 of the
17    Methamphetamine Control and Community Protection Act,
18    Section 5-6-3.3 or 5-6-3.4 of the Unified Code of
19    Corrections, Section 12-4.3 or subdivision (b)(1) of
20    Section 12-3.05 of the Criminal Code of 1961 or the
21    Criminal Code of 2012, Section 10-102 of the Illinois
22    Alcoholism and Other Drug Dependency Act, Section 40-10 of
23    the Substance Use Disorder Act, or Section 10 of the
24    Steroid Control Act.
25        (8) If the petitioner has been granted a certificate
26    of innocence under Section 2-702 of the Code of Civil

 

 

SB2612- 128 -LRB103 34492 JAG 64324 b

1    Procedure, the court that grants the certificate of
2    innocence shall also enter an order expunging the
3    conviction for which the petitioner has been determined to
4    be innocent as provided in subsection (h) of Section 2-702
5    of the Code of Civil Procedure.
6    (c) Sealing.
7        (1) Applicability. Notwithstanding any other provision
8    of this Act to the contrary, and cumulative with any
9    rights to expungement of criminal records, this subsection
10    authorizes the sealing of criminal records of adults and
11    of minors prosecuted as adults. Subsection (g) of this
12    Section provides for immediate sealing of certain records.
13        (2) Eligible Records. The following records may be
14    sealed:
15            (A) All arrests resulting in release without
16        charging;
17            (B) Arrests or charges not initiated by arrest
18        resulting in acquittal, dismissal, or conviction when
19        the conviction was reversed or vacated, except as
20        excluded by subsection (a)(3)(B);
21            (C) Arrests or charges not initiated by arrest
22        resulting in orders of supervision, including orders
23        of supervision for municipal ordinance violations,
24        successfully completed by the petitioner, unless
25        excluded by subsection (a)(3);
26            (D) Arrests or charges not initiated by arrest

 

 

SB2612- 129 -LRB103 34492 JAG 64324 b

1        resulting in convictions, including convictions on
2        municipal ordinance violations, unless excluded by
3        subsection (a)(3);
4            (E) Arrests or charges not initiated by arrest
5        resulting in orders of first offender probation under
6        Section 10 of the Cannabis Control Act, Section 410 of
7        the Illinois Controlled Substances Act, Section 70 of
8        the Methamphetamine Control and Community Protection
9        Act, or Section 5-6-3.3 of the Unified Code of
10        Corrections; and
11            (F) Arrests or charges not initiated by arrest
12        resulting in felony convictions unless otherwise
13        excluded by subsection (a) paragraph (3) of this
14        Section.
15        (3) When Records Are Eligible to Be Sealed. Records
16    identified as eligible under subsection (c)(2) may be
17    sealed as follows:
18            (A) Records identified as eligible under
19        subsections (c)(2)(A) and (c)(2)(B) may be sealed at
20        any time.
21            (B) Except as otherwise provided in subparagraph
22        (E) of this paragraph (3), records identified as
23        eligible under subsection (c)(2)(C) may be sealed 2
24        years after the termination of petitioner's last
25        sentence (as defined in subsection (a)(1)(F)).
26            (C) Except as otherwise provided in subparagraph

 

 

SB2612- 130 -LRB103 34492 JAG 64324 b

1        (E) of this paragraph (3), records identified as
2        eligible under subsections (c)(2)(D), (c)(2)(E), and
3        (c)(2)(F) may be sealed 3 years after the termination
4        of the petitioner's last sentence (as defined in
5        subsection (a)(1)(F)). Convictions requiring public
6        registration under the Arsonist Registration Act, the
7        Sex Offender Registration Act, or the Murderer and
8        Violent Offender Against Youth Registration Act may
9        not be sealed until the petitioner is no longer
10        required to register under that relevant Act.
11            (D) Records identified in subsection
12        (a)(3)(A)(iii) may be sealed after the petitioner has
13        reached the age of 25 years.
14            (E) Records identified as eligible under
15        subsection (c)(2)(C), (c)(2)(D), (c)(2)(E), or
16        (c)(2)(F) may be sealed upon termination of the
17        petitioner's last sentence if the petitioner earned a
18        high school diploma, associate's degree, career
19        certificate, vocational technical certification, or
20        bachelor's degree, or passed the high school level
21        Test of General Educational Development, during the
22        period of his or her sentence or mandatory supervised
23        release. This subparagraph shall apply only to a
24        petitioner who has not completed the same educational
25        goal prior to the period of his or her sentence or
26        mandatory supervised release. If a petition for

 

 

SB2612- 131 -LRB103 34492 JAG 64324 b

1        sealing eligible records filed under this subparagraph
2        is denied by the court, the time periods under
3        subparagraph (B) or (C) shall apply to any subsequent
4        petition for sealing filed by the petitioner.
5        (4) Subsequent felony convictions. A person may not
6    have subsequent felony conviction records sealed as
7    provided in this subsection (c) if he or she is convicted
8    of any felony offense after the date of the sealing of
9    prior felony convictions as provided in this subsection
10    (c). The court may, upon conviction for a subsequent
11    felony offense, order the unsealing of prior felony
12    conviction records previously ordered sealed by the court.
13        (5) Notice of eligibility for sealing. Upon entry of a
14    disposition for an eligible record under this subsection
15    (c), the petitioner shall be informed by the court of the
16    right to have the records sealed and the procedures for
17    the sealing of the records.
18    (d) Procedure. The following procedures apply to
19expungement under subsections (b), (e), and (e-6) and sealing
20under subsections (c) and (e-5):
21        (1) Filing the petition. Upon becoming eligible to
22    petition for the expungement or sealing of records under
23    this Section, the petitioner shall file a petition
24    requesting the expungement or sealing of records with the
25    clerk of the court where the arrests occurred or the
26    charges were brought, or both. If arrests occurred or

 

 

SB2612- 132 -LRB103 34492 JAG 64324 b

1    charges were brought in multiple jurisdictions, a petition
2    must be filed in each such jurisdiction. The petitioner
3    shall pay the applicable fee, except no fee shall be
4    required if the petitioner has obtained a court order
5    waiving fees under Supreme Court Rule 298 or it is
6    otherwise waived.
7        (1.5) County fee waiver pilot program. From August 9,
8    2019 (the effective date of Public Act 101-306) through
9    December 31, 2020, in a county of 3,000,000 or more
10    inhabitants, no fee shall be required to be paid by a
11    petitioner if the records sought to be expunged or sealed
12    were arrests resulting in release without charging or
13    arrests or charges not initiated by arrest resulting in
14    acquittal, dismissal, or conviction when the conviction
15    was reversed or vacated, unless excluded by subsection
16    (a)(3)(B). The provisions of this paragraph (1.5), other
17    than this sentence, are inoperative on and after January
18    1, 2022.
19        (2) Contents of petition. The petition shall be
20    verified and shall contain the petitioner's name, date of
21    birth, current address and, for each arrest or charge not
22    initiated by arrest sought to be sealed or expunged, the
23    case number, the date of arrest (if any), the identity of
24    the arresting authority, and such other information as the
25    court may require. During the pendency of the proceeding,
26    the petitioner shall promptly notify the circuit court

 

 

SB2612- 133 -LRB103 34492 JAG 64324 b

1    clerk of any change of his or her address. If the
2    petitioner has received a certificate of eligibility for
3    sealing from the Prisoner Review Board under paragraph
4    (10) of subsection (a) of Section 3-3-2 of the Unified
5    Code of Corrections, the certificate shall be attached to
6    the petition.
7        (3) Drug test. The petitioner must attach to the
8    petition proof that the petitioner has taken within 30
9    days before the filing of the petition a test showing the
10    absence within his or her body of all illegal substances
11    as defined by the Illinois Controlled Substances Act and
12    the Methamphetamine Control and Community Protection Act
13    if he or she is petitioning to:
14            (A) seal felony records under clause (c)(2)(E);
15            (B) seal felony records for a violation of the
16        Illinois Controlled Substances Act, the
17        Methamphetamine Control and Community Protection Act,
18        or the Cannabis Control Act under clause (c)(2)(F);
19            (C) seal felony records under subsection (e-5); or
20            (D) expunge felony records of a qualified
21        probation under clause (b)(1)(iv).
22        (4) Service of petition. The circuit court clerk shall
23    promptly serve a copy of the petition and documentation to
24    support the petition under subsection (e-5) or (e-6) on
25    the State's Attorney or prosecutor charged with the duty
26    of prosecuting the offense, the Illinois State Police, the

 

 

SB2612- 134 -LRB103 34492 JAG 64324 b

1    arresting agency and the chief legal officer of the unit
2    of local government effecting the arrest.
3        (5) Objections.
4            (A) Any party entitled to notice of the petition
5        may file an objection to the petition. All objections
6        shall be in writing, shall be filed with the circuit
7        court clerk, and shall state with specificity the
8        basis of the objection. Whenever a person who has been
9        convicted of an offense is granted a pardon by the
10        Governor which specifically authorizes expungement, an
11        objection to the petition may not be filed.
12            (B) Objections to a petition to expunge or seal
13        must be filed within 60 days of the date of service of
14        the petition.
15        (6) Entry of order.
16            (A) The Chief Judge of the circuit wherein the
17        charge was brought, any judge of that circuit
18        designated by the Chief Judge, or in counties of less
19        than 3,000,000 inhabitants, the presiding trial judge
20        at the petitioner's trial, if any, shall rule on the
21        petition to expunge or seal as set forth in this
22        subsection (d)(6).
23            (B) Unless the State's Attorney or prosecutor, the
24        Illinois State Police, the arresting agency, or the
25        chief legal officer files an objection to the petition
26        to expunge or seal within 60 days from the date of

 

 

SB2612- 135 -LRB103 34492 JAG 64324 b

1        service of the petition, the court shall enter an
2        order granting or denying the petition.
3            (C) Notwithstanding any other provision of law,
4        the court shall not deny a petition for sealing under
5        this Section because the petitioner has not satisfied
6        an outstanding legal financial obligation established,
7        imposed, or originated by a court, law enforcement
8        agency, or a municipal, State, county, or other unit
9        of local government, including, but not limited to,
10        any cost, assessment, fine, or fee. An outstanding
11        legal financial obligation does not include any court
12        ordered restitution to a victim under Section 5-5-6 of
13        the Unified Code of Corrections, unless the
14        restitution has been converted to a civil judgment.
15        Nothing in this subparagraph (C) waives, rescinds, or
16        abrogates a legal financial obligation or otherwise
17        eliminates or affects the right of the holder of any
18        financial obligation to pursue collection under
19        applicable federal, State, or local law.
20            (D) Notwithstanding any other provision of law,
21        the court shall not deny a petition to expunge or seal
22        under this Section because the petitioner has
23        submitted a drug test taken within 30 days before the
24        filing of the petition to expunge or seal that
25        indicates a positive test for the presence of cannabis
26        within the petitioner's body. In this subparagraph

 

 

SB2612- 136 -LRB103 34492 JAG 64324 b

1        (D), "cannabis" has the meaning ascribed to it in
2        Section 3 of the Cannabis Control Act.
3        (7) Hearings. If an objection is filed, the court
4    shall set a date for a hearing and notify the petitioner
5    and all parties entitled to notice of the petition of the
6    hearing date at least 30 days prior to the hearing. Prior
7    to the hearing, the State's Attorney shall consult with
8    the Illinois State Police as to the appropriateness of the
9    relief sought in the petition to expunge or seal. At the
10    hearing, the court shall hear evidence on whether the
11    petition should or should not be granted, and shall grant
12    or deny the petition to expunge or seal the records based
13    on the evidence presented at the hearing. The court may
14    consider the following:
15            (A) the strength of the evidence supporting the
16        defendant's conviction;
17            (B) the reasons for retention of the conviction
18        records by the State;
19            (C) the petitioner's age, criminal record history,
20        and employment history;
21            (D) the period of time between the petitioner's
22        arrest on the charge resulting in the conviction and
23        the filing of the petition under this Section; and
24            (E) the specific adverse consequences the
25        petitioner may be subject to if the petition is
26        denied.

 

 

SB2612- 137 -LRB103 34492 JAG 64324 b

1        (8) Service of order. After entering an order to
2    expunge or seal records, the court must provide copies of
3    the order to the Illinois State Police, in a form and
4    manner prescribed by the Illinois State Police, to the
5    petitioner, to the State's Attorney or prosecutor charged
6    with the duty of prosecuting the offense, to the arresting
7    agency, to the chief legal officer of the unit of local
8    government effecting the arrest, and to such other
9    criminal justice agencies as may be ordered by the court.
10        (9) Implementation of order.
11            (A) Upon entry of an order to expunge records
12        pursuant to subsection (b)(2)(A) or (b)(2)(B)(ii), or
13        both:
14                (i) the records shall be expunged (as defined
15            in subsection (a)(1)(E)) by the arresting agency,
16            the Illinois State Police, and any other agency as
17            ordered by the court, within 60 days of the date of
18            service of the order, unless a motion to vacate,
19            modify, or reconsider the order is filed pursuant
20            to paragraph (12) of subsection (d) of this
21            Section;
22                (ii) the records of the circuit court clerk
23            shall be impounded until further order of the
24            court upon good cause shown and the name of the
25            petitioner obliterated on the official index
26            required to be kept by the circuit court clerk

 

 

SB2612- 138 -LRB103 34492 JAG 64324 b

1            under Section 16 of the Clerks of Courts Act, but
2            the order shall not affect any index issued by the
3            circuit court clerk before the entry of the order;
4            and
5                (iii) in response to an inquiry for expunged
6            records, the court, the Illinois State Police, or
7            the agency receiving such inquiry, shall reply as
8            it does in response to inquiries when no records
9            ever existed.
10            (B) Upon entry of an order to expunge records
11        pursuant to subsection (b)(2)(B)(i) or (b)(2)(C), or
12        both:
13                (i) the records shall be expunged (as defined
14            in subsection (a)(1)(E)) by the arresting agency
15            and any other agency as ordered by the court,
16            within 60 days of the date of service of the order,
17            unless a motion to vacate, modify, or reconsider
18            the order is filed pursuant to paragraph (12) of
19            subsection (d) of this Section;
20                (ii) the records of the circuit court clerk
21            shall be impounded until further order of the
22            court upon good cause shown and the name of the
23            petitioner obliterated on the official index
24            required to be kept by the circuit court clerk
25            under Section 16 of the Clerks of Courts Act, but
26            the order shall not affect any index issued by the

 

 

SB2612- 139 -LRB103 34492 JAG 64324 b

1            circuit court clerk before the entry of the order;
2                (iii) the records shall be impounded by the
3            Illinois State Police within 60 days of the date
4            of service of the order as ordered by the court,
5            unless a motion to vacate, modify, or reconsider
6            the order is filed pursuant to paragraph (12) of
7            subsection (d) of this Section;
8                (iv) records impounded by the Illinois State
9            Police may be disseminated by the Illinois State
10            Police only as required by law or to the arresting
11            authority, the State's Attorney, and the court
12            upon a later arrest for the same or a similar
13            offense or for the purpose of sentencing for any
14            subsequent felony, and to the Department of
15            Corrections upon conviction for any offense; and
16                (v) in response to an inquiry for such records
17            from anyone not authorized by law to access such
18            records, the court, the Illinois State Police, or
19            the agency receiving such inquiry shall reply as
20            it does in response to inquiries when no records
21            ever existed.
22            (B-5) Upon entry of an order to expunge records
23        under subsection (e-6):
24                (i) the records shall be expunged (as defined
25            in subsection (a)(1)(E)) by the arresting agency
26            and any other agency as ordered by the court,

 

 

SB2612- 140 -LRB103 34492 JAG 64324 b

1            within 60 days of the date of service of the order,
2            unless a motion to vacate, modify, or reconsider
3            the order is filed under paragraph (12) of
4            subsection (d) of this Section;
5                (ii) the records of the circuit court clerk
6            shall be impounded until further order of the
7            court upon good cause shown and the name of the
8            petitioner obliterated on the official index
9            required to be kept by the circuit court clerk
10            under Section 16 of the Clerks of Courts Act, but
11            the order shall not affect any index issued by the
12            circuit court clerk before the entry of the order;
13                (iii) the records shall be impounded by the
14            Illinois State Police within 60 days of the date
15            of service of the order as ordered by the court,
16            unless a motion to vacate, modify, or reconsider
17            the order is filed under paragraph (12) of
18            subsection (d) of this Section;
19                (iv) records impounded by the Illinois State
20            Police may be disseminated by the Illinois State
21            Police only as required by law or to the arresting
22            authority, the State's Attorney, and the court
23            upon a later arrest for the same or a similar
24            offense or for the purpose of sentencing for any
25            subsequent felony, and to the Department of
26            Corrections upon conviction for any offense; and

 

 

SB2612- 141 -LRB103 34492 JAG 64324 b

1                (v) in response to an inquiry for these
2            records from anyone not authorized by law to
3            access the records, the court, the Illinois State
4            Police, or the agency receiving the inquiry shall
5            reply as it does in response to inquiries when no
6            records ever existed.
7            (C) Upon entry of an order to seal records under
8        subsection (c), the arresting agency, any other agency
9        as ordered by the court, the Illinois State Police,
10        and the court shall seal the records (as defined in
11        subsection (a)(1)(K)). In response to an inquiry for
12        such records, from anyone not authorized by law to
13        access such records, the court, the Illinois State
14        Police, or the agency receiving such inquiry shall
15        reply as it does in response to inquiries when no
16        records ever existed.
17            (D) The Illinois State Police shall send written
18        notice to the petitioner of its compliance with each
19        order to expunge or seal records within 60 days of the
20        date of service of that order or, if a motion to
21        vacate, modify, or reconsider is filed, within 60 days
22        of service of the order resolving the motion, if that
23        order requires the Illinois State Police to expunge or
24        seal records. In the event of an appeal from the
25        circuit court order, the Illinois State Police shall
26        send written notice to the petitioner of its

 

 

SB2612- 142 -LRB103 34492 JAG 64324 b

1        compliance with an Appellate Court or Supreme Court
2        judgment to expunge or seal records within 60 days of
3        the issuance of the court's mandate. The notice is not
4        required while any motion to vacate, modify, or
5        reconsider, or any appeal or petition for
6        discretionary appellate review, is pending.
7            (E) Upon motion, the court may order that a sealed
8        judgment or other court record necessary to
9        demonstrate the amount of any legal financial
10        obligation due and owing be made available for the
11        limited purpose of collecting any legal financial
12        obligations owed by the petitioner that were
13        established, imposed, or originated in the criminal
14        proceeding for which those records have been sealed.
15        The records made available under this subparagraph (E)
16        shall not be entered into the official index required
17        to be kept by the circuit court clerk under Section 16
18        of the Clerks of Courts Act and shall be immediately
19        re-impounded upon the collection of the outstanding
20        financial obligations.
21            (F) Notwithstanding any other provision of this
22        Section, a circuit court clerk may access a sealed
23        record for the limited purpose of collecting payment
24        for any legal financial obligations that were
25        established, imposed, or originated in the criminal
26        proceedings for which those records have been sealed.

 

 

SB2612- 143 -LRB103 34492 JAG 64324 b

1        (10) Fees. The Illinois State Police may charge the
2    petitioner a fee equivalent to the cost of processing any
3    order to expunge or seal records. Notwithstanding any
4    provision of the Clerks of Courts Act to the contrary, the
5    circuit court clerk may charge a fee equivalent to the
6    cost associated with the sealing or expungement of records
7    by the circuit court clerk. From the total filing fee
8    collected for the petition to seal or expunge, the circuit
9    court clerk shall deposit $10 into the Circuit Court Clerk
10    Operation and Administrative Fund, to be used to offset
11    the costs incurred by the circuit court clerk in
12    performing the additional duties required to serve the
13    petition to seal or expunge on all parties. The circuit
14    court clerk shall collect and remit the Illinois State
15    Police portion of the fee to the State Treasurer and it
16    shall be deposited in the State Police Services Fund. If
17    the record brought under an expungement petition was
18    previously sealed under this Section, the fee for the
19    expungement petition for that same record shall be waived.
20        (11) Final Order. No court order issued under the
21    expungement or sealing provisions of this Section shall
22    become final for purposes of appeal until 30 days after
23    service of the order on the petitioner and all parties
24    entitled to notice of the petition.
25        (12) Motion to Vacate, Modify, or Reconsider. Under
26    Section 2-1203 of the Code of Civil Procedure, the

 

 

SB2612- 144 -LRB103 34492 JAG 64324 b

1    petitioner or any party entitled to notice may file a
2    motion to vacate, modify, or reconsider the order granting
3    or denying the petition to expunge or seal within 60 days
4    of service of the order. If filed more than 60 days after
5    service of the order, a petition to vacate, modify, or
6    reconsider shall comply with subsection (c) of Section
7    2-1401 of the Code of Civil Procedure. Upon filing of a
8    motion to vacate, modify, or reconsider, notice of the
9    motion shall be served upon the petitioner and all parties
10    entitled to notice of the petition.
11        (13) Effect of Order. An order granting a petition
12    under the expungement or sealing provisions of this
13    Section shall not be considered void because it fails to
14    comply with the provisions of this Section or because of
15    any error asserted in a motion to vacate, modify, or
16    reconsider. The circuit court retains jurisdiction to
17    determine whether the order is voidable and to vacate,
18    modify, or reconsider its terms based on a motion filed
19    under paragraph (12) of this subsection (d).
20        (14) Compliance with Order Granting Petition to Seal
21    Records. Unless a court has entered a stay of an order
22    granting a petition to seal, all parties entitled to
23    notice of the petition must fully comply with the terms of
24    the order within 60 days of service of the order even if a
25    party is seeking relief from the order through a motion
26    filed under paragraph (12) of this subsection (d) or is

 

 

SB2612- 145 -LRB103 34492 JAG 64324 b

1    appealing the order.
2        (15) Compliance with Order Granting Petition to
3    Expunge Records. While a party is seeking relief from the
4    order granting the petition to expunge through a motion
5    filed under paragraph (12) of this subsection (d) or is
6    appealing the order, and unless a court has entered a stay
7    of that order, the parties entitled to notice of the
8    petition must seal, but need not expunge, the records
9    until there is a final order on the motion for relief or,
10    in the case of an appeal, the issuance of that court's
11    mandate.
12        (16) The changes to this subsection (d) made by Public
13    Act 98-163 apply to all petitions pending on August 5,
14    2013 (the effective date of Public Act 98-163) and to all
15    orders ruling on a petition to expunge or seal on or after
16    August 5, 2013 (the effective date of Public Act 98-163).
17    (e) Whenever a person who has been convicted of an offense
18is granted a pardon by the Governor which specifically
19authorizes expungement, he or she may, upon verified petition
20to the Chief Judge of the circuit where the person had been
21convicted, any judge of the circuit designated by the Chief
22Judge, or in counties of less than 3,000,000 inhabitants, the
23presiding trial judge at the defendant's trial, have a court
24order entered expunging the record of arrest from the official
25records of the arresting authority and order that the records
26of the circuit court clerk and the Illinois State Police be

 

 

SB2612- 146 -LRB103 34492 JAG 64324 b

1sealed until further order of the court upon good cause shown
2or as otherwise provided herein, and the name of the defendant
3obliterated from the official index requested to be kept by
4the circuit court clerk under Section 16 of the Clerks of
5Courts Act in connection with the arrest and conviction for
6the offense for which he or she had been pardoned but the order
7shall not affect any index issued by the circuit court clerk
8before the entry of the order. All records sealed by the
9Illinois State Police may be disseminated by the Illinois
10State Police only to the arresting authority, the State's
11Attorney, and the court upon a later arrest for the same or
12similar offense or for the purpose of sentencing for any
13subsequent felony. Upon conviction for any subsequent offense,
14the Department of Corrections shall have access to all sealed
15records of the Illinois State Police pertaining to that
16individual. Upon entry of the order of expungement, the
17circuit court clerk shall promptly mail a copy of the order to
18the person who was pardoned.
19    (e-5) Whenever a person who has been convicted of an
20offense is granted a certificate of eligibility for sealing by
21the Prisoner Review Board which specifically authorizes
22sealing, he or she may, upon verified petition to the Chief
23Judge of the circuit where the person had been convicted, any
24judge of the circuit designated by the Chief Judge, or in
25counties of less than 3,000,000 inhabitants, the presiding
26trial judge at the petitioner's trial, have a court order

 

 

SB2612- 147 -LRB103 34492 JAG 64324 b

1entered sealing the record of arrest from the official records
2of the arresting authority and order that the records of the
3circuit court clerk and the Illinois State Police be sealed
4until further order of the court upon good cause shown or as
5otherwise provided herein, and the name of the petitioner
6obliterated from the official index requested to be kept by
7the circuit court clerk under Section 16 of the Clerks of
8Courts Act in connection with the arrest and conviction for
9the offense for which he or she had been granted the
10certificate but the order shall not affect any index issued by
11the circuit court clerk before the entry of the order. All
12records sealed by the Illinois State Police may be
13disseminated by the Illinois State Police only as required by
14this Act or to the arresting authority, a law enforcement
15agency, the State's Attorney, and the court upon a later
16arrest for the same or similar offense or for the purpose of
17sentencing for any subsequent felony. Upon conviction for any
18subsequent offense, the Department of Corrections shall have
19access to all sealed records of the Illinois State Police
20pertaining to that individual. Upon entry of the order of
21sealing, the circuit court clerk shall promptly mail a copy of
22the order to the person who was granted the certificate of
23eligibility for sealing.
24    (e-6) Whenever a person who has been convicted of an
25offense is granted a certificate of eligibility for
26expungement by the Prisoner Review Board which specifically

 

 

SB2612- 148 -LRB103 34492 JAG 64324 b

1authorizes expungement, he or she may, upon verified petition
2to the Chief Judge of the circuit where the person had been
3convicted, any judge of the circuit designated by the Chief
4Judge, or in counties of less than 3,000,000 inhabitants, the
5presiding trial judge at the petitioner's trial, have a court
6order entered expunging the record of arrest from the official
7records of the arresting authority and order that the records
8of the circuit court clerk and the Illinois State Police be
9sealed until further order of the court upon good cause shown
10or as otherwise provided herein, and the name of the
11petitioner obliterated from the official index requested to be
12kept by the circuit court clerk under Section 16 of the Clerks
13of Courts Act in connection with the arrest and conviction for
14the offense for which he or she had been granted the
15certificate but the order shall not affect any index issued by
16the circuit court clerk before the entry of the order. All
17records sealed by the Illinois State Police may be
18disseminated by the Illinois State Police only as required by
19this Act or to the arresting authority, a law enforcement
20agency, the State's Attorney, and the court upon a later
21arrest for the same or similar offense or for the purpose of
22sentencing for any subsequent felony. Upon conviction for any
23subsequent offense, the Department of Corrections shall have
24access to all expunged records of the Illinois State Police
25pertaining to that individual. Upon entry of the order of
26expungement, the circuit court clerk shall promptly mail a

 

 

SB2612- 149 -LRB103 34492 JAG 64324 b

1copy of the order to the person who was granted the certificate
2of eligibility for expungement.
3    (f) Subject to available funding, the Illinois Department
4of Corrections shall conduct a study of the impact of sealing,
5especially on employment and recidivism rates, utilizing a
6random sample of those who apply for the sealing of their
7criminal records under Public Act 93-211. At the request of
8the Illinois Department of Corrections, records of the
9Illinois Department of Employment Security shall be utilized
10as appropriate to assist in the study. The study shall not
11disclose any data in a manner that would allow the
12identification of any particular individual or employing unit.
13The study shall be made available to the General Assembly no
14later than September 1, 2010.
15    (g) Immediate Sealing.
16        (1) Applicability. Notwithstanding any other provision
17    of this Act to the contrary, and cumulative with any
18    rights to expungement or sealing of criminal records, this
19    subsection authorizes the immediate sealing of criminal
20    records of adults and of minors prosecuted as adults.
21        (2) Eligible Records. Arrests or charges not initiated
22    by arrest resulting in acquittal or dismissal with
23    prejudice, except as excluded by subsection (a)(3)(B),
24    that occur on or after January 1, 2018 (the effective date
25    of Public Act 100-282), may be sealed immediately if the
26    petition is filed with the circuit court clerk on the same

 

 

SB2612- 150 -LRB103 34492 JAG 64324 b

1    day and during the same hearing in which the case is
2    disposed.
3        (3) When Records are Eligible to be Immediately
4    Sealed. Eligible records under paragraph (2) of this
5    subsection (g) may be sealed immediately after entry of
6    the final disposition of a case, notwithstanding the
7    disposition of other charges in the same case.
8        (4) Notice of Eligibility for Immediate Sealing. Upon
9    entry of a disposition for an eligible record under this
10    subsection (g), the defendant shall be informed by the
11    court of his or her right to have eligible records
12    immediately sealed and the procedure for the immediate
13    sealing of these records.
14        (5) Procedure. The following procedures apply to
15    immediate sealing under this subsection (g).
16            (A) Filing the Petition. Upon entry of the final
17        disposition of the case, the defendant's attorney may
18        immediately petition the court, on behalf of the
19        defendant, for immediate sealing of eligible records
20        under paragraph (2) of this subsection (g) that are
21        entered on or after January 1, 2018 (the effective
22        date of Public Act 100-282). The immediate sealing
23        petition may be filed with the circuit court clerk
24        during the hearing in which the final disposition of
25        the case is entered. If the defendant's attorney does
26        not file the petition for immediate sealing during the

 

 

SB2612- 151 -LRB103 34492 JAG 64324 b

1        hearing, the defendant may file a petition for sealing
2        at any time as authorized under subsection (c)(3)(A).
3            (B) Contents of Petition. The immediate sealing
4        petition shall be verified and shall contain the
5        petitioner's name, date of birth, current address, and
6        for each eligible record, the case number, the date of
7        arrest if applicable, the identity of the arresting
8        authority if applicable, and other information as the
9        court may require.
10            (C) Drug Test. The petitioner shall not be
11        required to attach proof that he or she has passed a
12        drug test.
13            (D) Service of Petition. A copy of the petition
14        shall be served on the State's Attorney in open court.
15        The petitioner shall not be required to serve a copy of
16        the petition on any other agency.
17            (E) Entry of Order. The presiding trial judge
18        shall enter an order granting or denying the petition
19        for immediate sealing during the hearing in which it
20        is filed. Petitions for immediate sealing shall be
21        ruled on in the same hearing in which the final
22        disposition of the case is entered.
23            (F) Hearings. The court shall hear the petition
24        for immediate sealing on the same day and during the
25        same hearing in which the disposition is rendered.
26            (G) Service of Order. An order to immediately seal

 

 

SB2612- 152 -LRB103 34492 JAG 64324 b

1        eligible records shall be served in conformance with
2        subsection (d)(8).
3            (H) Implementation of Order. An order to
4        immediately seal records shall be implemented in
5        conformance with subsections (d)(9)(C) and (d)(9)(D).
6            (I) Fees. The fee imposed by the circuit court
7        clerk and the Illinois State Police shall comply with
8        paragraph (1) of subsection (d) of this Section.
9            (J) Final Order. No court order issued under this
10        subsection (g) shall become final for purposes of
11        appeal until 30 days after service of the order on the
12        petitioner and all parties entitled to service of the
13        order in conformance with subsection (d)(8).
14            (K) Motion to Vacate, Modify, or Reconsider. Under
15        Section 2-1203 of the Code of Civil Procedure, the
16        petitioner, State's Attorney, or the Illinois State
17        Police may file a motion to vacate, modify, or
18        reconsider the order denying the petition to
19        immediately seal within 60 days of service of the
20        order. If filed more than 60 days after service of the
21        order, a petition to vacate, modify, or reconsider
22        shall comply with subsection (c) of Section 2-1401 of
23        the Code of Civil Procedure.
24            (L) Effect of Order. An order granting an
25        immediate sealing petition shall not be considered
26        void because it fails to comply with the provisions of

 

 

SB2612- 153 -LRB103 34492 JAG 64324 b

1        this Section or because of an error asserted in a
2        motion to vacate, modify, or reconsider. The circuit
3        court retains jurisdiction to determine whether the
4        order is voidable, and to vacate, modify, or
5        reconsider its terms based on a motion filed under
6        subparagraph (L) of this subsection (g).
7            (M) Compliance with Order Granting Petition to
8        Seal Records. Unless a court has entered a stay of an
9        order granting a petition to immediately seal, all
10        parties entitled to service of the order must fully
11        comply with the terms of the order within 60 days of
12        service of the order.
13    (h) Sealing; trafficking victims.
14        (1) A trafficking victim as defined by paragraph (10)
15    of subsection (a) of Section 10-9 of the Criminal Code of
16    2012 shall be eligible to petition for immediate sealing
17    of his or her criminal record upon the completion of his or
18    her last sentence if his or her participation in the
19    underlying offense was a direct result of human
20    trafficking under Section 10-9 of the Criminal Code of
21    2012 or a severe form of trafficking under the federal
22    Trafficking Victims Protection Act.
23        (2) A petitioner under this subsection (h), in
24    addition to the requirements provided under paragraph (4)
25    of subsection (d) of this Section, shall include in his or
26    her petition a clear and concise statement that: (A) he or

 

 

SB2612- 154 -LRB103 34492 JAG 64324 b

1    she was a victim of human trafficking at the time of the
2    offense; and (B) that his or her participation in the
3    offense was a direct result of human trafficking under
4    Section 10-9 of the Criminal Code of 2012 or a severe form
5    of trafficking under the federal Trafficking Victims
6    Protection Act.
7        (3) If an objection is filed alleging that the
8    petitioner is not entitled to immediate sealing under this
9    subsection (h), the court shall conduct a hearing under
10    paragraph (7) of subsection (d) of this Section and the
11    court shall determine whether the petitioner is entitled
12    to immediate sealing under this subsection (h). A
13    petitioner is eligible for immediate relief under this
14    subsection (h) if he or she shows, by a preponderance of
15    the evidence, that: (A) he or she was a victim of human
16    trafficking at the time of the offense; and (B) that his or
17    her participation in the offense was a direct result of
18    human trafficking under Section 10-9 of the Criminal Code
19    of 2012 or a severe form of trafficking under the federal
20    Trafficking Victims Protection Act.
21    (i) Minor Cannabis Offenses under the Cannabis Control
22Act.
23        (1) Expungement of Arrest Records of Minor Cannabis
24    Offenses.
25            (A) The Illinois State Police and all law
26        enforcement agencies within the State shall

 

 

SB2612- 155 -LRB103 34492 JAG 64324 b

1        automatically expunge all criminal history records of
2        an arrest, charge not initiated by arrest, order of
3        supervision, or order of qualified probation for a
4        Minor Cannabis Offense committed prior to June 25,
5        2019 (the effective date of Public Act 101-27) if:
6                (i) One year or more has elapsed since the
7            date of the arrest or law enforcement interaction
8            documented in the records; and
9                (ii) No criminal charges were filed relating
10            to the arrest or law enforcement interaction or
11            criminal charges were filed and subsequently
12            dismissed or vacated or the arrestee was
13            acquitted.
14            (B) If the law enforcement agency is unable to
15        verify satisfaction of condition (ii) in paragraph
16        (A), records that satisfy condition (i) in paragraph
17        (A) shall be automatically expunged.
18            (C) Records shall be expunged by the law
19        enforcement agency under the following timelines:
20                (i) Records created prior to June 25, 2019
21            (the effective date of Public Act 101-27), but on
22            or after January 1, 2013, shall be automatically
23            expunged prior to January 1, 2021;
24                (ii) Records created prior to January 1, 2013,
25            but on or after January 1, 2000, shall be
26            automatically expunged prior to January 1, 2025

 

 

SB2612- 156 -LRB103 34492 JAG 64324 b

1            2023;
2                (iii) Records created prior to January 1, 2000
3            shall be automatically expunged prior to January
4            1, 2027 2025.
5            In response to an inquiry for expunged records,
6        the law enforcement agency receiving such inquiry
7        shall reply as it does in response to inquiries when no
8        records ever existed; however, it shall provide a
9        certificate of disposition or confirmation that the
10        record was expunged to the individual whose record was
11        expunged if such a record exists.
12            (D) Nothing in this Section shall be construed to
13        restrict or modify an individual's right to have that
14        individual's records expunged except as otherwise may
15        be provided in this Act, or diminish or abrogate any
16        rights or remedies otherwise available to the
17        individual.
18        (2) Pardons Authorizing Expungement of Minor Cannabis
19    Offenses.
20            (A) Upon June 25, 2019 (the effective date of
21        Public Act 101-27), the Illinois Department of State
22        Police shall review all criminal history record
23        information and identify all records that meet all of
24        the following criteria:
25                (i) one or more convictions for a Minor
26            Cannabis Offense;

 

 

SB2612- 157 -LRB103 34492 JAG 64324 b

1                (ii) the conviction identified in paragraph
2            (2)(A)(i) did not include a penalty enhancement
3            under Section 7 of the Cannabis Control Act; and
4                (iii) the conviction identified in paragraph
5            (2)(A)(i) is not associated with a conviction for
6            a violent crime as defined in subsection (c) of
7            Section 3 of the Rights of Crime Victims and
8            Witnesses Act.
9            (B) Within 180 days after June 25, 2019 (the
10        effective date of Public Act 101-27), the Department
11        of State Police shall notify the Prisoner Review Board
12        of all such records that meet the criteria established
13        in paragraph (2)(A).
14                (i) The Prisoner Review Board shall notify the
15            State's Attorney of the county of conviction of
16            each record identified by State Police in
17            paragraph (2)(A) that is classified as a Class 4
18            felony. The State's Attorney may provide a written
19            objection to the Prisoner Review Board on the sole
20            basis that the record identified does not meet the
21            criteria established in paragraph (2)(A). Such an
22            objection must be filed within 60 days or by such
23            later date set by the Prisoner Review Board in the
24            notice after the State's Attorney received notice
25            from the Prisoner Review Board.
26                (ii) In response to a written objection from a

 

 

SB2612- 158 -LRB103 34492 JAG 64324 b

1            State's Attorney, the Prisoner Review Board is
2            authorized to conduct a non-public hearing to
3            evaluate the information provided in the
4            objection.
5                (iii) The Prisoner Review Board shall make a
6            confidential and privileged recommendation to the
7            Governor as to whether to grant a pardon
8            authorizing expungement for each of the records
9            identified by the Illinois Department of State
10            Police as described in paragraph (2)(A).
11            (C) If an individual has been granted a pardon
12        authorizing expungement as described in this Section,
13        the Prisoner Review Board, through the Attorney
14        General, shall file a petition for expungement with
15        the Chief Judge of the circuit or any judge of the
16        circuit designated by the Chief Judge where the
17        individual had been convicted. Such petition may
18        include more than one individual. Whenever an
19        individual who has been convicted of an offense is
20        granted a pardon by the Governor that specifically
21        authorizes expungement, an objection to the petition
22        may not be filed. Petitions to expunge under this
23        subsection (i) may include more than one individual.
24        Within 90 days of the filing of such a petition, the
25        court shall enter an order expunging the records of
26        arrest from the official records of the arresting

 

 

SB2612- 159 -LRB103 34492 JAG 64324 b

1        authority and order that the records of the circuit
2        court clerk and the Illinois State Police be expunged
3        and the name of the defendant obliterated from the
4        official index requested to be kept by the circuit
5        court clerk under Section 16 of the Clerks of Courts
6        Act in connection with the arrest and conviction for
7        the offense for which the individual had received a
8        pardon but the order shall not affect any index issued
9        by the circuit court clerk before the entry of the
10        order. Upon entry of the order of expungement, the
11        circuit court clerk shall promptly provide a copy of
12        the order and a certificate of disposition to the
13        individual who was pardoned to the individual's last
14        known address or by electronic means (if available) or
15        otherwise make it available to the individual upon
16        request.
17            (D) Nothing in this Section is intended to
18        diminish or abrogate any rights or remedies otherwise
19        available to the individual.
20        (3) Any individual may file a motion to vacate and
21    expunge a conviction for a misdemeanor or Class 4 felony
22    violation of Section 4 or Section 5 of the Cannabis
23    Control Act. Motions to vacate and expunge under this
24    subsection (i) may be filed with the circuit court, Chief
25    Judge of a judicial circuit or any judge of the circuit
26    designated by the Chief Judge. The circuit court clerk

 

 

SB2612- 160 -LRB103 34492 JAG 64324 b

1    shall promptly serve a copy of the motion to vacate and
2    expunge, and any supporting documentation, on the State's
3    Attorney or prosecutor charged with the duty of
4    prosecuting the offense. When considering such a motion to
5    vacate and expunge, a court shall consider the following:
6    the reasons to retain the records provided by law
7    enforcement, the petitioner's age, the petitioner's age at
8    the time of offense, the time since the conviction, and
9    the specific adverse consequences if denied. An individual
10    may file such a petition after the completion of any
11    non-financial sentence or non-financial condition imposed
12    by the conviction. Within 60 days of the filing of such
13    motion, a State's Attorney may file an objection to such a
14    petition along with supporting evidence. If a motion to
15    vacate and expunge is granted, the records shall be
16    expunged in accordance with subparagraphs (d)(8) and
17    (d)(9)(A) of this Section. An agency providing civil legal
18    aid, as defined by Section 15 of the Public Interest
19    Attorney Assistance Act, assisting individuals seeking to
20    file a motion to vacate and expunge under this subsection
21    may file motions to vacate and expunge with the Chief
22    Judge of a judicial circuit or any judge of the circuit
23    designated by the Chief Judge, and the motion may include
24    more than one individual. Motions filed by an agency
25    providing civil legal aid concerning more than one
26    individual may be prepared, presented, and signed

 

 

SB2612- 161 -LRB103 34492 JAG 64324 b

1    electronically.
2        (4) Any State's Attorney may file a motion to vacate
3    and expunge a conviction for a misdemeanor or Class 4
4    felony violation of Section 4 or Section 5 of the Cannabis
5    Control Act. Motions to vacate and expunge under this
6    subsection (i) may be filed with the circuit court, Chief
7    Judge of a judicial circuit or any judge of the circuit
8    designated by the Chief Judge, and may include more than
9    one individual. Motions filed by a State's Attorney
10    concerning more than one individual may be prepared,
11    presented, and signed electronically. When considering
12    such a motion to vacate and expunge, a court shall
13    consider the following: the reasons to retain the records
14    provided by law enforcement, the individual's age, the
15    individual's age at the time of offense, the time since
16    the conviction, and the specific adverse consequences if
17    denied. Upon entry of an order granting a motion to vacate
18    and expunge records pursuant to this Section, the State's
19    Attorney shall notify the Prisoner Review Board within 30
20    days. Upon entry of the order of expungement, the circuit
21    court clerk shall promptly provide a copy of the order and
22    a certificate of disposition to the individual whose
23    records will be expunged to the individual's last known
24    address or by electronic means (if available) or otherwise
25    make available to the individual upon request. If a motion
26    to vacate and expunge is granted, the records shall be

 

 

SB2612- 162 -LRB103 34492 JAG 64324 b

1    expunged in accordance with subparagraphs (d)(8) and
2    (d)(9)(A) of this Section.
3        (5) In the public interest, the State's Attorney of a
4    county has standing to file motions to vacate and expunge
5    pursuant to this Section in the circuit court with
6    jurisdiction over the underlying conviction.
7        (6) If a person is arrested for a Minor Cannabis
8    Offense as defined in this Section before June 25, 2019
9    (the effective date of Public Act 101-27) and the person's
10    case is still pending but a sentence has not been imposed,
11    the person may petition the court in which the charges are
12    pending for an order to summarily dismiss those charges
13    against him or her, and expunge all official records of
14    his or her arrest, plea, trial, conviction, incarceration,
15    supervision, or expungement. If the court determines, upon
16    review, that: (A) the person was arrested before June 25,
17    2019 (the effective date of Public Act 101-27) for an
18    offense that has been made eligible for expungement; (B)
19    the case is pending at the time; and (C) the person has not
20    been sentenced of the minor cannabis violation eligible
21    for expungement under this subsection, the court shall
22    consider the following: the reasons to retain the records
23    provided by law enforcement, the petitioner's age, the
24    petitioner's age at the time of offense, the time since
25    the conviction, and the specific adverse consequences if
26    denied. If a motion to dismiss and expunge is granted, the

 

 

SB2612- 163 -LRB103 34492 JAG 64324 b

1    records shall be expunged in accordance with subparagraph
2    (d)(9)(A) of this Section.
3        (7) A person imprisoned solely as a result of one or
4    more convictions for Minor Cannabis Offenses under this
5    subsection (i) shall be released from incarceration upon
6    the issuance of an order under this subsection.
7        (8) The Illinois State Police shall allow a person to
8    use the access and review process, established in the
9    Illinois State Police, for verifying that his or her
10    records relating to Minor Cannabis Offenses of the
11    Cannabis Control Act eligible under this Section have been
12    expunged.
13        (9) No conviction vacated pursuant to this Section
14    shall serve as the basis for damages for time unjustly
15    served as provided in the Court of Claims Act.
16        (10) Effect of Expungement. A person's right to
17    expunge an expungeable offense shall not be limited under
18    this Section. The effect of an order of expungement shall
19    be to restore the person to the status he or she occupied
20    before the arrest, charge, or conviction.
21        (11) Information. The Illinois State Police shall post
22    general information on its website about the expungement
23    process described in this subsection (i).
24    (j) Felony Prostitution Convictions.
25        (1) Any individual may file a motion to vacate and
26    expunge a conviction for a prior Class 4 felony violation

 

 

SB2612- 164 -LRB103 34492 JAG 64324 b

1    of prostitution. Motions to vacate and expunge under this
2    subsection (j) may be filed with the circuit court, Chief
3    Judge of a judicial circuit, or any judge of the circuit
4    designated by the Chief Judge. When considering the motion
5    to vacate and expunge, a court shall consider the
6    following:
7            (A) the reasons to retain the records provided by
8        law enforcement;
9            (B) the petitioner's age;
10            (C) the petitioner's age at the time of offense;
11        and
12            (D) the time since the conviction, and the
13        specific adverse consequences if denied. An individual
14        may file the petition after the completion of any
15        sentence or condition imposed by the conviction.
16        Within 60 days of the filing of the motion, a State's
17        Attorney may file an objection to the petition along
18        with supporting evidence. If a motion to vacate and
19        expunge is granted, the records shall be expunged in
20        accordance with subparagraph (d)(9)(A) of this
21        Section. An agency providing civil legal aid, as
22        defined in Section 15 of the Public Interest Attorney
23        Assistance Act, assisting individuals seeking to file
24        a motion to vacate and expunge under this subsection
25        may file motions to vacate and expunge with the Chief
26        Judge of a judicial circuit or any judge of the circuit

 

 

SB2612- 165 -LRB103 34492 JAG 64324 b

1        designated by the Chief Judge, and the motion may
2        include more than one individual.
3        (2) Any State's Attorney may file a motion to vacate
4    and expunge a conviction for a Class 4 felony violation of
5    prostitution. Motions to vacate and expunge under this
6    subsection (j) may be filed with the circuit court, Chief
7    Judge of a judicial circuit, or any judge of the circuit
8    court designated by the Chief Judge, and may include more
9    than one individual. When considering the motion to vacate
10    and expunge, a court shall consider the following reasons:
11            (A) the reasons to retain the records provided by
12        law enforcement;
13            (B) the petitioner's age;
14            (C) the petitioner's age at the time of offense;
15            (D) the time since the conviction; and
16            (E) the specific adverse consequences if denied.
17        If the State's Attorney files a motion to vacate and
18    expunge records for felony prostitution convictions
19    pursuant to this Section, the State's Attorney shall
20    notify the Prisoner Review Board within 30 days of the
21    filing. If a motion to vacate and expunge is granted, the
22    records shall be expunged in accordance with subparagraph
23    (d)(9)(A) of this Section.
24        (3) In the public interest, the State's Attorney of a
25    county has standing to file motions to vacate and expunge
26    pursuant to this Section in the circuit court with

 

 

SB2612- 166 -LRB103 34492 JAG 64324 b

1    jurisdiction over the underlying conviction.
2        (4) The Illinois State Police shall allow a person to
3    a use the access and review process, established in the
4    Illinois State Police, for verifying that his or her
5    records relating to felony prostitution eligible under
6    this Section have been expunged.
7        (5) No conviction vacated pursuant to this Section
8    shall serve as the basis for damages for time unjustly
9    served as provided in the Court of Claims Act.
10        (6) Effect of Expungement. A person's right to expunge
11    an expungeable offense shall not be limited under this
12    Section. The effect of an order of expungement shall be to
13    restore the person to the status he or she occupied before
14    the arrest, charge, or conviction.
15        (7) Information. The Illinois State Police shall post
16    general information on its website about the expungement
17    process described in this subsection (j).
18(Source: P.A. 101-27, eff. 6-25-19; 101-81, eff. 7-12-19;
19101-159, eff. 1-1-20; 101-306, eff. 8-9-19; 101-593, eff.
2012-4-19; 101-645, eff. 6-26-20; 102-145, eff. 7-23-21;
21102-558, 8-20-21; 102-639, eff. 8-27-21; 102-813, eff.
225-13-22; 102-933, eff. 1-1-23; 130-154, eff. 6-30-23.)
 
23    (Text of Section after amendment by P.A. 103-35)
24    Sec. 5.2. Expungement, sealing, and immediate sealing.
25    (a) General Provisions.

 

 

SB2612- 167 -LRB103 34492 JAG 64324 b

1        (1) Definitions. In this Act, words and phrases have
2    the meanings set forth in this subsection, except when a
3    particular context clearly requires a different meaning.
4            (A) The following terms shall have the meanings
5        ascribed to them in the following Sections of the
6        Unified Code of Corrections:
7                Business Offense, Section 5-1-2.
8                Charge, Section 5-1-3.
9                Court, Section 5-1-6.
10                Defendant, Section 5-1-7.
11                Felony, Section 5-1-9.
12                Imprisonment, Section 5-1-10.
13                Judgment, Section 5-1-12.
14                Misdemeanor, Section 5-1-14.
15                Offense, Section 5-1-15.
16                Parole, Section 5-1-16.
17                Petty Offense, Section 5-1-17.
18                Probation, Section 5-1-18.
19                Sentence, Section 5-1-19.
20                Supervision, Section 5-1-21.
21                Victim, Section 5-1-22.
22            (B) As used in this Section, "charge not initiated
23        by arrest" means a charge (as defined by Section 5-1-3
24        of the Unified Code of Corrections) brought against a
25        defendant where the defendant is not arrested prior to
26        or as a direct result of the charge.

 

 

SB2612- 168 -LRB103 34492 JAG 64324 b

1            (C) "Conviction" means a judgment of conviction or
2        sentence entered upon a plea of guilty or upon a
3        verdict or finding of guilty of an offense, rendered
4        by a legally constituted jury or by a court of
5        competent jurisdiction authorized to try the case
6        without a jury. An order of supervision successfully
7        completed by the petitioner is not a conviction. An
8        order of qualified probation (as defined in subsection
9        (a)(1)(J)) successfully completed by the petitioner is
10        not a conviction. An order of supervision or an order
11        of qualified probation that is terminated
12        unsatisfactorily is a conviction, unless the
13        unsatisfactory termination is reversed, vacated, or
14        modified and the judgment of conviction, if any, is
15        reversed or vacated.
16            (D) "Criminal offense" means a petty offense,
17        business offense, misdemeanor, felony, or municipal
18        ordinance violation (as defined in subsection
19        (a)(1)(H)). As used in this Section, a minor traffic
20        offense (as defined in subsection (a)(1)(G)) shall not
21        be considered a criminal offense.
22            (E) "Expunge" means to physically destroy the
23        records or return them to the petitioner and to
24        obliterate the petitioner's name from any official
25        index or public record, or both. Nothing in this Act
26        shall require the physical destruction of the circuit

 

 

SB2612- 169 -LRB103 34492 JAG 64324 b

1        court file, but such records relating to arrests or
2        charges, or both, ordered expunged shall be impounded
3        as required by subsections (d)(9)(A)(ii) and
4        (d)(9)(B)(ii).
5            (F) As used in this Section, "last sentence" means
6        the sentence, order of supervision, or order of
7        qualified probation (as defined by subsection
8        (a)(1)(J)), for a criminal offense (as defined by
9        subsection (a)(1)(D)) that terminates last in time in
10        any jurisdiction, regardless of whether the petitioner
11        has included the criminal offense for which the
12        sentence or order of supervision or qualified
13        probation was imposed in his or her petition. If
14        multiple sentences, orders of supervision, or orders
15        of qualified probation terminate on the same day and
16        are last in time, they shall be collectively
17        considered the "last sentence" regardless of whether
18        they were ordered to run concurrently.
19            (G) "Minor traffic offense" means a petty offense,
20        business offense, or Class C misdemeanor under the
21        Illinois Vehicle Code or a similar provision of a
22        municipal or local ordinance.
23            (G-5) "Minor Cannabis Offense" means a violation
24        of Section 4 or 5 of the Cannabis Control Act
25        concerning not more than 30 grams of any substance
26        containing cannabis, provided the violation did not

 

 

SB2612- 170 -LRB103 34492 JAG 64324 b

1        include a penalty enhancement under Section 7 of the
2        Cannabis Control Act and is not associated with an
3        arrest, conviction or other disposition for a violent
4        crime as defined in subsection (c) of Section 3 of the
5        Rights of Crime Victims and Witnesses Act.
6            (H) "Municipal ordinance violation" means an
7        offense defined by a municipal or local ordinance that
8        is criminal in nature and with which the petitioner
9        was charged or for which the petitioner was arrested
10        and released without charging.
11            (I) "Petitioner" means an adult or a minor
12        prosecuted as an adult who has applied for relief
13        under this Section.
14            (J) "Qualified probation" means an order of
15        probation under Section 10 of the Cannabis Control
16        Act, Section 410 of the Illinois Controlled Substances
17        Act, Section 70 of the Methamphetamine Control and
18        Community Protection Act, Section 5-6-3.3 or 5-6-3.4
19        of the Unified Code of Corrections, Section
20        12-4.3(b)(1) and (2) of the Criminal Code of 1961 (as
21        those provisions existed before their deletion by
22        Public Act 89-313), Section 10-102 of the Illinois
23        Alcoholism and Other Drug Dependency Act, Section
24        40-10 of the Substance Use Disorder Act, or Section 10
25        of the Steroid Control Act. For the purpose of this
26        Section, "successful completion" of an order of

 

 

SB2612- 171 -LRB103 34492 JAG 64324 b

1        qualified probation under Section 10-102 of the
2        Illinois Alcoholism and Other Drug Dependency Act and
3        Section 40-10 of the Substance Use Disorder Act means
4        that the probation was terminated satisfactorily and
5        the judgment of conviction was vacated.
6            (K) "Seal" means to physically and electronically
7        maintain the records, unless the records would
8        otherwise be destroyed due to age, but to make the
9        records unavailable without a court order, subject to
10        the exceptions in Sections 12 and 13 of this Act. The
11        petitioner's name shall also be obliterated from the
12        official index required to be kept by the circuit
13        court clerk under Section 16 of the Clerks of Courts
14        Act, but any index issued by the circuit court clerk
15        before the entry of the order to seal shall not be
16        affected.
17            (L) "Sexual offense committed against a minor"
18        includes, but is not limited to, the offenses of
19        indecent solicitation of a child or criminal sexual
20        abuse when the victim of such offense is under 18 years
21        of age.
22            (M) "Terminate" as it relates to a sentence or
23        order of supervision or qualified probation includes
24        either satisfactory or unsatisfactory termination of
25        the sentence, unless otherwise specified in this
26        Section. A sentence is terminated notwithstanding any

 

 

SB2612- 172 -LRB103 34492 JAG 64324 b

1        outstanding financial legal obligation.
2        (2) Minor Traffic Offenses. Orders of supervision or
3    convictions for minor traffic offenses shall not affect a
4    petitioner's eligibility to expunge or seal records
5    pursuant to this Section.
6        (2.5) Commencing 180 days after July 29, 2016 (the
7    effective date of Public Act 99-697), the law enforcement
8    agency issuing the citation shall automatically expunge,
9    on or before January 1 and July 1 of each year, the law
10    enforcement records of a person found to have committed a
11    civil law violation of subsection (a) of Section 4 of the
12    Cannabis Control Act or subsection (c) of Section 3.5 of
13    the Drug Paraphernalia Control Act in the law enforcement
14    agency's possession or control and which contains the
15    final satisfactory disposition which pertain to the person
16    issued a citation for that offense. The law enforcement
17    agency shall provide by rule the process for access,
18    review, and to confirm the automatic expungement by the
19    law enforcement agency issuing the citation. Commencing
20    180 days after July 29, 2016 (the effective date of Public
21    Act 99-697), the clerk of the circuit court shall expunge,
22    upon order of the court, or in the absence of a court order
23    on or before January 1 and July 1 of each year, the court
24    records of a person found in the circuit court to have
25    committed a civil law violation of subsection (a) of
26    Section 4 of the Cannabis Control Act or subsection (c) of

 

 

SB2612- 173 -LRB103 34492 JAG 64324 b

1    Section 3.5 of the Drug Paraphernalia Control Act in the
2    clerk's possession or control and which contains the final
3    satisfactory disposition which pertain to the person
4    issued a citation for any of those offenses.
5            (2.6) Commencing 180 days after the effective date
6    of this amendatory Act of the 103rd General Assembly, the
7    law enforcement agency issuing the citation shall
8    automatically expunge, on or before January 1 and July 1
9    of each year, the law enforcement records of a person
10    found to have committed a violation of subsection (e) of
11    Section 401 of the Illinois Controlled Substances Act by
12    possessing psilocybin and psilocin or of subsection (a) of
13    Section 3.5 of the Drug Paraphernalia Control Act by
14    possessing paraphernalia used in relation to psilocybin
15    and psilocin in the law enforcement agency's possession or
16    control and which contains the final satisfactory
17    disposition which pertain to the person issued a citation
18    for that offense. The law enforcement agency shall provide
19    by rule the process for access, review, and to confirm the
20    automatic expungement by the law enforcement agency
21    issuing the citation. Commencing 180 days after the
22    effective date of this amendatory Act of the 103rd General
23    Assembly, the clerk of the circuit court shall expunge,
24    upon order of the court, or in the absence of a court order
25    on or before January 1 and July 1 of each year, the court
26    records of a person found in the circuit court to have

 

 

SB2612- 174 -LRB103 34492 JAG 64324 b

1    committed a violation of subsection (e) of Section 401 of
2    the Illinois Controlled Substances Act by possessing
3    psilocybin and psilocin or of subsection (a) of Section
4    3.5 of the Drug Paraphernalia Control Act by possessing
5    paraphernalia used in relation to psilocybin and psilocin
6    in the clerk's possession or control and which contains
7    the final satisfactory disposition which pertain to the
8    person issued a citation for any of those offenses.
9        (3) Exclusions. Except as otherwise provided in
10    subsections (b)(5), (b)(6), (b)(8), (e), (e-5), and (e-6)
11    of this Section, the court shall not order:
12            (A) the sealing or expungement of the records of
13        arrests or charges not initiated by arrest that result
14        in an order of supervision for or conviction of: (i)
15        any sexual offense committed against a minor; (ii)
16        Section 11-501 of the Illinois Vehicle Code or a
17        similar provision of a local ordinance; or (iii)
18        Section 11-503 of the Illinois Vehicle Code or a
19        similar provision of a local ordinance, unless the
20        arrest or charge is for a misdemeanor violation of
21        subsection (a) of Section 11-503 or a similar
22        provision of a local ordinance, that occurred prior to
23        the offender reaching the age of 25 years and the
24        offender has no other conviction for violating Section
25        11-501 or 11-503 of the Illinois Vehicle Code or a
26        similar provision of a local ordinance.

 

 

SB2612- 175 -LRB103 34492 JAG 64324 b

1            (B) the sealing or expungement of records of minor
2        traffic offenses (as defined in subsection (a)(1)(G)),
3        unless the petitioner was arrested and released
4        without charging.
5            (C) the sealing of the records of arrests or
6        charges not initiated by arrest which result in an
7        order of supervision or a conviction for the following
8        offenses:
9                (i) offenses included in Article 11 of the
10            Criminal Code of 1961 or the Criminal Code of 2012
11            or a similar provision of a local ordinance,
12            except Section 11-14 and a misdemeanor violation
13            of Section 11-30 of the Criminal Code of 1961 or
14            the Criminal Code of 2012, or a similar provision
15            of a local ordinance;
16                (ii) Section 11-1.50, 12-3.4, 12-15, 12-30,
17            26-5, or 48-1 of the Criminal Code of 1961 or the
18            Criminal Code of 2012, or a similar provision of a
19            local ordinance;
20                (iii) Section 12-3.1 or 12-3.2 of the Criminal
21            Code of 1961 or the Criminal Code of 2012, or
22            Section 125 of the Stalking No Contact Order Act,
23            or Section 219 of the Civil No Contact Order Act,
24            or a similar provision of a local ordinance;
25                (iv) Class A misdemeanors or felony offenses
26            under the Humane Care for Animals Act; or

 

 

SB2612- 176 -LRB103 34492 JAG 64324 b

1                (v) any offense or attempted offense that
2            would subject a person to registration under the
3            Sex Offender Registration Act.
4            (D) (blank).
5    (b) Expungement.
6        (1) A petitioner may petition the circuit court to
7    expunge the records of his or her arrests and charges not
8    initiated by arrest when each arrest or charge not
9    initiated by arrest sought to be expunged resulted in: (i)
10    acquittal, dismissal, or the petitioner's release without
11    charging, unless excluded by subsection (a)(3)(B); (ii) a
12    conviction which was vacated or reversed, unless excluded
13    by subsection (a)(3)(B); (iii) an order of supervision and
14    such supervision was successfully completed by the
15    petitioner, unless excluded by subsection (a)(3)(A) or
16    (a)(3)(B); or (iv) an order of qualified probation (as
17    defined in subsection (a)(1)(J)) and such probation was
18    successfully completed by the petitioner.
19        (1.5) When a petitioner seeks to have a record of
20    arrest expunged under this Section, and the offender has
21    been convicted of a criminal offense, the State's Attorney
22    may object to the expungement on the grounds that the
23    records contain specific relevant information aside from
24    the mere fact of the arrest.
25        (2) Time frame for filing a petition to expunge.
26            (A) When the arrest or charge not initiated by

 

 

SB2612- 177 -LRB103 34492 JAG 64324 b

1        arrest sought to be expunged resulted in an acquittal,
2        dismissal, the petitioner's release without charging,
3        or the reversal or vacation of a conviction, there is
4        no waiting period to petition for the expungement of
5        such records.
6            (B) When the arrest or charge not initiated by
7        arrest sought to be expunged resulted in an order of
8        supervision, successfully completed by the petitioner,
9        the following time frames will apply:
10                (i) Those arrests or charges that resulted in
11            orders of supervision under Section 3-707, 3-708,
12            3-710, or 5-401.3 of the Illinois Vehicle Code or
13            a similar provision of a local ordinance, or under
14            Section 11-1.50, 12-3.2, or 12-15 of the Criminal
15            Code of 1961 or the Criminal Code of 2012, or a
16            similar provision of a local ordinance, shall not
17            be eligible for expungement until 5 years have
18            passed following the satisfactory termination of
19            the supervision.
20                (i-5) Those arrests or charges that resulted
21            in orders of supervision for a misdemeanor
22            violation of subsection (a) of Section 11-503 of
23            the Illinois Vehicle Code or a similar provision
24            of a local ordinance, that occurred prior to the
25            offender reaching the age of 25 years and the
26            offender has no other conviction for violating

 

 

SB2612- 178 -LRB103 34492 JAG 64324 b

1            Section 11-501 or 11-503 of the Illinois Vehicle
2            Code or a similar provision of a local ordinance
3            shall not be eligible for expungement until the
4            petitioner has reached the age of 25 years.
5                (ii) Those arrests or charges that resulted in
6            orders of supervision for any other offenses shall
7            not be eligible for expungement until 2 years have
8            passed following the satisfactory termination of
9            the supervision.
10            (C) When the arrest or charge not initiated by
11        arrest sought to be expunged resulted in an order of
12        qualified probation, successfully completed by the
13        petitioner, such records shall not be eligible for
14        expungement until 5 years have passed following the
15        satisfactory termination of the probation.
16        (3) Those records maintained by the Illinois State
17    Police for persons arrested prior to their 17th birthday
18    shall be expunged as provided in Section 5-915 of the
19    Juvenile Court Act of 1987.
20        (4) Whenever a person has been arrested for or
21    convicted of any offense, in the name of a person whose
22    identity he or she has stolen or otherwise come into
23    possession of, the aggrieved person from whom the identity
24    was stolen or otherwise obtained without authorization,
25    upon learning of the person having been arrested using his
26    or her identity, may, upon verified petition to the chief

 

 

SB2612- 179 -LRB103 34492 JAG 64324 b

1    judge of the circuit wherein the arrest was made, have a
2    court order entered nunc pro tunc by the Chief Judge to
3    correct the arrest record, conviction record, if any, and
4    all official records of the arresting authority, the
5    Illinois State Police, other criminal justice agencies,
6    the prosecutor, and the trial court concerning such
7    arrest, if any, by removing his or her name from all such
8    records in connection with the arrest and conviction, if
9    any, and by inserting in the records the name of the
10    offender, if known or ascertainable, in lieu of the
11    aggrieved's name. The records of the circuit court clerk
12    shall be sealed until further order of the court upon good
13    cause shown and the name of the aggrieved person
14    obliterated on the official index required to be kept by
15    the circuit court clerk under Section 16 of the Clerks of
16    Courts Act, but the order shall not affect any index
17    issued by the circuit court clerk before the entry of the
18    order. Nothing in this Section shall limit the Illinois
19    State Police or other criminal justice agencies or
20    prosecutors from listing under an offender's name the
21    false names he or she has used.
22        (5) Whenever a person has been convicted of criminal
23    sexual assault, aggravated criminal sexual assault,
24    predatory criminal sexual assault of a child, criminal
25    sexual abuse, or aggravated criminal sexual abuse, the
26    victim of that offense may request that the State's

 

 

SB2612- 180 -LRB103 34492 JAG 64324 b

1    Attorney of the county in which the conviction occurred
2    file a verified petition with the presiding trial judge at
3    the petitioner's trial to have a court order entered to
4    seal the records of the circuit court clerk in connection
5    with the proceedings of the trial court concerning that
6    offense. However, the records of the arresting authority
7    and the Illinois State Police concerning the offense shall
8    not be sealed. The court, upon good cause shown, shall
9    make the records of the circuit court clerk in connection
10    with the proceedings of the trial court concerning the
11    offense available for public inspection.
12        (6) If a conviction has been set aside on direct
13    review or on collateral attack and the court determines by
14    clear and convincing evidence that the petitioner was
15    factually innocent of the charge, the court that finds the
16    petitioner factually innocent of the charge shall enter an
17    expungement order for the conviction for which the
18    petitioner has been determined to be innocent as provided
19    in subsection (b) of Section 5-5-4 of the Unified Code of
20    Corrections.
21        (7) Nothing in this Section shall prevent the Illinois
22    State Police from maintaining all records of any person
23    who is admitted to probation upon terms and conditions and
24    who fulfills those terms and conditions pursuant to
25    Section 10 of the Cannabis Control Act, Section 410 of the
26    Illinois Controlled Substances Act, Section 70 of the

 

 

SB2612- 181 -LRB103 34492 JAG 64324 b

1    Methamphetamine Control and Community Protection Act,
2    Section 5-6-3.3 or 5-6-3.4 of the Unified Code of
3    Corrections, Section 12-4.3 or subdivision (b)(1) of
4    Section 12-3.05 of the Criminal Code of 1961 or the
5    Criminal Code of 2012, Section 10-102 of the Illinois
6    Alcoholism and Other Drug Dependency Act, Section 40-10 of
7    the Substance Use Disorder Act, or Section 10 of the
8    Steroid Control Act.
9        (8) If the petitioner has been granted a certificate
10    of innocence under Section 2-702 of the Code of Civil
11    Procedure, the court that grants the certificate of
12    innocence shall also enter an order expunging the
13    conviction for which the petitioner has been determined to
14    be innocent as provided in subsection (h) of Section 2-702
15    of the Code of Civil Procedure.
16    (c) Sealing.
17        (1) Applicability. Notwithstanding any other provision
18    of this Act to the contrary, and cumulative with any
19    rights to expungement of criminal records, this subsection
20    authorizes the sealing of criminal records of adults and
21    of minors prosecuted as adults. Subsection (g) of this
22    Section provides for immediate sealing of certain records.
23        (2) Eligible Records. The following records may be
24    sealed:
25            (A) All arrests resulting in release without
26        charging;

 

 

SB2612- 182 -LRB103 34492 JAG 64324 b

1            (B) Arrests or charges not initiated by arrest
2        resulting in acquittal, dismissal, or conviction when
3        the conviction was reversed or vacated, except as
4        excluded by subsection (a)(3)(B);
5            (C) Arrests or charges not initiated by arrest
6        resulting in orders of supervision, including orders
7        of supervision for municipal ordinance violations,
8        successfully completed by the petitioner, unless
9        excluded by subsection (a)(3);
10            (D) Arrests or charges not initiated by arrest
11        resulting in convictions, including convictions on
12        municipal ordinance violations, unless excluded by
13        subsection (a)(3);
14            (E) Arrests or charges not initiated by arrest
15        resulting in orders of first offender probation under
16        Section 10 of the Cannabis Control Act, Section 410 of
17        the Illinois Controlled Substances Act, Section 70 of
18        the Methamphetamine Control and Community Protection
19        Act, or Section 5-6-3.3 of the Unified Code of
20        Corrections; and
21            (F) Arrests or charges not initiated by arrest
22        resulting in felony convictions unless otherwise
23        excluded by subsection (a) paragraph (3) of this
24        Section.
25        (3) When Records Are Eligible to Be Sealed. Records
26    identified as eligible under subsection (c)(2) may be

 

 

SB2612- 183 -LRB103 34492 JAG 64324 b

1    sealed as follows:
2            (A) Records identified as eligible under
3        subsections (c)(2)(A) and (c)(2)(B) may be sealed at
4        any time.
5            (B) Except as otherwise provided in subparagraph
6        (E) of this paragraph (3), records identified as
7        eligible under subsection (c)(2)(C) may be sealed 2
8        years after the termination of petitioner's last
9        sentence (as defined in subsection (a)(1)(F)).
10            (C) Except as otherwise provided in subparagraph
11        (E) of this paragraph (3), records identified as
12        eligible under subsections (c)(2)(D), (c)(2)(E), and
13        (c)(2)(F) may be sealed 3 years after the termination
14        of the petitioner's last sentence (as defined in
15        subsection (a)(1)(F)). Convictions requiring public
16        registration under the Arsonist Registration Act, the
17        Sex Offender Registration Act, or the Murderer and
18        Violent Offender Against Youth Registration Act may
19        not be sealed until the petitioner is no longer
20        required to register under that relevant Act.
21            (D) Records identified in subsection
22        (a)(3)(A)(iii) may be sealed after the petitioner has
23        reached the age of 25 years.
24            (E) Records identified as eligible under
25        subsection (c)(2)(C), (c)(2)(D), (c)(2)(E), or
26        (c)(2)(F) may be sealed upon termination of the

 

 

SB2612- 184 -LRB103 34492 JAG 64324 b

1        petitioner's last sentence if the petitioner earned a
2        high school diploma, associate's degree, career
3        certificate, vocational technical certification, or
4        bachelor's degree, or passed the high school level
5        Test of General Educational Development, during the
6        period of his or her sentence or mandatory supervised
7        release. This subparagraph shall apply only to a
8        petitioner who has not completed the same educational
9        goal prior to the period of his or her sentence or
10        mandatory supervised release. If a petition for
11        sealing eligible records filed under this subparagraph
12        is denied by the court, the time periods under
13        subparagraph (B) or (C) shall apply to any subsequent
14        petition for sealing filed by the petitioner.
15        (4) Subsequent felony convictions. A person may not
16    have subsequent felony conviction records sealed as
17    provided in this subsection (c) if he or she is convicted
18    of any felony offense after the date of the sealing of
19    prior felony convictions as provided in this subsection
20    (c). The court may, upon conviction for a subsequent
21    felony offense, order the unsealing of prior felony
22    conviction records previously ordered sealed by the court.
23        (5) Notice of eligibility for sealing. Upon entry of a
24    disposition for an eligible record under this subsection
25    (c), the petitioner shall be informed by the court of the
26    right to have the records sealed and the procedures for

 

 

SB2612- 185 -LRB103 34492 JAG 64324 b

1    the sealing of the records.
2    (d) Procedure. The following procedures apply to
3expungement under subsections (b), (e), and (e-6) and sealing
4under subsections (c) and (e-5):
5        (1) Filing the petition. Upon becoming eligible to
6    petition for the expungement or sealing of records under
7    this Section, the petitioner shall file a petition
8    requesting the expungement or sealing of records with the
9    clerk of the court where the arrests occurred or the
10    charges were brought, or both. If arrests occurred or
11    charges were brought in multiple jurisdictions, a petition
12    must be filed in each such jurisdiction. The petitioner
13    shall pay the applicable fee, except no fee shall be
14    required if the petitioner has obtained a court order
15    waiving fees under Supreme Court Rule 298 or it is
16    otherwise waived.
17        (1.5) County fee waiver pilot program. From August 9,
18    2019 (the effective date of Public Act 101-306) through
19    December 31, 2020, in a county of 3,000,000 or more
20    inhabitants, no fee shall be required to be paid by a
21    petitioner if the records sought to be expunged or sealed
22    were arrests resulting in release without charging or
23    arrests or charges not initiated by arrest resulting in
24    acquittal, dismissal, or conviction when the conviction
25    was reversed or vacated, unless excluded by subsection
26    (a)(3)(B). The provisions of this paragraph (1.5), other

 

 

SB2612- 186 -LRB103 34492 JAG 64324 b

1    than this sentence, are inoperative on and after January
2    1, 2022.
3        (2) Contents of petition. The petition shall be
4    verified and shall contain the petitioner's name, date of
5    birth, current address and, for each arrest or charge not
6    initiated by arrest sought to be sealed or expunged, the
7    case number, the date of arrest (if any), the identity of
8    the arresting authority, and such other information as the
9    court may require. During the pendency of the proceeding,
10    the petitioner shall promptly notify the circuit court
11    clerk of any change of his or her address. If the
12    petitioner has received a certificate of eligibility for
13    sealing from the Prisoner Review Board under paragraph
14    (10) of subsection (a) of Section 3-3-2 of the Unified
15    Code of Corrections, the certificate shall be attached to
16    the petition.
17        (3) Drug test. The petitioner must attach to the
18    petition proof that the petitioner has taken within 30
19    days before the filing of the petition a test showing the
20    absence within his or her body of all illegal substances
21    as defined by the Illinois Controlled Substances Act and
22    the Methamphetamine Control and Community Protection Act
23    if he or she is petitioning to:
24            (A) seal felony records under clause (c)(2)(E);
25            (B) seal felony records for a violation of the
26        Illinois Controlled Substances Act, the

 

 

SB2612- 187 -LRB103 34492 JAG 64324 b

1        Methamphetamine Control and Community Protection Act,
2        or the Cannabis Control Act under clause (c)(2)(F);
3            (C) seal felony records under subsection (e-5); or
4            (D) expunge felony records of a qualified
5        probation under clause (b)(1)(iv).
6        (4) Service of petition. The circuit court clerk shall
7    promptly serve a copy of the petition and documentation to
8    support the petition under subsection (e-5) or (e-6) on
9    the State's Attorney or prosecutor charged with the duty
10    of prosecuting the offense, the Illinois State Police, the
11    arresting agency and the chief legal officer of the unit
12    of local government effecting the arrest.
13        (5) Objections.
14            (A) Any party entitled to notice of the petition
15        may file an objection to the petition. All objections
16        shall be in writing, shall be filed with the circuit
17        court clerk, and shall state with specificity the
18        basis of the objection. Whenever a person who has been
19        convicted of an offense is granted a pardon by the
20        Governor which specifically authorizes expungement, an
21        objection to the petition may not be filed.
22            (B) Objections to a petition to expunge or seal
23        must be filed within 60 days of the date of service of
24        the petition.
25        (6) Entry of order.
26            (A) The Chief Judge of the circuit wherein the

 

 

SB2612- 188 -LRB103 34492 JAG 64324 b

1        charge was brought, any judge of that circuit
2        designated by the Chief Judge, or in counties of less
3        than 3,000,000 inhabitants, the presiding trial judge
4        at the petitioner's trial, if any, shall rule on the
5        petition to expunge or seal as set forth in this
6        subsection (d)(6).
7            (B) Unless the State's Attorney or prosecutor, the
8        Illinois State Police, the arresting agency, or the
9        chief legal officer files an objection to the petition
10        to expunge or seal within 60 days from the date of
11        service of the petition, the court shall enter an
12        order granting or denying the petition.
13            (C) Notwithstanding any other provision of law,
14        the court shall not deny a petition for sealing under
15        this Section because the petitioner has not satisfied
16        an outstanding legal financial obligation established,
17        imposed, or originated by a court, law enforcement
18        agency, or a municipal, State, county, or other unit
19        of local government, including, but not limited to,
20        any cost, assessment, fine, or fee. An outstanding
21        legal financial obligation does not include any court
22        ordered restitution to a victim under Section 5-5-6 of
23        the Unified Code of Corrections, unless the
24        restitution has been converted to a civil judgment.
25        Nothing in this subparagraph (C) waives, rescinds, or
26        abrogates a legal financial obligation or otherwise

 

 

SB2612- 189 -LRB103 34492 JAG 64324 b

1        eliminates or affects the right of the holder of any
2        financial obligation to pursue collection under
3        applicable federal, State, or local law.
4            (D) Notwithstanding any other provision of law,
5        the court shall not deny a petition to expunge or seal
6        under this Section because the petitioner has
7        submitted a drug test taken within 30 days before the
8        filing of the petition to expunge or seal that
9        indicates a positive test for the presence of cannabis
10        within the petitioner's body. In this subparagraph
11        (D), "cannabis" has the meaning ascribed to it in
12        Section 3 of the Cannabis Control Act.
13        (7) Hearings. If an objection is filed, the court
14    shall set a date for a hearing and notify the petitioner
15    and all parties entitled to notice of the petition of the
16    hearing date at least 30 days prior to the hearing. Prior
17    to the hearing, the State's Attorney shall consult with
18    the Illinois State Police as to the appropriateness of the
19    relief sought in the petition to expunge or seal. At the
20    hearing, the court shall hear evidence on whether the
21    petition should or should not be granted, and shall grant
22    or deny the petition to expunge or seal the records based
23    on the evidence presented at the hearing. The court may
24    consider the following:
25            (A) the strength of the evidence supporting the
26        defendant's conviction;

 

 

SB2612- 190 -LRB103 34492 JAG 64324 b

1            (B) the reasons for retention of the conviction
2        records by the State;
3            (C) the petitioner's age, criminal record history,
4        and employment history;
5            (D) the period of time between the petitioner's
6        arrest on the charge resulting in the conviction and
7        the filing of the petition under this Section; and
8            (E) the specific adverse consequences the
9        petitioner may be subject to if the petition is
10        denied.
11        (8) Service of order. After entering an order to
12    expunge or seal records, the court must provide copies of
13    the order to the Illinois State Police, in a form and
14    manner prescribed by the Illinois State Police, to the
15    petitioner, to the State's Attorney or prosecutor charged
16    with the duty of prosecuting the offense, to the arresting
17    agency, to the chief legal officer of the unit of local
18    government effecting the arrest, and to such other
19    criminal justice agencies as may be ordered by the court.
20        (9) Implementation of order.
21            (A) Upon entry of an order to expunge records
22        pursuant to subsection (b)(2)(A) or (b)(2)(B)(ii), or
23        both:
24                (i) the records shall be expunged (as defined
25            in subsection (a)(1)(E)) by the arresting agency,
26            the Illinois State Police, and any other agency as

 

 

SB2612- 191 -LRB103 34492 JAG 64324 b

1            ordered by the court, within 60 days of the date of
2            service of the order, unless a motion to vacate,
3            modify, or reconsider the order is filed pursuant
4            to paragraph (12) of subsection (d) of this
5            Section;
6                (ii) the records of the circuit court clerk
7            shall be impounded until further order of the
8            court upon good cause shown and the name of the
9            petitioner obliterated on the official index
10            required to be kept by the circuit court clerk
11            under Section 16 of the Clerks of Courts Act, but
12            the order shall not affect any index issued by the
13            circuit court clerk before the entry of the order;
14            and
15                (iii) in response to an inquiry for expunged
16            records, the court, the Illinois State Police, or
17            the agency receiving such inquiry, shall reply as
18            it does in response to inquiries when no records
19            ever existed.
20            (B) Upon entry of an order to expunge records
21        pursuant to subsection (b)(2)(B)(i) or (b)(2)(C), or
22        both:
23                (i) the records shall be expunged (as defined
24            in subsection (a)(1)(E)) by the arresting agency
25            and any other agency as ordered by the court,
26            within 60 days of the date of service of the order,

 

 

SB2612- 192 -LRB103 34492 JAG 64324 b

1            unless a motion to vacate, modify, or reconsider
2            the order is filed pursuant to paragraph (12) of
3            subsection (d) of this Section;
4                (ii) the records of the circuit court clerk
5            shall be impounded until further order of the
6            court upon good cause shown and the name of the
7            petitioner obliterated on the official index
8            required to be kept by the circuit court clerk
9            under Section 16 of the Clerks of Courts Act, but
10            the order shall not affect any index issued by the
11            circuit court clerk before the entry of the order;
12                (iii) the records shall be impounded by the
13            Illinois State Police within 60 days of the date
14            of service of the order as ordered by the court,
15            unless a motion to vacate, modify, or reconsider
16            the order is filed pursuant to paragraph (12) of
17            subsection (d) of this Section;
18                (iv) records impounded by the Illinois State
19            Police may be disseminated by the Illinois State
20            Police only as required by law or to the arresting
21            authority, the State's Attorney, and the court
22            upon a later arrest for the same or a similar
23            offense or for the purpose of sentencing for any
24            subsequent felony, and to the Department of
25            Corrections upon conviction for any offense; and
26                (v) in response to an inquiry for such records

 

 

SB2612- 193 -LRB103 34492 JAG 64324 b

1            from anyone not authorized by law to access such
2            records, the court, the Illinois State Police, or
3            the agency receiving such inquiry shall reply as
4            it does in response to inquiries when no records
5            ever existed.
6            (B-5) Upon entry of an order to expunge records
7        under subsection (e-6):
8                (i) the records shall be expunged (as defined
9            in subsection (a)(1)(E)) by the arresting agency
10            and any other agency as ordered by the court,
11            within 60 days of the date of service of the order,
12            unless a motion to vacate, modify, or reconsider
13            the order is filed under paragraph (12) of
14            subsection (d) of this Section;
15                (ii) the records of the circuit court clerk
16            shall be impounded until further order of the
17            court upon good cause shown and the name of the
18            petitioner obliterated on the official index
19            required to be kept by the circuit court clerk
20            under Section 16 of the Clerks of Courts Act, but
21            the order shall not affect any index issued by the
22            circuit court clerk before the entry of the order;
23                (iii) the records shall be impounded by the
24            Illinois State Police within 60 days of the date
25            of service of the order as ordered by the court,
26            unless a motion to vacate, modify, or reconsider

 

 

SB2612- 194 -LRB103 34492 JAG 64324 b

1            the order is filed under paragraph (12) of
2            subsection (d) of this Section;
3                (iv) records impounded by the Illinois State
4            Police may be disseminated by the Illinois State
5            Police only as required by law or to the arresting
6            authority, the State's Attorney, and the court
7            upon a later arrest for the same or a similar
8            offense or for the purpose of sentencing for any
9            subsequent felony, and to the Department of
10            Corrections upon conviction for any offense; and
11                (v) in response to an inquiry for these
12            records from anyone not authorized by law to
13            access the records, the court, the Illinois State
14            Police, or the agency receiving the inquiry shall
15            reply as it does in response to inquiries when no
16            records ever existed.
17            (C) Upon entry of an order to seal records under
18        subsection (c), the arresting agency, any other agency
19        as ordered by the court, the Illinois State Police,
20        and the court shall seal the records (as defined in
21        subsection (a)(1)(K)). In response to an inquiry for
22        such records, from anyone not authorized by law to
23        access such records, the court, the Illinois State
24        Police, or the agency receiving such inquiry shall
25        reply as it does in response to inquiries when no
26        records ever existed.

 

 

SB2612- 195 -LRB103 34492 JAG 64324 b

1            (D) The Illinois State Police shall send written
2        notice to the petitioner of its compliance with each
3        order to expunge or seal records within 60 days of the
4        date of service of that order or, if a motion to
5        vacate, modify, or reconsider is filed, within 60 days
6        of service of the order resolving the motion, if that
7        order requires the Illinois State Police to expunge or
8        seal records. In the event of an appeal from the
9        circuit court order, the Illinois State Police shall
10        send written notice to the petitioner of its
11        compliance with an Appellate Court or Supreme Court
12        judgment to expunge or seal records within 60 days of
13        the issuance of the court's mandate. The notice is not
14        required while any motion to vacate, modify, or
15        reconsider, or any appeal or petition for
16        discretionary appellate review, is pending.
17            (E) Upon motion, the court may order that a sealed
18        judgment or other court record necessary to
19        demonstrate the amount of any legal financial
20        obligation due and owing be made available for the
21        limited purpose of collecting any legal financial
22        obligations owed by the petitioner that were
23        established, imposed, or originated in the criminal
24        proceeding for which those records have been sealed.
25        The records made available under this subparagraph (E)
26        shall not be entered into the official index required

 

 

SB2612- 196 -LRB103 34492 JAG 64324 b

1        to be kept by the circuit court clerk under Section 16
2        of the Clerks of Courts Act and shall be immediately
3        re-impounded upon the collection of the outstanding
4        financial obligations.
5            (F) Notwithstanding any other provision of this
6        Section, a circuit court clerk may access a sealed
7        record for the limited purpose of collecting payment
8        for any legal financial obligations that were
9        established, imposed, or originated in the criminal
10        proceedings for which those records have been sealed.
11        (10) Fees. The Illinois State Police may charge the
12    petitioner a fee equivalent to the cost of processing any
13    order to expunge or seal records. Notwithstanding any
14    provision of the Clerks of Courts Act to the contrary, the
15    circuit court clerk may charge a fee equivalent to the
16    cost associated with the sealing or expungement of records
17    by the circuit court clerk. From the total filing fee
18    collected for the petition to seal or expunge, the circuit
19    court clerk shall deposit $10 into the Circuit Court Clerk
20    Operation and Administrative Fund, to be used to offset
21    the costs incurred by the circuit court clerk in
22    performing the additional duties required to serve the
23    petition to seal or expunge on all parties. The circuit
24    court clerk shall collect and remit the Illinois State
25    Police portion of the fee to the State Treasurer and it
26    shall be deposited in the State Police Services Fund. If

 

 

SB2612- 197 -LRB103 34492 JAG 64324 b

1    the record brought under an expungement petition was
2    previously sealed under this Section, the fee for the
3    expungement petition for that same record shall be waived.
4        (11) Final Order. No court order issued under the
5    expungement or sealing provisions of this Section shall
6    become final for purposes of appeal until 30 days after
7    service of the order on the petitioner and all parties
8    entitled to notice of the petition.
9        (12) Motion to Vacate, Modify, or Reconsider. Under
10    Section 2-1203 of the Code of Civil Procedure, the
11    petitioner or any party entitled to notice may file a
12    motion to vacate, modify, or reconsider the order granting
13    or denying the petition to expunge or seal within 60 days
14    of service of the order. If filed more than 60 days after
15    service of the order, a petition to vacate, modify, or
16    reconsider shall comply with subsection (c) of Section
17    2-1401 of the Code of Civil Procedure. Upon filing of a
18    motion to vacate, modify, or reconsider, notice of the
19    motion shall be served upon the petitioner and all parties
20    entitled to notice of the petition.
21        (13) Effect of Order. An order granting a petition
22    under the expungement or sealing provisions of this
23    Section shall not be considered void because it fails to
24    comply with the provisions of this Section or because of
25    any error asserted in a motion to vacate, modify, or
26    reconsider. The circuit court retains jurisdiction to

 

 

SB2612- 198 -LRB103 34492 JAG 64324 b

1    determine whether the order is voidable and to vacate,
2    modify, or reconsider its terms based on a motion filed
3    under paragraph (12) of this subsection (d).
4        (14) Compliance with Order Granting Petition to Seal
5    Records. Unless a court has entered a stay of an order
6    granting a petition to seal, all parties entitled to
7    notice of the petition must fully comply with the terms of
8    the order within 60 days of service of the order even if a
9    party is seeking relief from the order through a motion
10    filed under paragraph (12) of this subsection (d) or is
11    appealing the order.
12        (15) Compliance with Order Granting Petition to
13    Expunge Records. While a party is seeking relief from the
14    order granting the petition to expunge through a motion
15    filed under paragraph (12) of this subsection (d) or is
16    appealing the order, and unless a court has entered a stay
17    of that order, the parties entitled to notice of the
18    petition must seal, but need not expunge, the records
19    until there is a final order on the motion for relief or,
20    in the case of an appeal, the issuance of that court's
21    mandate.
22        (16) The changes to this subsection (d) made by Public
23    Act 98-163 apply to all petitions pending on August 5,
24    2013 (the effective date of Public Act 98-163) and to all
25    orders ruling on a petition to expunge or seal on or after
26    August 5, 2013 (the effective date of Public Act 98-163).

 

 

SB2612- 199 -LRB103 34492 JAG 64324 b

1    (e) Whenever a person who has been convicted of an offense
2is granted a pardon by the Governor which specifically
3authorizes expungement, he or she may, upon verified petition
4to the Chief Judge of the circuit where the person had been
5convicted, any judge of the circuit designated by the Chief
6Judge, or in counties of less than 3,000,000 inhabitants, the
7presiding trial judge at the defendant's trial, have a court
8order entered expunging the record of arrest from the official
9records of the arresting authority and order that the records
10of the circuit court clerk and the Illinois State Police be
11sealed until further order of the court upon good cause shown
12or as otherwise provided herein, and the name of the defendant
13obliterated from the official index requested to be kept by
14the circuit court clerk under Section 16 of the Clerks of
15Courts Act in connection with the arrest and conviction for
16the offense for which he or she had been pardoned but the order
17shall not affect any index issued by the circuit court clerk
18before the entry of the order. All records sealed by the
19Illinois State Police may be disseminated by the Illinois
20State Police only to the arresting authority, the State's
21Attorney, and the court upon a later arrest for the same or
22similar offense or for the purpose of sentencing for any
23subsequent felony. Upon conviction for any subsequent offense,
24the Department of Corrections shall have access to all sealed
25records of the Illinois State Police pertaining to that
26individual. Upon entry of the order of expungement, the

 

 

SB2612- 200 -LRB103 34492 JAG 64324 b

1circuit court clerk shall promptly mail a copy of the order to
2the person who was pardoned.
3    (e-5) Whenever a person who has been convicted of an
4offense is granted a certificate of eligibility for sealing by
5the Prisoner Review Board which specifically authorizes
6sealing, he or she may, upon verified petition to the Chief
7Judge of the circuit where the person had been convicted, any
8judge of the circuit designated by the Chief Judge, or in
9counties of less than 3,000,000 inhabitants, the presiding
10trial judge at the petitioner's trial, have a court order
11entered sealing the record of arrest from the official records
12of the arresting authority and order that the records of the
13circuit court clerk and the Illinois State Police be sealed
14until further order of the court upon good cause shown or as
15otherwise provided herein, and the name of the petitioner
16obliterated from the official index requested to be kept by
17the circuit court clerk under Section 16 of the Clerks of
18Courts Act in connection with the arrest and conviction for
19the offense for which he or she had been granted the
20certificate but the order shall not affect any index issued by
21the circuit court clerk before the entry of the order. All
22records sealed by the Illinois State Police may be
23disseminated by the Illinois State Police only as required by
24this Act or to the arresting authority, a law enforcement
25agency, the State's Attorney, and the court upon a later
26arrest for the same or similar offense or for the purpose of

 

 

SB2612- 201 -LRB103 34492 JAG 64324 b

1sentencing for any subsequent felony. Upon conviction for any
2subsequent offense, the Department of Corrections shall have
3access to all sealed records of the Illinois State Police
4pertaining to that individual. Upon entry of the order of
5sealing, the circuit court clerk shall promptly mail a copy of
6the order to the person who was granted the certificate of
7eligibility for sealing.
8    (e-6) Whenever a person who has been convicted of an
9offense is granted a certificate of eligibility for
10expungement by the Prisoner Review Board which specifically
11authorizes expungement, he or she may, upon verified petition
12to the Chief Judge of the circuit where the person had been
13convicted, any judge of the circuit designated by the Chief
14Judge, or in counties of less than 3,000,000 inhabitants, the
15presiding trial judge at the petitioner's trial, have a court
16order entered expunging the record of arrest from the official
17records of the arresting authority and order that the records
18of the circuit court clerk and the Illinois State Police be
19sealed until further order of the court upon good cause shown
20or as otherwise provided herein, and the name of the
21petitioner obliterated from the official index requested to be
22kept by the circuit court clerk under Section 16 of the Clerks
23of Courts Act in connection with the arrest and conviction for
24the offense for which he or she had been granted the
25certificate but the order shall not affect any index issued by
26the circuit court clerk before the entry of the order. All

 

 

SB2612- 202 -LRB103 34492 JAG 64324 b

1records sealed by the Illinois State Police may be
2disseminated by the Illinois State Police only as required by
3this Act or to the arresting authority, a law enforcement
4agency, the State's Attorney, and the court upon a later
5arrest for the same or similar offense or for the purpose of
6sentencing for any subsequent felony. Upon conviction for any
7subsequent offense, the Department of Corrections shall have
8access to all expunged records of the Illinois State Police
9pertaining to that individual. Upon entry of the order of
10expungement, the circuit court clerk shall promptly mail a
11copy of the order to the person who was granted the certificate
12of eligibility for expungement.
13    (f) Subject to available funding, the Illinois Department
14of Corrections shall conduct a study of the impact of sealing,
15especially on employment and recidivism rates, utilizing a
16random sample of those who apply for the sealing of their
17criminal records under Public Act 93-211. At the request of
18the Illinois Department of Corrections, records of the
19Illinois Department of Employment Security shall be utilized
20as appropriate to assist in the study. The study shall not
21disclose any data in a manner that would allow the
22identification of any particular individual or employing unit.
23The study shall be made available to the General Assembly no
24later than September 1, 2010.
25    (g) Immediate Sealing.
26        (1) Applicability. Notwithstanding any other provision

 

 

SB2612- 203 -LRB103 34492 JAG 64324 b

1    of this Act to the contrary, and cumulative with any
2    rights to expungement or sealing of criminal records, this
3    subsection authorizes the immediate sealing of criminal
4    records of adults and of minors prosecuted as adults.
5        (2) Eligible Records. Arrests or charges not initiated
6    by arrest resulting in acquittal or dismissal with
7    prejudice, except as excluded by subsection (a)(3)(B),
8    that occur on or after January 1, 2018 (the effective date
9    of Public Act 100-282), may be sealed immediately if the
10    petition is filed with the circuit court clerk on the same
11    day and during the same hearing in which the case is
12    disposed.
13        (3) When Records are Eligible to be Immediately
14    Sealed. Eligible records under paragraph (2) of this
15    subsection (g) may be sealed immediately after entry of
16    the final disposition of a case, notwithstanding the
17    disposition of other charges in the same case.
18        (4) Notice of Eligibility for Immediate Sealing. Upon
19    entry of a disposition for an eligible record under this
20    subsection (g), the defendant shall be informed by the
21    court of his or her right to have eligible records
22    immediately sealed and the procedure for the immediate
23    sealing of these records.
24        (5) Procedure. The following procedures apply to
25    immediate sealing under this subsection (g).
26            (A) Filing the Petition. Upon entry of the final

 

 

SB2612- 204 -LRB103 34492 JAG 64324 b

1        disposition of the case, the defendant's attorney may
2        immediately petition the court, on behalf of the
3        defendant, for immediate sealing of eligible records
4        under paragraph (2) of this subsection (g) that are
5        entered on or after January 1, 2018 (the effective
6        date of Public Act 100-282). The immediate sealing
7        petition may be filed with the circuit court clerk
8        during the hearing in which the final disposition of
9        the case is entered. If the defendant's attorney does
10        not file the petition for immediate sealing during the
11        hearing, the defendant may file a petition for sealing
12        at any time as authorized under subsection (c)(3)(A).
13            (B) Contents of Petition. The immediate sealing
14        petition shall be verified and shall contain the
15        petitioner's name, date of birth, current address, and
16        for each eligible record, the case number, the date of
17        arrest if applicable, the identity of the arresting
18        authority if applicable, and other information as the
19        court may require.
20            (C) Drug Test. The petitioner shall not be
21        required to attach proof that he or she has passed a
22        drug test.
23            (D) Service of Petition. A copy of the petition
24        shall be served on the State's Attorney in open court.
25        The petitioner shall not be required to serve a copy of
26        the petition on any other agency.

 

 

SB2612- 205 -LRB103 34492 JAG 64324 b

1            (E) Entry of Order. The presiding trial judge
2        shall enter an order granting or denying the petition
3        for immediate sealing during the hearing in which it
4        is filed. Petitions for immediate sealing shall be
5        ruled on in the same hearing in which the final
6        disposition of the case is entered.
7            (F) Hearings. The court shall hear the petition
8        for immediate sealing on the same day and during the
9        same hearing in which the disposition is rendered.
10            (G) Service of Order. An order to immediately seal
11        eligible records shall be served in conformance with
12        subsection (d)(8).
13            (H) Implementation of Order. An order to
14        immediately seal records shall be implemented in
15        conformance with subsections (d)(9)(C) and (d)(9)(D).
16            (I) Fees. The fee imposed by the circuit court
17        clerk and the Illinois State Police shall comply with
18        paragraph (1) of subsection (d) of this Section.
19            (J) Final Order. No court order issued under this
20        subsection (g) shall become final for purposes of
21        appeal until 30 days after service of the order on the
22        petitioner and all parties entitled to service of the
23        order in conformance with subsection (d)(8).
24            (K) Motion to Vacate, Modify, or Reconsider. Under
25        Section 2-1203 of the Code of Civil Procedure, the
26        petitioner, State's Attorney, or the Illinois State

 

 

SB2612- 206 -LRB103 34492 JAG 64324 b

1        Police may file a motion to vacate, modify, or
2        reconsider the order denying the petition to
3        immediately seal within 60 days of service of the
4        order. If filed more than 60 days after service of the
5        order, a petition to vacate, modify, or reconsider
6        shall comply with subsection (c) of Section 2-1401 of
7        the Code of Civil Procedure.
8            (L) Effect of Order. An order granting an
9        immediate sealing petition shall not be considered
10        void because it fails to comply with the provisions of
11        this Section or because of an error asserted in a
12        motion to vacate, modify, or reconsider. The circuit
13        court retains jurisdiction to determine whether the
14        order is voidable, and to vacate, modify, or
15        reconsider its terms based on a motion filed under
16        subparagraph (L) of this subsection (g).
17            (M) Compliance with Order Granting Petition to
18        Seal Records. Unless a court has entered a stay of an
19        order granting a petition to immediately seal, all
20        parties entitled to service of the order must fully
21        comply with the terms of the order within 60 days of
22        service of the order.
23    (h) Sealing or vacation and expungement of trafficking
24victims' crimes.
25        (1) A trafficking victim, as defined by paragraph (10)
26    of subsection (a) of Section 10-9 of the Criminal Code of

 

 

SB2612- 207 -LRB103 34492 JAG 64324 b

1    2012, may petition for vacation and expungement or
2    immediate sealing of his or her criminal record upon the
3    completion of his or her last sentence if his or her
4    participation in the underlying offense was a result of
5    human trafficking under Section 10-9 of the Criminal Code
6    of 2012 or a severe form of trafficking under the federal
7    Trafficking Victims Protection Act.
8        (1.5) A petition under paragraph (1) shall be
9    prepared, signed, and filed in accordance with Supreme
10    Court Rule 9. The court may allow the petitioner to attend
11    any required hearing remotely in accordance with local
12    rules. The court may allow a petition to be filed under
13    seal if the public filing of the petition would constitute
14    a risk of harm to the petitioner.
15        (2) A petitioner under this subsection (h), in
16    addition to the requirements provided under paragraph (4)
17    of subsection (d) of this Section, shall include in his or
18    her petition a clear and concise statement that: (A) he or
19    she was a victim of human trafficking at the time of the
20    offense; and (B) that his or her participation in the
21    offense was a result of human trafficking under Section
22    10-9 of the Criminal Code of 2012 or a severe form of
23    trafficking under the federal Trafficking Victims
24    Protection Act.
25        (3) If an objection is filed alleging that the
26    petitioner is not entitled to vacation and expungement or

 

 

SB2612- 208 -LRB103 34492 JAG 64324 b

1    immediate sealing under this subsection (h), the court
2    shall conduct a hearing under paragraph (7) of subsection
3    (d) of this Section and the court shall determine whether
4    the petitioner is entitled to vacation and expungement or
5    immediate sealing under this subsection (h). A petitioner
6    is eligible for vacation and expungement or immediate
7    relief under this subsection (h) if he or she shows, by a
8    preponderance of the evidence, that: (A) he or she was a
9    victim of human trafficking at the time of the offense;
10    and (B) that his or her participation in the offense was a
11    result of human trafficking under Section 10-9 of the
12    Criminal Code of 2012 or a severe form of trafficking
13    under the federal Trafficking Victims Protection Act.
14    (i) Minor Cannabis Offenses under the Cannabis Control
15Act.
16        (1) Expungement of Arrest Records of Minor Cannabis
17    Offenses.
18            (A) The Illinois State Police and all law
19        enforcement agencies within the State shall
20        automatically expunge all criminal history records of
21        an arrest, charge not initiated by arrest, order of
22        supervision, or order of qualified probation for a
23        Minor Cannabis Offense committed prior to June 25,
24        2019 (the effective date of Public Act 101-27) if:
25                (i) One year or more has elapsed since the
26            date of the arrest or law enforcement interaction

 

 

SB2612- 209 -LRB103 34492 JAG 64324 b

1            documented in the records; and
2                (ii) No criminal charges were filed relating
3            to the arrest or law enforcement interaction or
4            criminal charges were filed and subsequently
5            dismissed or vacated or the arrestee was
6            acquitted.
7            (B) If the law enforcement agency is unable to
8        verify satisfaction of condition (ii) in paragraph
9        (A), records that satisfy condition (i) in paragraph
10        (A) shall be automatically expunged.
11            (C) Records shall be expunged by the law
12        enforcement agency under the following timelines:
13                (i) Records created prior to June 25, 2019
14            (the effective date of Public Act 101-27), but on
15            or after January 1, 2013, shall be automatically
16            expunged prior to January 1, 2021;
17                (ii) Records created prior to January 1, 2013,
18            but on or after January 1, 2000, shall be
19            automatically expunged prior to January 1, 2025
20            2023;
21                (iii) Records created prior to January 1, 2000
22            shall be automatically expunged prior to January
23            1, 2027 2025.
24            In response to an inquiry for expunged records,
25        the law enforcement agency receiving such inquiry
26        shall reply as it does in response to inquiries when no

 

 

SB2612- 210 -LRB103 34492 JAG 64324 b

1        records ever existed; however, it shall provide a
2        certificate of disposition or confirmation that the
3        record was expunged to the individual whose record was
4        expunged if such a record exists.
5            (D) Nothing in this Section shall be construed to
6        restrict or modify an individual's right to have that
7        individual's records expunged except as otherwise may
8        be provided in this Act, or diminish or abrogate any
9        rights or remedies otherwise available to the
10        individual.
11        (2) Pardons Authorizing Expungement of Minor Cannabis
12    Offenses.
13            (A) Upon June 25, 2019 (the effective date of
14        Public Act 101-27), the Illinois Department of State
15        Police shall review all criminal history record
16        information and identify all records that meet all of
17        the following criteria:
18                (i) one or more convictions for a Minor
19            Cannabis Offense;
20                (ii) the conviction identified in paragraph
21            (2)(A)(i) did not include a penalty enhancement
22            under Section 7 of the Cannabis Control Act; and
23                (iii) the conviction identified in paragraph
24            (2)(A)(i) is not associated with a conviction for
25            a violent crime as defined in subsection (c) of
26            Section 3 of the Rights of Crime Victims and

 

 

SB2612- 211 -LRB103 34492 JAG 64324 b

1            Witnesses Act.
2            (B) Within 180 days after June 25, 2019 (the
3        effective date of Public Act 101-27), the Department
4        of State Police shall notify the Prisoner Review Board
5        of all such records that meet the criteria established
6        in paragraph (2)(A).
7                (i) The Prisoner Review Board shall notify the
8            State's Attorney of the county of conviction of
9            each record identified by State Police in
10            paragraph (2)(A) that is classified as a Class 4
11            felony. The State's Attorney may provide a written
12            objection to the Prisoner Review Board on the sole
13            basis that the record identified does not meet the
14            criteria established in paragraph (2)(A). Such an
15            objection must be filed within 60 days or by such
16            later date set by the Prisoner Review Board in the
17            notice after the State's Attorney received notice
18            from the Prisoner Review Board.
19                (ii) In response to a written objection from a
20            State's Attorney, the Prisoner Review Board is
21            authorized to conduct a non-public hearing to
22            evaluate the information provided in the
23            objection.
24                (iii) The Prisoner Review Board shall make a
25            confidential and privileged recommendation to the
26            Governor as to whether to grant a pardon

 

 

SB2612- 212 -LRB103 34492 JAG 64324 b

1            authorizing expungement for each of the records
2            identified by the Department of State Police as
3            described in paragraph (2)(A).
4            (C) If an individual has been granted a pardon
5        authorizing expungement as described in this Section,
6        the Prisoner Review Board, through the Attorney
7        General, shall file a petition for expungement with
8        the Chief Judge of the circuit or any judge of the
9        circuit designated by the Chief Judge where the
10        individual had been convicted. Such petition may
11        include more than one individual. Whenever an
12        individual who has been convicted of an offense is
13        granted a pardon by the Governor that specifically
14        authorizes expungement, an objection to the petition
15        may not be filed. Petitions to expunge under this
16        subsection (i) may include more than one individual.
17        Within 90 days of the filing of such a petition, the
18        court shall enter an order expunging the records of
19        arrest from the official records of the arresting
20        authority and order that the records of the circuit
21        court clerk and the Illinois State Police be expunged
22        and the name of the defendant obliterated from the
23        official index requested to be kept by the circuit
24        court clerk under Section 16 of the Clerks of Courts
25        Act in connection with the arrest and conviction for
26        the offense for which the individual had received a

 

 

SB2612- 213 -LRB103 34492 JAG 64324 b

1        pardon but the order shall not affect any index issued
2        by the circuit court clerk before the entry of the
3        order. Upon entry of the order of expungement, the
4        circuit court clerk shall promptly provide a copy of
5        the order and a certificate of disposition to the
6        individual who was pardoned to the individual's last
7        known address or by electronic means (if available) or
8        otherwise make it available to the individual upon
9        request.
10            (D) Nothing in this Section is intended to
11        diminish or abrogate any rights or remedies otherwise
12        available to the individual.
13        (3) Any individual may file a motion to vacate and
14    expunge a conviction for a misdemeanor or Class 4 felony
15    violation of Section 4 or Section 5 of the Cannabis
16    Control Act. Motions to vacate and expunge under this
17    subsection (i) may be filed with the circuit court, Chief
18    Judge of a judicial circuit or any judge of the circuit
19    designated by the Chief Judge. The circuit court clerk
20    shall promptly serve a copy of the motion to vacate and
21    expunge, and any supporting documentation, on the State's
22    Attorney or prosecutor charged with the duty of
23    prosecuting the offense. When considering such a motion to
24    vacate and expunge, a court shall consider the following:
25    the reasons to retain the records provided by law
26    enforcement, the petitioner's age, the petitioner's age at

 

 

SB2612- 214 -LRB103 34492 JAG 64324 b

1    the time of offense, the time since the conviction, and
2    the specific adverse consequences if denied. An individual
3    may file such a petition after the completion of any
4    non-financial sentence or non-financial condition imposed
5    by the conviction. Within 60 days of the filing of such
6    motion, a State's Attorney may file an objection to such a
7    petition along with supporting evidence. If a motion to
8    vacate and expunge is granted, the records shall be
9    expunged in accordance with subparagraphs (d)(8) and
10    (d)(9)(A) of this Section. An agency providing civil legal
11    aid, as defined by Section 15 of the Public Interest
12    Attorney Assistance Act, assisting individuals seeking to
13    file a motion to vacate and expunge under this subsection
14    may file motions to vacate and expunge with the Chief
15    Judge of a judicial circuit or any judge of the circuit
16    designated by the Chief Judge, and the motion may include
17    more than one individual. Motions filed by an agency
18    providing civil legal aid concerning more than one
19    individual may be prepared, presented, and signed
20    electronically.
21        (4) Any State's Attorney may file a motion to vacate
22    and expunge a conviction for a misdemeanor or Class 4
23    felony violation of Section 4 or Section 5 of the Cannabis
24    Control Act. Motions to vacate and expunge under this
25    subsection (i) may be filed with the circuit court, Chief
26    Judge of a judicial circuit or any judge of the circuit

 

 

SB2612- 215 -LRB103 34492 JAG 64324 b

1    designated by the Chief Judge, and may include more than
2    one individual. Motions filed by a State's Attorney
3    concerning more than one individual may be prepared,
4    presented, and signed electronically. When considering
5    such a motion to vacate and expunge, a court shall
6    consider the following: the reasons to retain the records
7    provided by law enforcement, the individual's age, the
8    individual's age at the time of offense, the time since
9    the conviction, and the specific adverse consequences if
10    denied. Upon entry of an order granting a motion to vacate
11    and expunge records pursuant to this Section, the State's
12    Attorney shall notify the Prisoner Review Board within 30
13    days. Upon entry of the order of expungement, the circuit
14    court clerk shall promptly provide a copy of the order and
15    a certificate of disposition to the individual whose
16    records will be expunged to the individual's last known
17    address or by electronic means (if available) or otherwise
18    make available to the individual upon request. If a motion
19    to vacate and expunge is granted, the records shall be
20    expunged in accordance with subparagraphs (d)(8) and
21    (d)(9)(A) of this Section.
22        (5) In the public interest, the State's Attorney of a
23    county has standing to file motions to vacate and expunge
24    pursuant to this Section in the circuit court with
25    jurisdiction over the underlying conviction.
26        (6) If a person is arrested for a Minor Cannabis

 

 

SB2612- 216 -LRB103 34492 JAG 64324 b

1    Offense as defined in this Section before June 25, 2019
2    (the effective date of Public Act 101-27) and the person's
3    case is still pending but a sentence has not been imposed,
4    the person may petition the court in which the charges are
5    pending for an order to summarily dismiss those charges
6    against him or her, and expunge all official records of
7    his or her arrest, plea, trial, conviction, incarceration,
8    supervision, or expungement. If the court determines, upon
9    review, that: (A) the person was arrested before June 25,
10    2019 (the effective date of Public Act 101-27) for an
11    offense that has been made eligible for expungement; (B)
12    the case is pending at the time; and (C) the person has not
13    been sentenced of the minor cannabis violation eligible
14    for expungement under this subsection, the court shall
15    consider the following: the reasons to retain the records
16    provided by law enforcement, the petitioner's age, the
17    petitioner's age at the time of offense, the time since
18    the conviction, and the specific adverse consequences if
19    denied. If a motion to dismiss and expunge is granted, the
20    records shall be expunged in accordance with subparagraph
21    (d)(9)(A) of this Section.
22        (7) A person imprisoned solely as a result of one or
23    more convictions for Minor Cannabis Offenses under this
24    subsection (i) shall be released from incarceration upon
25    the issuance of an order under this subsection.
26        (8) The Illinois State Police shall allow a person to

 

 

SB2612- 217 -LRB103 34492 JAG 64324 b

1    use the access and review process, established in the
2    Illinois State Police, for verifying that his or her
3    records relating to Minor Cannabis Offenses of the
4    Cannabis Control Act eligible under this Section have been
5    expunged.
6        (9) No conviction vacated pursuant to this Section
7    shall serve as the basis for damages for time unjustly
8    served as provided in the Court of Claims Act.
9        (10) Effect of Expungement. A person's right to
10    expunge an expungeable offense shall not be limited under
11    this Section. The effect of an order of expungement shall
12    be to restore the person to the status he or she occupied
13    before the arrest, charge, or conviction.
14        (11) Information. The Illinois State Police shall post
15    general information on its website about the expungement
16    process described in this subsection (i).
17    (j) Felony Prostitution Convictions.
18        (1) Any individual may file a motion to vacate and
19    expunge a conviction for a prior Class 4 felony violation
20    of prostitution. Motions to vacate and expunge under this
21    subsection (j) may be filed with the circuit court, Chief
22    Judge of a judicial circuit, or any judge of the circuit
23    designated by the Chief Judge. When considering the motion
24    to vacate and expunge, a court shall consider the
25    following:
26            (A) the reasons to retain the records provided by

 

 

SB2612- 218 -LRB103 34492 JAG 64324 b

1        law enforcement;
2            (B) the petitioner's age;
3            (C) the petitioner's age at the time of offense;
4        and
5            (D) the time since the conviction, and the
6        specific adverse consequences if denied. An individual
7        may file the petition after the completion of any
8        sentence or condition imposed by the conviction.
9        Within 60 days of the filing of the motion, a State's
10        Attorney may file an objection to the petition along
11        with supporting evidence. If a motion to vacate and
12        expunge is granted, the records shall be expunged in
13        accordance with subparagraph (d)(9)(A) of this
14        Section. An agency providing civil legal aid, as
15        defined in Section 15 of the Public Interest Attorney
16        Assistance Act, assisting individuals seeking to file
17        a motion to vacate and expunge under this subsection
18        may file motions to vacate and expunge with the Chief
19        Judge of a judicial circuit or any judge of the circuit
20        designated by the Chief Judge, and the motion may
21        include more than one individual.
22        (2) Any State's Attorney may file a motion to vacate
23    and expunge a conviction for a Class 4 felony violation of
24    prostitution. Motions to vacate and expunge under this
25    subsection (j) may be filed with the circuit court, Chief
26    Judge of a judicial circuit, or any judge of the circuit

 

 

SB2612- 219 -LRB103 34492 JAG 64324 b

1    court designated by the Chief Judge, and may include more
2    than one individual. When considering the motion to vacate
3    and expunge, a court shall consider the following reasons:
4            (A) the reasons to retain the records provided by
5        law enforcement;
6            (B) the petitioner's age;
7            (C) the petitioner's age at the time of offense;
8            (D) the time since the conviction; and
9            (E) the specific adverse consequences if denied.
10        If the State's Attorney files a motion to vacate and
11    expunge records for felony prostitution convictions
12    pursuant to this Section, the State's Attorney shall
13    notify the Prisoner Review Board within 30 days of the
14    filing. If a motion to vacate and expunge is granted, the
15    records shall be expunged in accordance with subparagraph
16    (d)(9)(A) of this Section.
17        (3) In the public interest, the State's Attorney of a
18    county has standing to file motions to vacate and expunge
19    pursuant to this Section in the circuit court with
20    jurisdiction over the underlying conviction.
21        (4) The Illinois State Police shall allow a person to
22    a use the access and review process, established in the
23    Illinois State Police, for verifying that his or her
24    records relating to felony prostitution eligible under
25    this Section have been expunged.
26        (5) No conviction vacated pursuant to this Section

 

 

SB2612- 220 -LRB103 34492 JAG 64324 b

1    shall serve as the basis for damages for time unjustly
2    served as provided in the Court of Claims Act.
3        (6) Effect of Expungement. A person's right to expunge
4    an expungeable offense shall not be limited under this
5    Section. The effect of an order of expungement shall be to
6    restore the person to the status he or she occupied before
7    the arrest, charge, or conviction.
8        (7) Information. The Illinois State Police shall post
9    general information on its website about the expungement
10    process described in this subsection (j).
11(Source: P.A. 102-145, eff. 7-23-21; 102-558, 8-20-21;
12102-639, eff. 8-27-21; 102-813, eff. 5-13-22; 102-933, eff.
131-1-23; 103-35, eff. 1-1-24; 103-154, eff. 6-30-23.)
 
14    Section 550. The State Finance Act is amended by adding
15Sections 5.1015 and 5.1016 as follows:
 
16    (30 ILCS 105/5.1015 new)
17    Sec. 5.1015. The Psilocybin Control and Regulation Fund.
 
18    (30 ILCS 105/5.1016 new)
19    Sec. 5.1016. The Illinois Psilocybin Fund.
 
20    Section 555. The Illinois Independent Tax Tribunal Act of
212012 is amended by changing Section 1-45 as follows:
 

 

 

SB2612- 221 -LRB103 34492 JAG 64324 b

1    (35 ILCS 1010/1-45)
2    Sec. 1-45. Jurisdiction of the Tax Tribunal.
3    (a) Except as provided by the Constitution of the United
4States, the Constitution of the State of Illinois, or any
5statutes of this State, including, but not limited to, the
6State Officers and Employees Money Disposition Act, the Tax
7Tribunal shall have original jurisdiction over all
8determinations of the Department reflected on a Notice of
9Deficiency, Notice of Tax Liability, Notice of Claim Denial,
10or Notice of Penalty Liability issued under the Illinois
11Income Tax Act, the Use Tax Act, the Service Use Tax Act, the
12Service Occupation Tax Act, the Retailers' Occupation Tax Act,
13the Cigarette Tax Act, the Cigarette Use Tax Act, the Tobacco
14Products Tax Act of 1995, the Hotel Operators' Occupation Tax
15Act, the Motor Fuel Tax Law, the Automobile Renting Occupation
16and Use Tax Act, the Coin-Operated Amusement Device and
17Redemption Machine Tax Act, the Gas Revenue Tax Act, the Water
18Company Invested Capital Tax Act, the Telecommunications
19Excise Tax Act, the Telecommunications Infrastructure
20Maintenance Fee Act, the Public Utilities Revenue Act, the
21Electricity Excise Tax Law, the Aircraft Use Tax Law, the
22Watercraft Use Tax Law, the Gas Use Tax Law, or the Uniform
23Penalty and Interest Act, or the Compassionate Use and
24Research of Entheogens Act. Jurisdiction of the Tax Tribunal
25is limited to Notices of Tax Liability, Notices of Deficiency,
26Notices of Claim Denial, and Notices of Penalty Liability

 

 

SB2612- 222 -LRB103 34492 JAG 64324 b

1where the amount at issue in a notice, or the aggregate amount
2at issue in multiple notices issued for the same tax year or
3audit period, exceeds $15,000, exclusive of penalties and
4interest. In notices solely asserting either an interest or
5penalty assessment, or both, the Tax Tribunal shall have
6jurisdiction over cases where the combined total of all
7penalties or interest assessed exceeds $15,000.
8    (b) Except as otherwise permitted by this Act and by the
9Constitution of the State of Illinois or otherwise by State
10law, including, but not limited to, the State Officers and
11Employees Money Disposition Act, no person shall contest any
12matter within the jurisdiction of the Tax Tribunal in any
13action, suit, or proceeding in the circuit court or any other
14court of the State. If a person attempts to do so, then such
15action, suit, or proceeding shall be dismissed without
16prejudice. The improper commencement of any action, suit, or
17proceeding does not extend the time period for commencing a
18proceeding in the Tax Tribunal.
19    (c) The Tax Tribunal may require the taxpayer to post a
20bond equal to 25% of the liability at issue (1) upon motion of
21the Department and a showing that (A) the taxpayer's action is
22frivolous or legally insufficient or (B) the taxpayer is
23acting primarily for the purpose of delaying the collection of
24tax or prejudicing the ability ultimately to collect the tax,
25or (2) if, at any time during the proceedings, it is determined
26by the Tax Tribunal that the taxpayer is not pursuing the

 

 

SB2612- 223 -LRB103 34492 JAG 64324 b

1resolution of the case with due diligence. If the Tax Tribunal
2finds in a particular case that the taxpayer cannot procure
3and furnish a satisfactory surety or sureties for the kind of
4bond required herein, the Tax Tribunal may relieve the
5taxpayer of the obligation of filing such bond, if, upon the
6timely application for a lien in lieu thereof and accompanying
7proof therein submitted, the Tax Tribunal is satisfied that
8any such lien imposed would operate to secure the assessment
9in the manner and to the degree as would a bond. The Tax
10Tribunal shall adopt rules for the procedures to be used in
11securing a bond or lien under this Section.
12    (d) If, with or after the filing of a timely petition, the
13taxpayer pays all or part of the tax or other amount in issue
14before the Tax Tribunal has rendered a decision, the Tax
15Tribunal shall treat the taxpayer's petition as a protest of a
16denial of claim for refund of the amount so paid upon a written
17motion filed by the taxpayer.
18    (e) The Tax Tribunal shall not have jurisdiction to
19review:
20        (1) any assessment made under the Property Tax Code;
21        (2) any decisions relating to the issuance or denial
22    of an exemption ruling for any entity claiming exemption
23    from any tax imposed under the Property Tax Code or any
24    State tax administered by the Department;
25        (3) a notice of proposed tax liability, notice of
26    proposed deficiency, or any other notice of proposed

 

 

SB2612- 224 -LRB103 34492 JAG 64324 b

1    assessment or notice of intent to take some action;
2        (4) any action or determination of the Department
3    regarding tax liabilities that have become finalized by
4    law, including but not limited to the issuance of liens,
5    levies, and revocations, suspensions, or denials of
6    licenses or certificates of registration or any other
7    collection activities;
8        (5) any proceedings of the Department's informal
9    administrative appeals function; and
10        (6) any challenge to an administrative subpoena issued
11    by the Department.
12    (f) The Tax Tribunal shall decide questions regarding the
13constitutionality of statutes and rules adopted by the
14Department as applied to the taxpayer, but shall not have the
15power to declare a statute or rule unconstitutional or
16otherwise invalid on its face. A taxpayer challenging the
17constitutionality of a statute or rule on its face may present
18such challenge to the Tax Tribunal for the sole purpose of
19making a record for review by the Illinois Appellate Court.
20Failure to raise a constitutional issue regarding the
21application of a statute or regulations to the taxpayer shall
22not preclude the taxpayer or the Department from raising those
23issues at the appellate court level.
24(Source: P.A. 97-1129, eff. 8-28-12; 98-463, eff. 8-16-13.)
 
25    Section 560. The Illinois Controlled Substances Act is

 

 

SB2612- 225 -LRB103 34492 JAG 64324 b

1amended by changing Sections 102 and 204 as follows:
 
2    (720 ILCS 570/102)  (from Ch. 56 1/2, par. 1102)
3    Sec. 102. Definitions. As used in this Act, unless the
4context otherwise requires:
5    (a) "Addict" means any person who habitually uses any
6drug, chemical, substance or dangerous drug other than alcohol
7so as to endanger the public morals, health, safety or welfare
8or who is so far addicted to the use of a dangerous drug or
9controlled substance other than alcohol as to have lost the
10power of self control with reference to his or her addiction.
11    (b) "Administer" means the direct application of a
12controlled substance, whether by injection, inhalation,
13ingestion, or any other means, to the body of a patient,
14research subject, or animal (as defined by the Humane
15Euthanasia in Animal Shelters Act) by:
16        (1) a practitioner (or, in his or her presence, by his
17    or her authorized agent),
18        (2) the patient or research subject pursuant to an
19    order, or
20        (3) a euthanasia technician as defined by the Humane
21    Euthanasia in Animal Shelters Act.
22    (c) "Agent" means an authorized person who acts on behalf
23of or at the direction of a manufacturer, distributor,
24dispenser, prescriber, or practitioner. It does not include a
25common or contract carrier, public warehouseman or employee of

 

 

SB2612- 226 -LRB103 34492 JAG 64324 b

1the carrier or warehouseman.
2    (c-1) "Anabolic Steroids" means any drug or hormonal
3substance, chemically and pharmacologically related to
4testosterone (other than estrogens, progestins,
5corticosteroids, and dehydroepiandrosterone), and includes:
6    (i) 3[beta],17-dihydroxy-5a-androstane, 
7    (ii) 3[alpha],17[beta]-dihydroxy-5a-androstane, 
8    (iii) 5[alpha]-androstan-3,17-dione, 
9    (iv) 1-androstenediol (3[beta], 
10        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
11    (v) 1-androstenediol (3[alpha], 
12        17[beta]-dihydroxy-5[alpha]-androst-1-ene), 
13    (vi) 4-androstenediol  
14        (3[beta],17[beta]-dihydroxy-androst-4-ene), 
15    (vii) 5-androstenediol  
16        (3[beta],17[beta]-dihydroxy-androst-5-ene), 
17    (viii) 1-androstenedione  
18        ([5alpha]-androst-1-en-3,17-dione), 
19    (ix) 4-androstenedione  
20        (androst-4-en-3,17-dione), 
21    (x) 5-androstenedione  
22        (androst-5-en-3,17-dione), 
23    (xi) bolasterone (7[alpha],17a-dimethyl-17[beta]- 
24        hydroxyandrost-4-en-3-one), 
25    (xii) boldenone (17[beta]-hydroxyandrost- 
26        1,4,-diene-3-one), 

 

 

SB2612- 227 -LRB103 34492 JAG 64324 b

1    (xiii) boldione (androsta-1,4- 
2        diene-3,17-dione), 
3    (xiv) calusterone (7[beta],17[alpha]-dimethyl-17 
4        [beta]-hydroxyandrost-4-en-3-one), 
5    (xv) clostebol (4-chloro-17[beta]- 
6        hydroxyandrost-4-en-3-one), 
7    (xvi) dehydrochloromethyltestosterone (4-chloro- 
8        17[beta]-hydroxy-17[alpha]-methyl- 
9        androst-1,4-dien-3-one), 
10    (xvii) desoxymethyltestosterone 
11    (17[alpha]-methyl-5[alpha] 
12        -androst-2-en-17[beta]-ol)(a.k.a., madol), 
13    (xviii) [delta]1-dihydrotestosterone (a.k.a.  
14        '1-testosterone') (17[beta]-hydroxy- 
15        5[alpha]-androst-1-en-3-one), 
16    (xix) 4-dihydrotestosterone (17[beta]-hydroxy- 
17        androstan-3-one), 
18    (xx) drostanolone (17[beta]-hydroxy-2[alpha]-methyl- 
19        5[alpha]-androstan-3-one), 
20    (xxi) ethylestrenol (17[alpha]-ethyl-17[beta]- 
21        hydroxyestr-4-ene), 
22    (xxii) fluoxymesterone (9-fluoro-17[alpha]-methyl- 
23        1[beta],17[beta]-dihydroxyandrost-4-en-3-one), 
24    (xxiii) formebolone (2-formyl-17[alpha]-methyl-11[alpha], 
25        17[beta]-dihydroxyandrost-1,4-dien-3-one), 
26    (xxiv) furazabol (17[alpha]-methyl-17[beta]- 

 

 

SB2612- 228 -LRB103 34492 JAG 64324 b

1        hydroxyandrostano[2,3-c]-furazan), 
2    (xxv) 13[beta]-ethyl-17[beta]-hydroxygon-4-en-3-one, 
3    (xxvi) 4-hydroxytestosterone (4,17[beta]-dihydroxy- 
4        androst-4-en-3-one), 
5    (xxvii) 4-hydroxy-19-nortestosterone (4,17[beta]- 
6        dihydroxy-estr-4-en-3-one), 
7    (xxviii) mestanolone (17[alpha]-methyl-17[beta]- 
8        hydroxy-5-androstan-3-one), 
9    (xxix) mesterolone (1amethyl-17[beta]-hydroxy- 
10        [5a]-androstan-3-one), 
11    (xxx) methandienone (17[alpha]-methyl-17[beta]- 
12        hydroxyandrost-1,4-dien-3-one), 
13    (xxxi) methandriol (17[alpha]-methyl-3[beta],17[beta]- 
14        dihydroxyandrost-5-ene), 
15    (xxxii) methenolone (1-methyl-17[beta]-hydroxy- 
16        5[alpha]-androst-1-en-3-one), 
17    (xxxiii) 17[alpha]-methyl-3[beta], 17[beta]- 
18        dihydroxy-5a-androstane, 
19    (xxxiv) 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy 
20        -5a-androstane, 
21    (xxxv) 17[alpha]-methyl-3[beta],17[beta]- 
22        dihydroxyandrost-4-ene), 
23    (xxxvi) 17[alpha]-methyl-4-hydroxynandrolone (17[alpha]- 
24        methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one), 
25    (xxxvii) methyldienolone (17[alpha]-methyl-17[beta]- 
26        hydroxyestra-4,9(10)-dien-3-one), 

 

 

SB2612- 229 -LRB103 34492 JAG 64324 b

1    (xxxviii) methyltrienolone (17[alpha]-methyl-17[beta]- 
2        hydroxyestra-4,9-11-trien-3-one), 
3    (xxxix) methyltestosterone (17[alpha]-methyl-17[beta]- 
4        hydroxyandrost-4-en-3-one), 
5    (xl) mibolerone (7[alpha],17a-dimethyl-17[beta]- 
6        hydroxyestr-4-en-3-one), 
7    (xli) 17[alpha]-methyl-[delta]1-dihydrotestosterone  
8        (17b[beta]-hydroxy-17[alpha]-methyl-5[alpha]- 
9        androst-1-en-3-one)(a.k.a. '17-[alpha]-methyl- 
10        1-testosterone'), 
11    (xlii) nandrolone (17[beta]-hydroxyestr-4-en-3-one), 
12    (xliii) 19-nor-4-androstenediol (3[beta], 17[beta]- 
13        dihydroxyestr-4-ene), 
14    (xliv) 19-nor-4-androstenediol (3[alpha], 17[beta]- 
15        dihydroxyestr-4-ene), 
16    (xlv) 19-nor-5-androstenediol (3[beta], 17[beta]- 
17        dihydroxyestr-5-ene), 
18    (xlvi) 19-nor-5-androstenediol (3[alpha], 17[beta]- 
19        dihydroxyestr-5-ene), 
20    (xlvii) 19-nor-4,9(10)-androstadienedione  
21        (estra-4,9(10)-diene-3,17-dione), 
22    (xlviii) 19-nor-4-androstenedione (estr-4- 
23        en-3,17-dione), 
24    (xlix) 19-nor-5-androstenedione (estr-5- 
25        en-3,17-dione), 
26    (l) norbolethone (13[beta], 17a-diethyl-17[beta]- 

 

 

SB2612- 230 -LRB103 34492 JAG 64324 b

1        hydroxygon-4-en-3-one), 
2    (li) norclostebol (4-chloro-17[beta]- 
3        hydroxyestr-4-en-3-one), 
4    (lii) norethandrolone (17[alpha]-ethyl-17[beta]- 
5        hydroxyestr-4-en-3-one), 
6    (liii) normethandrolone (17[alpha]-methyl-17[beta]- 
7        hydroxyestr-4-en-3-one), 
8    (liv) oxandrolone (17[alpha]-methyl-17[beta]-hydroxy- 
9        2-oxa-5[alpha]-androstan-3-one), 
10    (lv) oxymesterone (17[alpha]-methyl-4,17[beta]- 
11        dihydroxyandrost-4-en-3-one), 
12    (lvi) oxymetholone (17[alpha]-methyl-2-hydroxymethylene- 
13        17[beta]-hydroxy-(5[alpha]-androstan-3-one), 
14    (lvii) stanozolol (17[alpha]-methyl-17[beta]-hydroxy- 
15        (5[alpha]-androst-2-eno[3,2-c]-pyrazole), 
16    (lviii) stenbolone (17[beta]-hydroxy-2-methyl- 
17        (5[alpha]-androst-1-en-3-one), 
18    (lix) testolactone (13-hydroxy-3-oxo-13,17- 
19        secoandrosta-1,4-dien-17-oic 
20        acid lactone), 
21    (lx) testosterone (17[beta]-hydroxyandrost- 
22        4-en-3-one), 
23    (lxi) tetrahydrogestrinone (13[beta], 17[alpha]- 
24        diethyl-17[beta]-hydroxygon- 
25        4,9,11-trien-3-one), 
26    (lxii) trenbolone (17[beta]-hydroxyestr-4,9, 

 

 

SB2612- 231 -LRB103 34492 JAG 64324 b

1        11-trien-3-one). 
2    Any person who is otherwise lawfully in possession of an
3anabolic steroid, or who otherwise lawfully manufactures,
4distributes, dispenses, delivers, or possesses with intent to
5deliver an anabolic steroid, which anabolic steroid is
6expressly intended for and lawfully allowed to be administered
7through implants to livestock or other nonhuman species, and
8which is approved by the Secretary of Health and Human
9Services for such administration, and which the person intends
10to administer or have administered through such implants,
11shall not be considered to be in unauthorized possession or to
12unlawfully manufacture, distribute, dispense, deliver, or
13possess with intent to deliver such anabolic steroid for
14purposes of this Act.
15    (d) "Administration" means the Drug Enforcement
16Administration, United States Department of Justice, or its
17successor agency.
18    (d-5) "Clinical Director, Prescription Monitoring Program"
19means a Department of Human Services administrative employee
20licensed to either prescribe or dispense controlled substances
21who shall run the clinical aspects of the Department of Human
22Services Prescription Monitoring Program and its Prescription
23Information Library.
24    (d-10) "Compounding" means the preparation and mixing of
25components, excluding flavorings, (1) as the result of a
26prescriber's prescription drug order or initiative based on

 

 

SB2612- 232 -LRB103 34492 JAG 64324 b

1the prescriber-patient-pharmacist relationship in the course
2of professional practice or (2) for the purpose of, or
3incident to, research, teaching, or chemical analysis and not
4for sale or dispensing. "Compounding" includes the preparation
5of drugs or devices in anticipation of receiving prescription
6drug orders based on routine, regularly observed dispensing
7patterns. Commercially available products may be compounded
8for dispensing to individual patients only if both of the
9following conditions are met: (i) the commercial product is
10not reasonably available from normal distribution channels in
11a timely manner to meet the patient's needs and (ii) the
12prescribing practitioner has requested that the drug be
13compounded.
14    (e) "Control" means to add a drug or other substance, or
15immediate precursor, to a Schedule whether by transfer from
16another Schedule or otherwise.
17    (f) "Controlled Substance" means (i) a drug, substance,
18immediate precursor, or synthetic drug in the Schedules of
19Article II of this Act or (ii) a drug or other substance, or
20immediate precursor, designated as a controlled substance by
21the Department through administrative rule. The term does not
22include: distilled spirits, wine, malt beverages, or tobacco,
23as those terms are defined or used in the Liquor Control Act of
241934 and the Tobacco Products Tax Act of 1995; or psilocybin or
25a psilocybin product, as those terms are defined or used in the
26Compassionate Use and Research of Entheogens Act.

 

 

SB2612- 233 -LRB103 34492 JAG 64324 b

1    (f-5) "Controlled substance analog" means a substance:
2        (1) the chemical structure of which is substantially
3    similar to the chemical structure of a controlled
4    substance in Schedule I or II;
5        (2) which has a stimulant, depressant, or
6    hallucinogenic effect on the central nervous system that
7    is substantially similar to or greater than the stimulant,
8    depressant, or hallucinogenic effect on the central
9    nervous system of a controlled substance in Schedule I or
10    II; or
11        (3) with respect to a particular person, which such
12    person represents or intends to have a stimulant,
13    depressant, or hallucinogenic effect on the central
14    nervous system that is substantially similar to or greater
15    than the stimulant, depressant, or hallucinogenic effect
16    on the central nervous system of a controlled substance in
17    Schedule I or II.
18    (g) "Counterfeit substance" means a controlled substance,
19which, or the container or labeling of which, without
20authorization bears the trademark, trade name, or other
21identifying mark, imprint, number or device, or any likeness
22thereof, of a manufacturer, distributor, or dispenser other
23than the person who in fact manufactured, distributed, or
24dispensed the substance.
25    (h) "Deliver" or "delivery" means the actual, constructive
26or attempted transfer of possession of a controlled substance,

 

 

SB2612- 234 -LRB103 34492 JAG 64324 b

1with or without consideration, whether or not there is an
2agency relationship. "Deliver" or "delivery" does not include
3the donation of drugs to the extent permitted under the
4Illinois Drug Reuse Opportunity Program Act.
5    (i) "Department" means the Illinois Department of Human
6Services (as successor to the Department of Alcoholism and
7Substance Abuse) or its successor agency.
8    (j) (Blank).
9    (k) "Department of Corrections" means the Department of
10Corrections of the State of Illinois or its successor agency.
11    (l) "Department of Financial and Professional Regulation"
12means the Department of Financial and Professional Regulation
13of the State of Illinois or its successor agency.
14    (m) "Depressant" means any drug that (i) causes an overall
15depression of central nervous system functions, (ii) causes
16impaired consciousness and awareness, and (iii) can be
17habit-forming or lead to a substance abuse problem, including,
18but not limited to, alcohol, cannabis and its active
19principles and their analogs, benzodiazepines and their
20analogs, barbiturates and their analogs, opioids (natural and
21synthetic) and their analogs, and chloral hydrate and similar
22sedative hypnotics.
23    (n) (Blank).
24    (o) "Director" means the Director of the Illinois State
25Police or his or her designated agents.
26    (p) "Dispense" means to deliver a controlled substance to

 

 

SB2612- 235 -LRB103 34492 JAG 64324 b

1an ultimate user or research subject by or pursuant to the
2lawful order of a prescriber, including the prescribing,
3administering, packaging, labeling, or compounding necessary
4to prepare the substance for that delivery.
5    (q) "Dispenser" means a practitioner who dispenses.
6    (r) "Distribute" means to deliver, other than by
7administering or dispensing, a controlled substance.
8    (s) "Distributor" means a person who distributes.
9    (t) "Drug" means (1) substances recognized as drugs in the
10official United States Pharmacopoeia, Official Homeopathic
11Pharmacopoeia of the United States, or official National
12Formulary, or any supplement to any of them; (2) substances
13intended for use in diagnosis, cure, mitigation, treatment, or
14prevention of disease in man or animals; (3) substances (other
15than food) intended to affect the structure of any function of
16the body of man or animals and (4) substances intended for use
17as a component of any article specified in clause (1), (2), or
18(3) of this subsection. It does not include devices or their
19components, parts, or accessories.
20    (t-3) "Electronic health record" or "EHR" means an
21electronic record of health-related information on an
22individual that is created, gathered, managed, and consulted
23by authorized health care clinicians and staff.
24    (t-3.5) "Electronic health record system" or "EHR system"
25means any computer-based system or combination of federally
26certified Health IT Modules (defined at 42 CFR 170.102 or its

 

 

SB2612- 236 -LRB103 34492 JAG 64324 b

1successor) used as a repository for electronic health records
2and accessed or updated by a prescriber or authorized
3surrogate in the ordinary course of his or her medical
4practice. For purposes of connecting to the Prescription
5Information Library maintained by the Bureau of Pharmacy and
6Clinical Support Systems or its successor, an EHR system may
7connect to the Prescription Information Library directly or
8through all or part of a computer program or system that is a
9federally certified Health IT Module maintained by a third
10party and used by the EHR system to secure access to the
11database.
12    (t-4) "Emergency medical services personnel" has the
13meaning ascribed to it in the Emergency Medical Services (EMS)
14Systems Act.
15    (t-5) "Euthanasia agency" means an entity certified by the
16Department of Financial and Professional Regulation for the
17purpose of animal euthanasia that holds an animal control
18facility license or animal shelter license under the Animal
19Welfare Act. A euthanasia agency is authorized to purchase,
20store, possess, and utilize Schedule II nonnarcotic and
21Schedule III nonnarcotic drugs for the sole purpose of animal
22euthanasia.
23    (t-10) "Euthanasia drugs" means Schedule II or Schedule
24III substances (nonnarcotic controlled substances) that are
25used by a euthanasia agency for the purpose of animal
26euthanasia.

 

 

SB2612- 237 -LRB103 34492 JAG 64324 b

1    (u) "Good faith" means the prescribing or dispensing of a
2controlled substance by a practitioner in the regular course
3of professional treatment to or for any person who is under his
4or her treatment for a pathology or condition other than that
5individual's physical or psychological dependence upon or
6addiction to a controlled substance, except as provided
7herein: and application of the term to a pharmacist shall mean
8the dispensing of a controlled substance pursuant to the
9prescriber's order which in the professional judgment of the
10pharmacist is lawful. The pharmacist shall be guided by
11accepted professional standards, including, but not limited
12to, the following, in making the judgment:
13        (1) lack of consistency of prescriber-patient
14    relationship,
15        (2) frequency of prescriptions for same drug by one
16    prescriber for large numbers of patients,
17        (3) quantities beyond those normally prescribed,
18        (4) unusual dosages (recognizing that there may be
19    clinical circumstances where more or less than the usual
20    dose may be used legitimately),
21        (5) unusual geographic distances between patient,
22    pharmacist and prescriber,
23        (6) consistent prescribing of habit-forming drugs.
24    (u-0.5) "Hallucinogen" means a drug that causes markedly
25altered sensory perception leading to hallucinations of any
26type.

 

 

SB2612- 238 -LRB103 34492 JAG 64324 b

1    (u-1) "Home infusion services" means services provided by
2a pharmacy in compounding solutions for direct administration
3to a patient in a private residence, long-term care facility,
4or hospice setting by means of parenteral, intravenous,
5intramuscular, subcutaneous, or intraspinal infusion.
6    (u-5) "Illinois State Police" means the Illinois State
7Police or its successor agency.
8    (v) "Immediate precursor" means a substance:
9        (1) which the Department has found to be and by rule
10    designated as being a principal compound used, or produced
11    primarily for use, in the manufacture of a controlled
12    substance;
13        (2) which is an immediate chemical intermediary used
14    or likely to be used in the manufacture of such controlled
15    substance; and
16        (3) the control of which is necessary to prevent,
17    curtail or limit the manufacture of such controlled
18    substance.
19    (w) "Instructional activities" means the acts of teaching,
20educating or instructing by practitioners using controlled
21substances within educational facilities approved by the State
22Board of Education or its successor agency.
23    (x) "Local authorities" means a duly organized State,
24County or Municipal peace unit or police force.
25    (y) "Look-alike substance" means a substance, other than a
26controlled substance which (1) by overall dosage unit

 

 

SB2612- 239 -LRB103 34492 JAG 64324 b

1appearance, including shape, color, size, markings or lack
2thereof, taste, consistency, or any other identifying physical
3characteristic of the substance, would lead a reasonable
4person to believe that the substance is a controlled
5substance, or (2) is expressly or impliedly represented to be
6a controlled substance or is distributed under circumstances
7which would lead a reasonable person to believe that the
8substance is a controlled substance. For the purpose of
9determining whether the representations made or the
10circumstances of the distribution would lead a reasonable
11person to believe the substance to be a controlled substance
12under this clause (2) of subsection (y), the court or other
13authority may consider the following factors in addition to
14any other factor that may be relevant:
15        (a) statements made by the owner or person in control
16    of the substance concerning its nature, use or effect;
17        (b) statements made to the buyer or recipient that the
18    substance may be resold for profit;
19        (c) whether the substance is packaged in a manner
20    normally used for the illegal distribution of controlled
21    substances;
22        (d) whether the distribution or attempted distribution
23    included an exchange of or demand for money or other
24    property as consideration, and whether the amount of the
25    consideration was substantially greater than the
26    reasonable retail market value of the substance.

 

 

SB2612- 240 -LRB103 34492 JAG 64324 b

1    Clause (1) of this subsection (y) shall not apply to a
2noncontrolled substance in its finished dosage form that was
3initially introduced into commerce prior to the initial
4introduction into commerce of a controlled substance in its
5finished dosage form which it may substantially resemble.
6    Nothing in this subsection (y) prohibits the dispensing or
7distributing of noncontrolled substances by persons authorized
8to dispense and distribute controlled substances under this
9Act, provided that such action would be deemed to be carried
10out in good faith under subsection (u) if the substances
11involved were controlled substances.
12    Nothing in this subsection (y) or in this Act prohibits
13the manufacture, preparation, propagation, compounding,
14processing, packaging, advertising or distribution of a drug
15or drugs by any person registered pursuant to Section 510 of
16the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360).
17    (y-1) "Mail-order pharmacy" means a pharmacy that is
18located in a state of the United States that delivers,
19dispenses or distributes, through the United States Postal
20Service or other common carrier, to Illinois residents, any
21substance which requires a prescription.
22    (z) "Manufacture" means the production, preparation,
23propagation, compounding, conversion or processing of a
24controlled substance other than methamphetamine, either
25directly or indirectly, by extraction from substances of
26natural origin, or independently by means of chemical

 

 

SB2612- 241 -LRB103 34492 JAG 64324 b

1synthesis, or by a combination of extraction and chemical
2synthesis, and includes any packaging or repackaging of the
3substance or labeling of its container, except that this term
4does not include:
5        (1) by an ultimate user, the preparation or
6    compounding of a controlled substance for his or her own
7    use;
8        (2) by a practitioner, or his or her authorized agent
9    under his or her supervision, the preparation,
10    compounding, packaging, or labeling of a controlled
11    substance:
12            (a) as an incident to his or her administering or
13        dispensing of a controlled substance in the course of
14        his or her professional practice; or
15            (b) as an incident to lawful research, teaching or
16        chemical analysis and not for sale; or
17        (3) the packaging, repackaging, or labeling of drugs
18    only to the extent permitted under the Illinois Drug Reuse
19    Opportunity Program Act.
20    (z-1) (Blank).
21    (z-5) "Medication shopping" means the conduct prohibited
22under subsection (a) of Section 314.5 of this Act.
23    (z-10) "Mid-level practitioner" means (i) a physician
24assistant who has been delegated authority to prescribe
25through a written delegation of authority by a physician
26licensed to practice medicine in all of its branches, in

 

 

SB2612- 242 -LRB103 34492 JAG 64324 b

1accordance with Section 7.5 of the Physician Assistant
2Practice Act of 1987, (ii) an advanced practice registered
3nurse who has been delegated authority to prescribe through a
4written delegation of authority by a physician licensed to
5practice medicine in all of its branches or by a podiatric
6physician, in accordance with Section 65-40 of the Nurse
7Practice Act, (iii) an advanced practice registered nurse
8certified as a nurse practitioner, nurse midwife, or clinical
9nurse specialist who has been granted authority to prescribe
10by a hospital affiliate in accordance with Section 65-45 of
11the Nurse Practice Act, (iv) an animal euthanasia agency, or
12(v) a prescribing psychologist.
13    (aa) "Narcotic drug" means any of the following, whether
14produced directly or indirectly by extraction from substances
15of vegetable origin, or independently by means of chemical
16synthesis, or by a combination of extraction and chemical
17synthesis:
18        (1) opium, opiates, derivatives of opium and opiates,
19    including their isomers, esters, ethers, salts, and salts
20    of isomers, esters, and ethers, whenever the existence of
21    such isomers, esters, ethers, and salts is possible within
22    the specific chemical designation; however the term
23    "narcotic drug" does not include the isoquinoline
24    alkaloids of opium;
25        (2) (blank);
26        (3) opium poppy and poppy straw;

 

 

SB2612- 243 -LRB103 34492 JAG 64324 b

1        (4) coca leaves, except coca leaves and extracts of
2    coca leaves from which substantially all of the cocaine
3    and ecgonine, and their isomers, derivatives and salts,
4    have been removed;
5        (5) cocaine, its salts, optical and geometric isomers,
6    and salts of isomers;
7        (6) ecgonine, its derivatives, their salts, isomers,
8    and salts of isomers;
9        (7) any compound, mixture, or preparation which
10    contains any quantity of any of the substances referred to
11    in subparagraphs (1) through (6).
12    (bb) "Nurse" means a registered nurse licensed under the
13Nurse Practice Act.
14    (cc) (Blank).
15    (dd) "Opiate" means any substance having an addiction
16forming or addiction sustaining liability similar to morphine
17or being capable of conversion into a drug having addiction
18forming or addiction sustaining liability.
19    (ee) "Opium poppy" means the plant of the species Papaver
20somniferum L., except its seeds.
21    (ee-5) "Oral dosage" means a tablet, capsule, elixir, or
22solution or other liquid form of medication intended for
23administration by mouth, but the term does not include a form
24of medication intended for buccal, sublingual, or transmucosal
25administration.
26    (ff) "Parole and Pardon Board" means the Parole and Pardon

 

 

SB2612- 244 -LRB103 34492 JAG 64324 b

1Board of the State of Illinois or its successor agency.
2    (gg) "Person" means any individual, corporation,
3mail-order pharmacy, government or governmental subdivision or
4agency, business trust, estate, trust, partnership or
5association, or any other entity.
6    (hh) "Pharmacist" means any person who holds a license or
7certificate of registration as a registered pharmacist, a
8local registered pharmacist or a registered assistant
9pharmacist under the Pharmacy Practice Act.
10    (ii) "Pharmacy" means any store, ship or other place in
11which pharmacy is authorized to be practiced under the
12Pharmacy Practice Act.
13    (ii-5) "Pharmacy shopping" means the conduct prohibited
14under subsection (b) of Section 314.5 of this Act.
15    (ii-10) "Physician" (except when the context otherwise
16requires) means a person licensed to practice medicine in all
17of its branches.
18    (jj) "Poppy straw" means all parts, except the seeds, of
19the opium poppy, after mowing.
20    (kk) "Practitioner" means a physician licensed to practice
21medicine in all its branches, dentist, optometrist, podiatric
22physician, veterinarian, scientific investigator, pharmacist,
23physician assistant, advanced practice registered nurse,
24licensed practical nurse, registered nurse, emergency medical
25services personnel, hospital, laboratory, or pharmacy, or
26other person licensed, registered, or otherwise lawfully

 

 

SB2612- 245 -LRB103 34492 JAG 64324 b

1permitted by the United States or this State to distribute,
2dispense, conduct research with respect to, administer or use
3in teaching or chemical analysis, a controlled substance in
4the course of professional practice or research.
5    (ll) "Pre-printed prescription" means a written
6prescription upon which the designated drug has been indicated
7prior to the time of issuance; the term does not mean a written
8prescription that is individually generated by machine or
9computer in the prescriber's office.
10    (mm) "Prescriber" means a physician licensed to practice
11medicine in all its branches, dentist, optometrist,
12prescribing psychologist licensed under Section 4.2 of the
13Clinical Psychologist Licensing Act with prescriptive
14authority delegated under Section 4.3 of the Clinical
15Psychologist Licensing Act, podiatric physician, or
16veterinarian who issues a prescription, a physician assistant
17who issues a prescription for a controlled substance in
18accordance with Section 303.05, a written delegation, and a
19written collaborative agreement required under Section 7.5 of
20the Physician Assistant Practice Act of 1987, an advanced
21practice registered nurse with prescriptive authority
22delegated under Section 65-40 of the Nurse Practice Act and in
23accordance with Section 303.05, a written delegation, and a
24written collaborative agreement under Section 65-35 of the
25Nurse Practice Act, an advanced practice registered nurse
26certified as a nurse practitioner, nurse midwife, or clinical

 

 

SB2612- 246 -LRB103 34492 JAG 64324 b

1nurse specialist who has been granted authority to prescribe
2by a hospital affiliate in accordance with Section 65-45 of
3the Nurse Practice Act and in accordance with Section 303.05,
4or an advanced practice registered nurse certified as a nurse
5practitioner, nurse midwife, or clinical nurse specialist who
6has full practice authority pursuant to Section 65-43 of the
7Nurse Practice Act.
8    (nn) "Prescription" means a written, facsimile, or oral
9order, or an electronic order that complies with applicable
10federal requirements, of a physician licensed to practice
11medicine in all its branches, dentist, podiatric physician or
12veterinarian for any controlled substance, of an optometrist
13in accordance with Section 15.1 of the Illinois Optometric
14Practice Act of 1987, of a prescribing psychologist licensed
15under Section 4.2 of the Clinical Psychologist Licensing Act
16with prescriptive authority delegated under Section 4.3 of the
17Clinical Psychologist Licensing Act, of a physician assistant
18for a controlled substance in accordance with Section 303.05,
19a written delegation, and a written collaborative agreement
20required under Section 7.5 of the Physician Assistant Practice
21Act of 1987, of an advanced practice registered nurse with
22prescriptive authority delegated under Section 65-40 of the
23Nurse Practice Act who issues a prescription for a controlled
24substance in accordance with Section 303.05, a written
25delegation, and a written collaborative agreement under
26Section 65-35 of the Nurse Practice Act, of an advanced

 

 

SB2612- 247 -LRB103 34492 JAG 64324 b

1practice registered nurse certified as a nurse practitioner,
2nurse midwife, or clinical nurse specialist who has been
3granted authority to prescribe by a hospital affiliate in
4accordance with Section 65-45 of the Nurse Practice Act and in
5accordance with Section 303.05 when required by law, or of an
6advanced practice registered nurse certified as a nurse
7practitioner, nurse midwife, or clinical nurse specialist who
8has full practice authority pursuant to Section 65-43 of the
9Nurse Practice Act.
10    (nn-5) "Prescription Information Library" (PIL) means an
11electronic library that contains reported controlled substance
12data.
13    (nn-10) "Prescription Monitoring Program" (PMP) means the
14entity that collects, tracks, and stores reported data on
15controlled substances and select drugs pursuant to Section
16316.
17    (oo) "Production" or "produce" means manufacture,
18planting, cultivating, growing, or harvesting of a controlled
19substance other than methamphetamine.
20    (pp) "Registrant" means every person who is required to
21register under Section 302 of this Act.
22    (qq) "Registry number" means the number assigned to each
23person authorized to handle controlled substances under the
24laws of the United States and of this State.
25    (qq-5) "Secretary" means, as the context requires, either
26the Secretary of the Department or the Secretary of the

 

 

SB2612- 248 -LRB103 34492 JAG 64324 b

1Department of Financial and Professional Regulation, and the
2Secretary's designated agents.
3    (rr) "State" includes the State of Illinois and any state,
4district, commonwealth, territory, insular possession thereof,
5and any area subject to the legal authority of the United
6States of America.
7    (rr-5) "Stimulant" means any drug that (i) causes an
8overall excitation of central nervous system functions, (ii)
9causes impaired consciousness and awareness, and (iii) can be
10habit-forming or lead to a substance abuse problem, including,
11but not limited to, amphetamines and their analogs,
12methylphenidate and its analogs, cocaine, and phencyclidine
13and its analogs.
14    (rr-10) "Synthetic drug" includes, but is not limited to,
15any synthetic cannabinoids or piperazines or any synthetic
16cathinones as provided for in Schedule I.
17    (ss) "Ultimate user" means a person who lawfully possesses
18a controlled substance for his or her own use or for the use of
19a member of his or her household or for administering to an
20animal owned by him or her or by a member of his or her
21household.
22(Source: P.A. 101-666, eff. 1-1-22; 102-389, eff. 1-1-22;
23102-538, eff. 8-20-21; 102-813, eff. 5-13-22.)
 
24    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
25    (Text of Section before amendment by P.A. 103-245)

 

 

SB2612- 249 -LRB103 34492 JAG 64324 b

1    Sec. 204. (a) The controlled substances listed in this
2Section are included in Schedule I.
3    (b) Unless specifically excepted or unless listed in
4another schedule, any of the following opiates, including
5their isomers, esters, ethers, salts, and salts of isomers,
6esters, and ethers, whenever the existence of such isomers,
7esters, ethers and salts is possible within the specific
8chemical designation:
9        (1) Acetylmethadol;
10        (1.1) Acetyl-alpha-methylfentanyl
11    (N-[1-(1-methyl-2-phenethyl)-
12    4-piperidinyl]-N-phenylacetamide);
13        (2) Allylprodine;
14        (3) Alphacetylmethadol, except
15    levo-alphacetylmethadol (also known as levo-alpha-
16    acetylmethadol, levomethadyl acetate, or LAAM);
17        (4) Alphameprodine;
18        (5) Alphamethadol;
19        (6) Alpha-methylfentanyl
20    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
21    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
22    propanilido) piperidine;
23        (6.1) Alpha-methylthiofentanyl
24    (N-[1-methyl-2-(2-thienyl)ethyl-
25    4-piperidinyl]-N-phenylpropanamide);
26        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);

 

 

SB2612- 250 -LRB103 34492 JAG 64324 b

1        (7.1) PEPAP
2    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
3        (8) Benzethidine;
4        (9) Betacetylmethadol;
5        (9.1) Beta-hydroxyfentanyl
6    (N-[1-(2-hydroxy-2-phenethyl)-
7    4-piperidinyl]-N-phenylpropanamide);
8        (10) Betameprodine;
9        (11) Betamethadol;
10        (12) Betaprodine;
11        (13) Clonitazene;
12        (14) Dextromoramide;
13        (15) Diampromide;
14        (16) Diethylthiambutene;
15        (17) Difenoxin;
16        (18) Dimenoxadol;
17        (19) Dimepheptanol;
18        (20) Dimethylthiambutene;
19        (21) Dioxaphetylbutyrate;
20        (22) Dipipanone;
21        (23) Ethylmethylthiambutene;
22        (24) Etonitazene;
23        (25) Etoxeridine;
24        (26) Furethidine;
25        (27) Hydroxpethidine;
26        (28) Ketobemidone;

 

 

SB2612- 251 -LRB103 34492 JAG 64324 b

1        (29) Levomoramide;
2        (30) Levophenacylmorphan;
3        (31) 3-Methylfentanyl
4    (N-[3-methyl-1-(2-phenylethyl)-
5    4-piperidyl]-N-phenylpropanamide);
6        (31.1) 3-Methylthiofentanyl
7    (N-[(3-methyl-1-(2-thienyl)ethyl-
8    4-piperidinyl]-N-phenylpropanamide);
9        (32) Morpheridine;
10        (33) Noracymethadol;
11        (34) Norlevorphanol;
12        (35) Normethadone;
13        (36) Norpipanone;
14        (36.1) Para-fluorofentanyl
15    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
16    4-piperidinyl]propanamide);
17        (37) Phenadoxone;
18        (38) Phenampromide;
19        (39) Phenomorphan;
20        (40) Phenoperidine;
21        (41) Piritramide;
22        (42) Proheptazine;
23        (43) Properidine;
24        (44) Propiram;
25        (45) Racemoramide;
26        (45.1) Thiofentanyl

 

 

SB2612- 252 -LRB103 34492 JAG 64324 b

1    (N-phenyl-N-[1-(2-thienyl)ethyl-
2    4-piperidinyl]-propanamide);
3        (46) Tilidine;
4        (47) Trimeperidine;
5        (48) Beta-hydroxy-3-methylfentanyl (other name:
6    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
7    N-phenylpropanamide);
8        (49) Furanyl fentanyl (FU-F);
9        (50) Butyryl fentanyl;
10        (51) Valeryl fentanyl;
11        (52) Acetyl fentanyl;
12        (53) Beta-hydroxy-thiofentanyl;
13        (54) 3,4-dichloro-N-[2-
14    (dimethylamino)cyclohexyl]-N-
15    methylbenzamide (U-47700); 
16        (55) 4-chloro-N-[1-[2-
17    (4-nitrophenyl)ethyl]-2-piperidinylidene]-
18    benzenesulfonamide (W-18); 
19        (56) 4-chloro-N-[1-(2-phenylethyl)
20    -2-piperidinylidene]-benzenesulfonamide (W-15); 
21        (57) acrylfentanyl (acryloylfentanyl). 
22    (c) Unless specifically excepted or unless listed in
23another schedule, any of the following opium derivatives, its
24salts, isomers and salts of isomers, whenever the existence of
25such salts, isomers and salts of isomers is possible within
26the specific chemical designation:

 

 

SB2612- 253 -LRB103 34492 JAG 64324 b

1        (1) Acetorphine;
2        (2) Acetyldihydrocodeine;
3        (3) Benzylmorphine;
4        (4) Codeine methylbromide;
5        (5) Codeine-N-Oxide;
6        (6) Cyprenorphine;
7        (7) Desomorphine;
8        (8) Diacetyldihydromorphine (Dihydroheroin);
9        (9) Dihydromorphine;
10        (10) Drotebanol;
11        (11) Etorphine (except hydrochloride salt);
12        (12) Heroin;
13        (13) Hydromorphinol;
14        (14) Methyldesorphine;
15        (15) Methyldihydromorphine;
16        (16) Morphine methylbromide;
17        (17) Morphine methylsulfonate;
18        (18) Morphine-N-Oxide;
19        (19) Myrophine;
20        (20) Nicocodeine;
21        (21) Nicomorphine;
22        (22) Normorphine;
23        (23) Pholcodine;
24        (24) Thebacon.
25    (d) Unless specifically excepted or unless listed in
26another schedule, any material, compound, mixture, or

 

 

SB2612- 254 -LRB103 34492 JAG 64324 b

1preparation which contains any quantity of the following
2hallucinogenic substances, or which contains any of its salts,
3isomers and salts of isomers, whenever the existence of such
4salts, isomers, and salts of isomers is possible within the
5specific chemical designation (for the purposes of this
6paragraph only, the term "isomer" includes the optical,
7position and geometric isomers):
8        (1) 3,4-methylenedioxyamphetamine
9    (alpha-methyl,3,4-methylenedioxyphenethylamine,
10    methylenedioxyamphetamine, MDA);
11        (1.1) Alpha-ethyltryptamine
12    (some trade or other names: etryptamine;
13    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
14    3-(2-aminobutyl)indole; a-ET; and AET);
15        (2) 3,4-methylenedioxymethamphetamine (MDMA);
16        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
17    (also known as: N-ethyl-alpha-methyl-
18    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
19    and MDEA);
20        (2.2) N-Benzylpiperazine (BZP);
21        (2.2-1) Trifluoromethylphenylpiperazine (TFMPP);
22        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
23        (4) 3,4,5-trimethoxyamphetamine (TMA);
24        (5) (Blank);
25        (6) Diethyltryptamine (DET);
26        (7) Dimethyltryptamine (DMT);

 

 

SB2612- 255 -LRB103 34492 JAG 64324 b

1        (7.1) 5-Methoxy-diallyltryptamine;
2        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
3        (9) Ibogaine  (some trade and other names:
4    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
5    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
6    indole; Tabernanthe iboga);
7        (10) Lysergic acid diethylamide;
8        (10.1) Salvinorin A;
9        (10.5) Salvia divinorum (meaning all parts of the
10    plant presently classified botanically as Salvia
11    divinorum, whether growing or not, the seeds thereof, any
12    extract from any part of that plant, and every compound,
13    manufacture, salts, isomers, and salts of isomers whenever
14    the existence of such salts, isomers, and salts of isomers
15    is possible within the specific chemical designation,
16    derivative, mixture, or preparation of that plant, its
17    seeds or extracts);
18        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
19        (12) Peyote (meaning all parts of the plant presently
20    classified botanically as Lophophora williamsii Lemaire,
21    whether growing or not, the seeds thereof, any extract
22    from any part of that plant, and every compound,
23    manufacture, salts, derivative, mixture, or preparation of
24    that plant, its seeds or extracts);
25        (13) N-ethyl-3-piperidyl benzilate (JB 318);
26        (14) N-methyl-3-piperidyl benzilate;

 

 

SB2612- 256 -LRB103 34492 JAG 64324 b

1        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
2    (also known as N-hydroxy-alpha-methyl-
3    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
4        (15) Parahexyl; some trade or other names:
5    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
6    dibenzo (b,d) pyran; Synhexyl;
7        (16) (Blank) Psilocybin;
8        (17) (Blank) Psilocyn;
9        (18) Alpha-methyltryptamine (AMT);
10        (19) 2,5-dimethoxyamphetamine
11    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
12        (20) 4-bromo-2,5-dimethoxyamphetamine
13    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
14    4-bromo-2,5-DMA);
15        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
16    Some trade or other names: 2-(4-bromo-
17    2,5-dimethoxyphenyl)-1-aminoethane;
18    alpha-desmethyl DOB, 2CB, Nexus;
19        (21) 4-methoxyamphetamine
20    (4-methoxy-alpha-methylphenethylamine;
21    paramethoxyamphetamine; PMA);
22        (22) (Blank);
23        (23) Ethylamine analog of phencyclidine.
24    Some trade or other names:
25    N-ethyl-1-phenylcyclohexylamine,
26    (1-phenylcyclohexyl) ethylamine,

 

 

SB2612- 257 -LRB103 34492 JAG 64324 b

1    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
2        (24) Pyrrolidine analog of phencyclidine. Some trade
3    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
4    PHP;
5        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
6        (26) 2,5-dimethoxy-4-ethylamphetamine
7    (another name: DOET);
8        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
9    (another name: TCPy);
10        (28) (Blank);
11        (29) Thiophene analog of phencyclidine (some trade
12    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
13    2-thienyl analog of phencyclidine; TPCP; TCP);
14        (29.1) Benzothiophene analog of phencyclidine. Some
15    trade or other names: BTCP or benocyclidine;
16        (29.2) 3-Methoxyphencyclidine (3-MeO-PCP);
17        (30) Bufotenine (some trade or other names:
18    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
19    3-(2-dimethylaminoethyl)-5-indolol;
20    5-hydroxy-N,N-dimethyltryptamine;
21    N,N-dimethylserotonin; mappine);
22        (31) (Blank);  
23        (32) (Blank);  
24        (33) (Blank);  
25        (34) (Blank); 
26        (34.5) (Blank);  

 

 

SB2612- 258 -LRB103 34492 JAG 64324 b

1        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
2    (2-methyloctan-2-yl)-6a,7, 
3    10,10a-tetrahydrobenzo[c]chromen-1-ol
4    Some trade or other names: HU-210; 
5        (35.5)  (6aS,10aS)-9-(hydroxymethyl)-6,6- 
6    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
7    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
8    salts, and salts of isomers; Some trade or other  
9    names: HU-210, Dexanabinol; 
10        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
11    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
12    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
13    Some trade or other names: HU-211;
14        (37) (Blank);
15        (38) (Blank);
16        (39) (Blank);
17        (40) (Blank);
18        (41) (Blank);
19        (42) Any compound structurally derived from
20    3-(1-naphthoyl)indole or
21    1H-indol-3-yl-(1-naphthyl)methane by substitution at the
22    nitrogen atom of the indole ring by alkyl, haloalkyl,
23    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
24    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
25    2-(4-morpholinyl)ethyl whether or not further substituted
26    in the indole ring to any extent, whether or not

 

 

SB2612- 259 -LRB103 34492 JAG 64324 b

1    substituted in the naphthyl ring to any extent. Examples
2    of this structural class include, but are not limited to,
3    JWH-018, AM-2201, JWH-175, JWH-184, and JWH-185;
4        (43) Any compound structurally derived from
5    3-(1-naphthoyl)pyrrole by substitution at the nitrogen
6    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
7    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
8    halide, 1-(N-methyl-2-piperidinyl)methyl, or
9    2-(4-morpholinyl)ethyl, whether or not further substituted
10    in the pyrrole ring to any extent, whether or not
11    substituted in the naphthyl ring to any extent. Examples
12    of this structural class include, but are not limited to,
13    JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;
14        (44) Any compound structurally derived from
15    1-(1-naphthylmethyl)indene by substitution at the
16    3-position of the indene ring by alkyl, haloalkyl,
17    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
18    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
19    2-(4-morpholinyl)ethyl whether or not further substituted
20    in the indene ring to any extent, whether or not
21    substituted in the naphthyl ring to any extent. Examples
22    of this structural class include, but are not limited to,
23    JWH-176;
24        (45) Any compound structurally derived from
25    3-phenylacetylindole by substitution at the nitrogen atom
26    of the indole ring with alkyl, haloalkyl, alkenyl,

 

 

SB2612- 260 -LRB103 34492 JAG 64324 b

1    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
2    halide, 1-(N-methyl-2-piperidinyl)methyl, or
3    2-(4-morpholinyl)ethyl, whether or not further substituted
4    in the indole ring to any extent, whether or not
5    substituted in the phenyl ring to any extent. Examples of
6    this structural class include, but are not limited to,
7    JWH-167, JWH-250, JWH-251, and RCS-8;
8        (46) Any compound structurally derived from
9    2-(3-hydroxycyclohexyl)phenol by substitution at the
10    5-position of the phenolic ring by alkyl, haloalkyl,
11    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
12    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
13    2-(4-morpholinyl)ethyl, whether or not substituted in the
14    cyclohexyl ring to any extent. Examples of this structural
15    class include, but are not limited to, CP 47, 497 and its
16    C8 homologue (cannabicyclohexanol);
17        (46.1) Any compound structurally derived from
18    3-(benzoyl) indole with substitution at the nitrogen atom
19    of the indole ring by an alkyl, haloalkyl, alkenyl,
20    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
21    halide, 1-(N-methyl-2-piperidinyl)methyl, or
22    2-(4-morpholinyl)ethyl group whether or not further
23    substituted in the indole ring to any extent and whether
24    or not substituted in the phenyl ring to any extent.
25    Examples of this structural class include, but are not
26    limited to, AM-630, AM-2233, AM-694, Pravadoline (WIN

 

 

SB2612- 261 -LRB103 34492 JAG 64324 b

1    48,098), and RCS-4;
2        (47) (Blank);
3        (48) (Blank);
4        (49) (Blank);
5        (50) (Blank);
6        (51) (Blank);
7        (52) (Blank);
8        (53) 2,5-Dimethoxy-4-(n)-propylthio-phenethylamine.
9    Some trade or other names: 2C-T-7;
10        (53.1) 4-ethyl-2,5-dimethoxyphenethylamine. Some
11    trade or other names: 2C-E;
12        (53.2) 2,5-dimethoxy-4-methylphenethylamine. Some
13    trade or other names: 2C-D;
14        (53.3) 4-chloro-2,5-dimethoxyphenethylamine. Some
15    trade or other names: 2C-C;
16        (53.4) 4-iodo-2,5-dimethoxyphenethylamine. Some trade
17    or other names: 2C-I;
18        (53.5) 4-ethylthio-2,5-dimethoxyphenethylamine. Some
19    trade or other names: 2C-T-2;
20        (53.6) 2,5-dimethoxy-4-isopropylthio-phenethylamine.
21    Some trade or other names: 2C-T-4;
22        (53.7) 2,5-dimethoxyphenethylamine. Some trade or
23    other names: 2C-H;
24        (53.8) 2,5-dimethoxy-4-nitrophenethylamine. Some
25    trade or other names: 2C-N;
26        (53.9) 2,5-dimethoxy-4-(n)-propylphenethylamine. Some

 

 

SB2612- 262 -LRB103 34492 JAG 64324 b

1    trade or other names: 2C-P;
2        (53.10) 2,5-dimethoxy-3,4-dimethylphenethylamine.
3    Some trade or other names: 2C-G;
4        (53.11) The N-(2-methoxybenzyl) derivative of any 2C
5    phenethylamine referred to in subparagraphs (20.1), (53),
6    (53.1), (53.2), (53.3), (53.4), (53.5), (53.6), (53.7),
7    (53.8), (53.9), and (53.10) including, but not limited to,
8    25I-NBOMe and 25C-NBOMe;
9        (54) 5-Methoxy-N,N-diisopropyltryptamine;
10        (55) (Blank);
11        (56) (Blank);
12        (57) (Blank);
13        (58) (Blank);
14        (59) 3-cyclopropoylindole with substitution at the
15    nitrogen atom of the indole ring by alkyl, haloalkyl,
16    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
17    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
18    2-(4-morpholinyl)ethyl, whether or not further substituted
19    on the indole ring to any extent, whether or not
20    substituted on the cyclopropyl ring to any extent:
21    including, but not limited to, XLR11, UR144, FUB-144;
22        (60) 3-adamantoylindole with substitution at the
23    nitrogen atom of the indole ring by alkyl, haloalkyl,
24    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
25    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
26    2-(4-morpholinyl)ethyl, whether or not further substituted

 

 

SB2612- 263 -LRB103 34492 JAG 64324 b

1    on the indole ring to any extent, whether or not
2    substituted on the adamantyl ring to any extent:
3    including, but not limited to, AB-001;
4        (61) N-(adamantyl)-indole-3-carboxamide with
5    substitution at the nitrogen atom of the indole ring by
6    alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
7    cycloalkylethyl, aryl halide, alkyl aryl halide,
8    1-(N-methyl-2-piperidinyl)methyl, or
9    2-(4-morpholinyl)ethyl, whether or not further substituted
10    on the indole ring to any extent, whether or not
11    substituted on the adamantyl ring to any extent:
12    including, but not limited to, APICA/2NE-1, STS-135;
13        (62) N-(adamantyl)-indazole-3-carboxamide with
14    substitution at a nitrogen atom of the indazole ring by
15    alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
16    cycloalkylethyl, aryl halide, alkyl aryl halide,
17    1-(N-methyl-2-piperidinyl)methyl, or
18    2-(4-morpholinyl)ethyl, whether or not further substituted
19    on the indazole ring to any extent, whether or not
20    substituted on the adamantyl ring to any extent:
21    including, but not limited to, AKB48, 5F-AKB48;
22        (63) 1H-indole-3-carboxylic acid 8-quinolinyl ester
23    with substitution at the nitrogen atom of the indole ring
24    by alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
25    cycloalkylethyl, aryl halide, alkyl aryl halide,
26    1-(N-methyl-2-piperidinyl)methyl, or

 

 

SB2612- 264 -LRB103 34492 JAG 64324 b

1    2-(4-morpholinyl)ethyl, whether or not further substituted
2    on the indole ring to any extent, whether or not
3    substituted on the quinoline ring to any extent:
4    including, but not limited to, PB22, 5F-PB22, FUB-PB-22;
5        (64) 3-(1-naphthoyl)indazole with substitution at the
6    nitrogen atom of the indazole ring by alkyl, haloalkyl,
7    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
8    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
9    2-(4-morpholinyl)ethyl, whether or not further substituted
10    on the indazole ring to any extent, whether or not
11    substituted on the naphthyl ring to any extent: including,
12    but not limited to, THJ-018, THJ-2201;
13        (65) 2-(1-naphthoyl)benzimidazole with substitution
14    at the nitrogen atom of the benzimidazole ring by alkyl,
15    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
16    aryl halide, alkyl aryl halide,
17    1-(N-methyl-2-piperidinyl)methyl, or
18    2-(4-morpholinyl)ethyl, whether or not further substituted
19    on the benzimidazole ring to any extent, whether or not
20    substituted on the naphthyl ring to any extent: including,
21    but not limited to, FUBIMINA;
22        (66)
23    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-
24    3-carboxamide with substitution on the nitrogen atom of
25    the indazole ring by alkyl, haloalkyl, alkenyl,
26    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl

 

 

SB2612- 265 -LRB103 34492 JAG 64324 b

1    halide, 1-(N-methyl-2-piperidinyl)methyl, or
2    2-(4-morpholinyl)ethyl, whether or not further substituted
3    on the indazole ring to any extent: including, but not
4    limited to, AB-PINACA, AB-FUBINACA, AB-CHMINACA;
5        (67) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
6    indazole-3-carboxamide with substitution on the nitrogen
7    atom of the indazole ring by alkyl, haloalkyl, alkenyl,
8    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
9    halide, 1-(N-methyl-2-piperidinyl)methyl, or
10    2-(4-morpholinyl)ethyl, whether or not further substituted
11    on the indazole ring to any extent: including, but not
12    limited to, ADB-PINACA, ADB-FUBINACA;
13        (68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
14    indole-3-carboxamide with substitution on the nitrogen
15    atom of the indole ring by alkyl, haloalkyl, alkenyl,
16    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
17    halide, 1-(N-methyl-2-piperidinyl)methyl, or
18    2-(4-morpholinyl)ethyl, whether or not further substituted
19    on the indole ring to any extent: including, but not
20    limited to, ADBICA, 5F-ADBICA;
21        (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indole-
22    3-carboxamide with substitution on the nitrogen atom of
23    the indole ring by alkyl, haloalkyl, alkenyl,
24    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
25    halide, 1-(N-methyl-2-piperidinyl)methyl, or
26    2-(4-morpholinyl)ethyl, whether or not further substituted

 

 

SB2612- 266 -LRB103 34492 JAG 64324 b

1    on the indole ring to any extent: including, but not
2    limited to, ABICA, 5F-ABICA;
3        (70) Methyl 2-(1H-indazole-3-carboxamido)-3-
4    methylbutanoate with substitution on the nitrogen atom of
5    the indazole ring by alkyl, haloalkyl, alkenyl,
6    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
7    halide, 1-(N-methyl-2-piperidinyl)methyl, or
8    2-(4-morpholinyl)ethyl, whether or not further substituted
9    on the indazole ring to any extent: including, but not
10    limited to, AMB, 5F-AMB;
11        (71) Methyl 2-(1H-indazole-3-carboxamido)-3,3-
12    dimethylbutanoate with substitution on the nitrogen atom
13    of the indazole ring by alkyl, haloalkyl, alkenyl,
14    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
15    halide, 1-(N-methyl-2-piperidinyl)methyl, or
16    2-(4-morpholinyl)ethyl, whether or not further substituted
17    on the indazole ring to any extent: including, but not
18    limited to, 5-fluoro-MDMB-PINACA, MDMB-FUBINACA;
19        (72) Methyl 2-(1H-indole-3-carboxamido)-3-
20    methylbutanoate with substitution on the nitrogen atom of
21    the indole ring by alkyl, haloalkyl, alkenyl,
22    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
23    halide, 1-(N-methyl-2-piperidinyl)methyl, or
24    2-(4-morpholinyl)ethyl, whether or not further substituted
25    on the indazole ring to any extent: including, but not
26    limited to, MMB018, MMB2201, and AMB-CHMICA;

 

 

SB2612- 267 -LRB103 34492 JAG 64324 b

1        (73) Methyl 2-(1H-indole-3-carboxamido)-3,3-
2    dimethylbutanoate with substitution on the nitrogen atom
3    of the indole ring by alkyl, haloalkyl, alkenyl,
4    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
5    halide, 1-(N-methyl-2-piperidinyl)methyl, or
6    2-(4-morpholinyl)ethyl, whether or not further substituted
7    on the indazole ring to any extent: including, but not
8    limited to, MDMB-CHMICA;
9        (74) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-
10    indazole-3-carboxamide with substitution on the nitrogen
11    atom of the indazole ring by alkyl, haloalkyl, alkenyl,
12    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
13    halide, 1-(N-methyl-2-piperidinyl)methyl, or
14    2-(4-morpholinyl)ethyl, whether or not further substituted
15    on the indazole ring to any     extent: including, but not
16    limited to, APP-CHMINACA, 5-fluoro-APP-PINACA;
17        (75) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-indole-
18    3-carboxamide with substitution on the nitrogen atom of
19    the indole ring by alkyl, haloalkyl, alkenyl,
20    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
21    halide, 1-(N-methyl-2-piperidinyl)methyl, or
22    2-(4-morpholinyl)ethyl, whether or not further substituted
23    on the indazole ring to any extent: including, but not
24    limited to, APP-PICA and 5-fluoro-APP-PICA;
25        (76) 4-Acetoxy-N,N-dimethyltryptamine: trade name
26    4-AcO-DMT;

 

 

SB2612- 268 -LRB103 34492 JAG 64324 b

1        (77) 5-Methoxy-N-methyl-N-isopropyltryptamine: trade
2    name 5-MeO-MIPT;
3        (78) 4-hydroxy Diethyltryptamine (4-HO-DET);
4        (79) 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET);
5        (80) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);
6        (81) 4-hydroxy-N-methyl-N-isopropyltryptamine
7    (4-HO-MiPT);
8        (82) Fluorophenylpiperazine;
9        (83) Methoxetamine;
10        (84) 1-(Ethylamino)-2-phenylpropan-2-one (iso-
11    ethcathinone).
12    (e) Unless specifically excepted or unless listed in
13another schedule, any material, compound, mixture, or
14preparation which contains any quantity of the following
15substances having a depressant effect on the central nervous
16system, including its salts, isomers, and salts of isomers
17whenever the existence of such salts, isomers, and salts of
18isomers is possible within the specific chemical designation:
19        (1) mecloqualone;
20        (2) methaqualone; and
21        (3) gamma hydroxybutyric acid.
22    (f) Unless specifically excepted or unless listed in
23another schedule, any material, compound, mixture, or
24preparation which contains any quantity of the following
25substances having a stimulant effect on the central nervous
26system, including its salts, isomers, and salts of isomers:

 

 

SB2612- 269 -LRB103 34492 JAG 64324 b

1        (1) Fenethylline;
2        (2) N-ethylamphetamine;
3        (3) Aminorex (some other names:
4    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
5    4-5-dihydro-5-phenyl-2-oxazolamine) and its
6    salts, optical isomers, and salts of optical isomers;
7        (4) Methcathinone (some other names:
8    2-methylamino-1-phenylpropan-1-one;
9    Ephedrone; 2-(methylamino)-propiophenone;
10    alpha-(methylamino)propiophenone; N-methylcathinone;
11    methycathinone; Monomethylpropion; UR 1431) and its
12    salts, optical isomers, and salts of optical isomers;
13        (5) Cathinone (some trade or other names:
14    2-aminopropiophenone; alpha-aminopropiophenone;
15    2-amino-1-phenyl-propanone; norephedrone);
16        (6) N,N-dimethylamphetamine (also known as:
17    N,N-alpha-trimethyl-benzeneethanamine;
18    N,N-alpha-trimethylphenethylamine);
19        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
20    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
21        (8) 3,4-Methylenedioxypyrovalerone (MDPV);
22        (9) Halogenated amphetamines and
23    methamphetamines - any compound derived from either
24    amphetamine or methamphetamine through the substitution
25    of a halogen on the phenyl ring, including, but not
26    limited to, 2-fluoroamphetamine, 3-

 

 

SB2612- 270 -LRB103 34492 JAG 64324 b

1    fluoroamphetamine and 4-fluoroamphetamine; 
2        (10) Aminopropylbenzofuran (APB):
3    including 4-(2-Aminopropyl) benzofuran, 5-
4    (2-Aminopropyl)benzofuran, 6-(2-Aminopropyl)
5    benzofuran, and 7-(2-Aminopropyl) benzofuran; 
6        (11) Aminopropyldihydrobenzofuran (APDB):
7    including 4-(2-Aminopropyl)-2,3- dihydrobenzofuran,
8    5-(2-Aminopropyl)-2, 3-dihydrobenzofuran,
9    6-(2-Aminopropyl)-2,3-dihydrobenzofuran,
10    and 7-(2-Aminopropyl)-2,3-dihydrobenzofuran; 
11        (12) Methylaminopropylbenzofuran
12    (MAPB): including 4-(2-methylaminopropyl)
13    benzofuran, 5-(2-methylaminopropyl)benzofuran,
14    6-(2-methylaminopropyl)benzofuran
15    and 7-(2-methylaminopropyl)benzofuran. 
16    (g) Temporary listing of substances subject to emergency
17scheduling. Any material, compound, mixture, or preparation
18that contains any quantity of the following substances:
19        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
20    (benzylfentanyl), its optical isomers, isomers, salts, and
21    salts of isomers;
22        (2) N-[1(2-thienyl) methyl-4-piperidyl]-N-
23    phenylpropanamide (thenylfentanyl), its optical isomers,
24    salts, and salts of isomers.
25    (h) Synthetic cathinones. Unless specifically excepted,
26any chemical compound which is not approved by the United

 

 

SB2612- 271 -LRB103 34492 JAG 64324 b

1States Food and Drug Administration or, if approved, is not
2dispensed or possessed in accordance with State or federal
3law, not including bupropion, structurally derived from
42-aminopropan-1-one by substitution at the 1-position with
5either phenyl, naphthyl, or thiophene ring systems, whether or
6not the compound is further modified in one or more of the
7following ways:
8        (1) by substitution in the ring system to any extent
9    with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or
10    halide substituents, whether or not further substituted in
11    the ring system by one or more other univalent
12    substituents. Examples of this class include, but are not
13    limited to, 3,4-Methylenedioxycathinone (bk-MDA);
14        (2) by substitution at the 3-position with an acyclic
15    alkyl substituent. Examples of this class include, but are
16    not limited to, 2-methylamino-1-phenylbutan-1-one
17    (buphedrone); or
18        (3) by substitution at the 2-amino nitrogen atom with
19    alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by
20    inclusion of the 2-amino nitrogen atom in a cyclic
21    structure. Examples of this class include, but are not
22    limited to, Dimethylcathinone, Ethcathinone, and
23    a-Pyrrolidinopropiophenone (a-PPP); or
24    Any other synthetic cathinone which is not approved by the
25United States Food and Drug Administration or, if approved, is
26not dispensed or possessed in accordance with State or federal

 

 

SB2612- 272 -LRB103 34492 JAG 64324 b

1law.
2    (i) Synthetic cannabinoids or piperazines. Any synthetic
3cannabinoid or piperazine which is not approved by the United
4States Food and Drug Administration or, if approved, which is
5not dispensed or possessed in accordance with State and
6federal law.
7(Source: P.A. 99-371, eff. 1-1-16; 100-201, eff. 8-18-17;
8100-368, eff. 1-1-18; 100-789, eff. 1-1-19; 100-863, eff.
98-14-18.)
 
10    (Text of Section after amendment by P.A. 103-245)
11    Sec. 204. (a) The controlled substances listed in this
12Section are included in Schedule I.
13    (b) Unless specifically excepted or unless listed in
14another schedule, any of the following opiates, including
15their isomers, esters, ethers, salts, and salts of isomers,
16esters, and ethers, whenever the existence of such isomers,
17esters, ethers and salts is possible within the specific
18chemical designation:
19        (1) Acetylmethadol;
20        (1.1) Acetyl-alpha-methylfentanyl
21    (N-[1-(1-methyl-2-phenethyl)-
22    4-piperidinyl]-N-phenylacetamide);
23        (2) Allylprodine;
24        (3) Alphacetylmethadol, except
25    levo-alphacetylmethadol (also known as levo-alpha-

 

 

SB2612- 273 -LRB103 34492 JAG 64324 b

1    acetylmethadol, levomethadyl acetate, or LAAM);
2        (4) Alphameprodine;
3        (5) Alphamethadol;
4        (6) Alpha-methylfentanyl
5    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
6    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
7    propanilido) piperidine;
8        (6.1) Alpha-methylthiofentanyl
9    (N-[1-methyl-2-(2-thienyl)ethyl-
10    4-piperidinyl]-N-phenylpropanamide);
11        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
12        (7.1) PEPAP
13    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
14        (8) Benzethidine;
15        (9) Betacetylmethadol;
16        (9.1) Beta-hydroxyfentanyl
17    (N-[1-(2-hydroxy-2-phenethyl)-
18    4-piperidinyl]-N-phenylpropanamide);
19        (10) Betameprodine;
20        (11) Betamethadol;
21        (12) Betaprodine;
22        (13) Clonitazene;
23        (14) Dextromoramide;
24        (15) Diampromide;
25        (16) Diethylthiambutene;
26        (17) Difenoxin;

 

 

SB2612- 274 -LRB103 34492 JAG 64324 b

1        (18) Dimenoxadol;
2        (19) Dimepheptanol;
3        (20) Dimethylthiambutene;
4        (21) Dioxaphetylbutyrate;
5        (22) Dipipanone;
6        (23) Ethylmethylthiambutene;
7        (24) Etonitazene;
8        (25) Etoxeridine;
9        (26) Furethidine;
10        (27) Hydroxpethidine;
11        (28) Ketobemidone;
12        (29) Levomoramide;
13        (30) Levophenacylmorphan;
14        (31) 3-Methylfentanyl
15    (N-[3-methyl-1-(2-phenylethyl)-
16    4-piperidyl]-N-phenylpropanamide);
17        (31.1) 3-Methylthiofentanyl
18    (N-[(3-methyl-1-(2-thienyl)ethyl-
19    4-piperidinyl]-N-phenylpropanamide);
20        (32) Morpheridine;
21        (33) Noracymethadol;
22        (34) Norlevorphanol;
23        (35) Normethadone;
24        (36) Norpipanone;
25        (36.1) Para-fluorofentanyl
26    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-

 

 

SB2612- 275 -LRB103 34492 JAG 64324 b

1    4-piperidinyl]propanamide);
2        (37) Phenadoxone;
3        (38) Phenampromide;
4        (39) Phenomorphan;
5        (40) Phenoperidine;
6        (41) Piritramide;
7        (42) Proheptazine;
8        (43) Properidine;
9        (44) Propiram;
10        (45) Racemoramide;
11        (45.1) Thiofentanyl
12    (N-phenyl-N-[1-(2-thienyl)ethyl-
13    4-piperidinyl]-propanamide);
14        (46) Tilidine;
15        (47) Trimeperidine;
16        (48) Beta-hydroxy-3-methylfentanyl (other name:
17    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
18    N-phenylpropanamide);
19        (49) Furanyl fentanyl (FU-F);
20        (50) Butyryl fentanyl;
21        (51) Valeryl fentanyl;
22        (52) Acetyl fentanyl;
23        (53) Beta-hydroxy-thiofentanyl;
24        (54) 3,4-dichloro-N-[2-
25    (dimethylamino)cyclohexyl]-N-
26    methylbenzamide (U-47700); 

 

 

SB2612- 276 -LRB103 34492 JAG 64324 b

1        (55) 4-chloro-N-[1-[2-
2    (4-nitrophenyl)ethyl]-2-piperidinylidene]-
3    benzenesulfonamide (W-18); 
4        (56) 4-chloro-N-[1-(2-phenylethyl)
5    -2-piperidinylidene]-benzenesulfonamide (W-15); 
6        (57) acrylfentanyl (acryloylfentanyl). 
7    (c) Unless specifically excepted or unless listed in
8another schedule, any of the following opium derivatives, its
9salts, isomers and salts of isomers, whenever the existence of
10such salts, isomers and salts of isomers is possible within
11the specific chemical designation:
12        (1) Acetorphine;
13        (2) Acetyldihydrocodeine;
14        (3) Benzylmorphine;
15        (4) Codeine methylbromide;
16        (5) Codeine-N-Oxide;
17        (6) Cyprenorphine;
18        (7) Desomorphine;
19        (8) Diacetyldihydromorphine (Dihydroheroin);
20        (9) Dihydromorphine;
21        (10) Drotebanol;
22        (11) Etorphine (except hydrochloride salt);
23        (12) Heroin;
24        (13) Hydromorphinol;
25        (14) Methyldesorphine;
26        (15) Methyldihydromorphine;

 

 

SB2612- 277 -LRB103 34492 JAG 64324 b

1        (16) Morphine methylbromide;
2        (17) Morphine methylsulfonate;
3        (18) Morphine-N-Oxide;
4        (19) Myrophine;
5        (20) Nicocodeine;
6        (21) Nicomorphine;
7        (22) Normorphine;
8        (23) Pholcodine;
9        (24) Thebacon.
10    (d) Unless specifically excepted or unless listed in
11another schedule, any material, compound, mixture, or
12preparation which contains any quantity of the following
13hallucinogenic substances, or which contains any of its salts,
14isomers and salts of isomers, whenever the existence of such
15salts, isomers, and salts of isomers is possible within the
16specific chemical designation (for the purposes of this
17paragraph only, the term "isomer" includes the optical,
18position and geometric isomers):
19        (1) 3,4-methylenedioxyamphetamine
20    (alpha-methyl,3,4-methylenedioxyphenethylamine,
21    methylenedioxyamphetamine, MDA);
22        (1.1) Alpha-ethyltryptamine
23    (some trade or other names: etryptamine;
24    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
25    3-(2-aminobutyl)indole; a-ET; and AET);
26        (2) 3,4-methylenedioxymethamphetamine (MDMA);

 

 

SB2612- 278 -LRB103 34492 JAG 64324 b

1        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
2    (also known as: N-ethyl-alpha-methyl-
3    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
4    and MDEA);
5        (2.2) N-Benzylpiperazine (BZP);
6        (2.2-1) Trifluoromethylphenylpiperazine (TFMPP);
7        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
8        (4) 3,4,5-trimethoxyamphetamine (TMA);
9        (5) (Blank);
10        (6) Diethyltryptamine (DET);
11        (7) Dimethyltryptamine (DMT);
12        (7.1) 5-Methoxy-diallyltryptamine;
13        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
14        (9) Ibogaine  (some trade and other names:
15    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
16    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
17    indole; Tabernanthe iboga);
18        (10) Lysergic acid diethylamide;
19        (10.1) Salvinorin A;
20        (10.5) Salvia divinorum (meaning all parts of the
21    plant presently classified botanically as Salvia
22    divinorum, whether growing or not, the seeds thereof, any
23    extract from any part of that plant, and every compound,
24    manufacture, salts, isomers, and salts of isomers whenever
25    the existence of such salts, isomers, and salts of isomers
26    is possible within the specific chemical designation,

 

 

SB2612- 279 -LRB103 34492 JAG 64324 b

1    derivative, mixture, or preparation of that plant, its
2    seeds or extracts);
3        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
4        (12) Peyote (meaning all parts of the plant presently
5    classified botanically as Lophophora williamsii Lemaire,
6    whether growing or not, the seeds thereof, any extract
7    from any part of that plant, and every compound,
8    manufacture, salts, derivative, mixture, or preparation of
9    that plant, its seeds or extracts);
10        (13) N-ethyl-3-piperidyl benzilate (JB 318);
11        (14) N-methyl-3-piperidyl benzilate;
12        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
13    (also known as N-hydroxy-alpha-methyl-
14    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
15        (15) Parahexyl; some trade or other names:
16    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
17    dibenzo (b,d) pyran; Synhexyl;
18        (16) (Blank); Psilocybin;
19        (17) (Blank); Psilocyn;
20        (18) Alpha-methyltryptamine (AMT);
21        (19) 2,5-dimethoxyamphetamine
22    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
23        (20) 4-bromo-2,5-dimethoxyamphetamine
24    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
25    4-bromo-2,5-DMA);
26        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.

 

 

SB2612- 280 -LRB103 34492 JAG 64324 b

1    Some trade or other names: 2-(4-bromo-
2    2,5-dimethoxyphenyl)-1-aminoethane;
3    alpha-desmethyl DOB, 2CB, Nexus;
4        (21) 4-methoxyamphetamine
5    (4-methoxy-alpha-methylphenethylamine;
6    paramethoxyamphetamine; PMA);
7        (22) (Blank);
8        (23) Ethylamine analog of phencyclidine.
9    Some trade or other names:
10    N-ethyl-1-phenylcyclohexylamine,
11    (1-phenylcyclohexyl) ethylamine,
12    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
13        (24) Pyrrolidine analog of phencyclidine. Some trade
14    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
15    PHP;
16        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
17        (26) 2,5-dimethoxy-4-ethylamphetamine
18    (another name: DOET);
19        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
20    (another name: TCPy);
21        (28) (Blank);
22        (29) Thiophene analog of phencyclidine (some trade
23    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
24    2-thienyl analog of phencyclidine; TPCP; TCP);
25        (29.1) Benzothiophene analog of phencyclidine. Some
26    trade or other names: BTCP or benocyclidine;

 

 

SB2612- 281 -LRB103 34492 JAG 64324 b

1        (29.2) 3-Methoxyphencyclidine (3-MeO-PCP);
2        (30) Bufotenine (some trade or other names:
3    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
4    3-(2-dimethylaminoethyl)-5-indolol;
5    5-hydroxy-N,N-dimethyltryptamine;
6    N,N-dimethylserotonin; mappine);
7        (31) (Blank);  
8        (32) (Blank);  
9        (33) (Blank);  
10        (34) (Blank); 
11        (34.5) (Blank);  
12        (35) (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-
13    (2-methyloctan-2-yl)-6a,7, 
14    10,10a-tetrahydrobenzo[c]chromen-1-ol
15    Some trade or other names: HU-210; 
16        (35.5)  (6aS,10aS)-9-(hydroxymethyl)-6,6- 
17    dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a- 
18    tetrahydrobenzo[c]chromen-1-ol, its isomers,  
19    salts, and salts of isomers; Some trade or other  
20    names: HU-210, Dexanabinol; 
21        (36) Dexanabinol, (6aS,10aS)-9-(hydroxymethyl)-
22    6,6-dimethyl-3-(2-methyloctan-2-yl)- 
23    6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol
24    Some trade or other names: HU-211;
25        (37) (Blank);
26        (38) (Blank);

 

 

SB2612- 282 -LRB103 34492 JAG 64324 b

1        (39) (Blank);
2        (40) (Blank);
3        (41) (Blank);
4        (42) Any compound structurally derived from
5    3-(1-naphthoyl)indole or
6    1H-indol-3-yl-(1-naphthyl)methane by substitution at the
7    nitrogen atom of the indole ring by alkyl, haloalkyl,
8    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
9    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
10    2-(4-morpholinyl)ethyl whether or not further substituted
11    in the indole ring to any extent, whether or not
12    substituted in the naphthyl ring to any extent. Examples
13    of this structural class include, but are not limited to,
14    JWH-018, AM-2201, JWH-175, JWH-184, and JWH-185;
15        (43) Any compound structurally derived from
16    3-(1-naphthoyl)pyrrole by substitution at the nitrogen
17    atom of the pyrrole ring by alkyl, haloalkyl, alkenyl,
18    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
19    halide, 1-(N-methyl-2-piperidinyl)methyl, or
20    2-(4-morpholinyl)ethyl, whether or not further substituted
21    in the pyrrole ring to any extent, whether or not
22    substituted in the naphthyl ring to any extent. Examples
23    of this structural class include, but are not limited to,
24    JWH-030, JWH-145, JWH-146, JWH-307, and JWH-368;
25        (44) Any compound structurally derived from
26    1-(1-naphthylmethyl)indene by substitution at the

 

 

SB2612- 283 -LRB103 34492 JAG 64324 b

1    3-position of the indene ring by alkyl, haloalkyl,
2    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
3    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
4    2-(4-morpholinyl)ethyl whether or not further substituted
5    in the indene ring to any extent, whether or not
6    substituted in the naphthyl ring to any extent. Examples
7    of this structural class include, but are not limited to,
8    JWH-176;
9        (45) Any compound structurally derived from
10    3-phenylacetylindole by substitution at the nitrogen atom
11    of the indole ring with alkyl, haloalkyl, alkenyl,
12    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
13    halide, 1-(N-methyl-2-piperidinyl)methyl, or
14    2-(4-morpholinyl)ethyl, whether or not further substituted
15    in the indole ring to any extent, whether or not
16    substituted in the phenyl ring to any extent. Examples of
17    this structural class include, but are not limited to,
18    JWH-167, JWH-250, JWH-251, and RCS-8;
19        (46) Any compound structurally derived from
20    2-(3-hydroxycyclohexyl)phenol by substitution at the
21    5-position of the phenolic ring by alkyl, haloalkyl,
22    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
23    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
24    2-(4-morpholinyl)ethyl, whether or not substituted in the
25    cyclohexyl ring to any extent. Examples of this structural
26    class include, but are not limited to, CP 47, 497 and its

 

 

SB2612- 284 -LRB103 34492 JAG 64324 b

1    C8 homologue (cannabicyclohexanol);
2        (46.1) Any compound structurally derived from
3    3-(benzoyl) indole with substitution at the nitrogen atom
4    of the indole ring by an alkyl, haloalkyl, alkenyl,
5    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
6    halide, 1-(N-methyl-2-piperidinyl)methyl, or
7    2-(4-morpholinyl)ethyl group whether or not further
8    substituted in the indole ring to any extent and whether
9    or not substituted in the phenyl ring to any extent.
10    Examples of this structural class include, but are not
11    limited to, AM-630, AM-2233, AM-694, Pravadoline (WIN
12    48,098), and RCS-4;
13        (47) (Blank);
14        (48) (Blank);
15        (49) (Blank);
16        (50) (Blank);
17        (51) (Blank);
18        (52) (Blank);
19        (53) 2,5-Dimethoxy-4-(n)-propylthio-phenethylamine.
20    Some trade or other names: 2C-T-7;
21        (53.1) 4-ethyl-2,5-dimethoxyphenethylamine. Some
22    trade or other names: 2C-E;
23        (53.2) 2,5-dimethoxy-4-methylphenethylamine. Some
24    trade or other names: 2C-D;
25        (53.3) 4-chloro-2,5-dimethoxyphenethylamine. Some
26    trade or other names: 2C-C;

 

 

SB2612- 285 -LRB103 34492 JAG 64324 b

1        (53.4) 4-iodo-2,5-dimethoxyphenethylamine. Some trade
2    or other names: 2C-I;
3        (53.5) 4-ethylthio-2,5-dimethoxyphenethylamine. Some
4    trade or other names: 2C-T-2;
5        (53.6) 2,5-dimethoxy-4-isopropylthio-phenethylamine.
6    Some trade or other names: 2C-T-4;
7        (53.7) 2,5-dimethoxyphenethylamine. Some trade or
8    other names: 2C-H;
9        (53.8) 2,5-dimethoxy-4-nitrophenethylamine. Some
10    trade or other names: 2C-N;
11        (53.9) 2,5-dimethoxy-4-(n)-propylphenethylamine. Some
12    trade or other names: 2C-P;
13        (53.10) 2,5-dimethoxy-3,4-dimethylphenethylamine.
14    Some trade or other names: 2C-G;
15        (53.11) The N-(2-methoxybenzyl) derivative of any 2C
16    phenethylamine referred to in subparagraphs (20.1), (53),
17    (53.1), (53.2), (53.3), (53.4), (53.5), (53.6), (53.7),
18    (53.8), (53.9), and (53.10) including, but not limited to,
19    25I-NBOMe and 25C-NBOMe;
20        (54) 5-Methoxy-N,N-diisopropyltryptamine;
21        (55) (Blank);
22        (56) (Blank);
23        (57) (Blank);
24        (58) (Blank);
25        (59) 3-cyclopropoylindole with substitution at the
26    nitrogen atom of the indole ring by alkyl, haloalkyl,

 

 

SB2612- 286 -LRB103 34492 JAG 64324 b

1    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
2    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
3    2-(4-morpholinyl)ethyl, whether or not further substituted
4    on the indole ring to any extent, whether or not
5    substituted on the cyclopropyl ring to any extent:
6    including, but not limited to, XLR11, UR144, FUB-144;
7        (60) 3-adamantoylindole with substitution at the
8    nitrogen atom of the indole ring by alkyl, haloalkyl,
9    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
10    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
11    2-(4-morpholinyl)ethyl, whether or not further substituted
12    on the indole ring to any extent, whether or not
13    substituted on the adamantyl ring to any extent:
14    including, but not limited to, AB-001;
15        (61) N-(adamantyl)-indole-3-carboxamide with
16    substitution at the nitrogen atom of the indole ring by
17    alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
18    cycloalkylethyl, aryl halide, alkyl aryl halide,
19    1-(N-methyl-2-piperidinyl)methyl, or
20    2-(4-morpholinyl)ethyl, whether or not further substituted
21    on the indole ring to any extent, whether or not
22    substituted on the adamantyl ring to any extent:
23    including, but not limited to, APICA/2NE-1, STS-135;
24        (62) N-(adamantyl)-indazole-3-carboxamide with
25    substitution at a nitrogen atom of the indazole ring by
26    alkyl, haloalkyl, alkenyl, cycloalkylmethyl,

 

 

SB2612- 287 -LRB103 34492 JAG 64324 b

1    cycloalkylethyl, aryl halide, alkyl aryl halide,
2    1-(N-methyl-2-piperidinyl)methyl, or
3    2-(4-morpholinyl)ethyl, whether or not further substituted
4    on the indazole ring to any extent, whether or not
5    substituted on the adamantyl ring to any extent:
6    including, but not limited to, AKB48, 5F-AKB48;
7        (63) 1H-indole-3-carboxylic acid 8-quinolinyl ester
8    with substitution at the nitrogen atom of the indole ring
9    by alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
10    cycloalkylethyl, aryl halide, alkyl aryl halide,
11    1-(N-methyl-2-piperidinyl)methyl, or
12    2-(4-morpholinyl)ethyl, whether or not further substituted
13    on the indole ring to any extent, whether or not
14    substituted on the quinoline ring to any extent:
15    including, but not limited to, PB22, 5F-PB22, FUB-PB-22;
16        (64) 3-(1-naphthoyl)indazole with substitution at the
17    nitrogen atom of the indazole ring by alkyl, haloalkyl,
18    alkenyl, cycloalkylmethyl, cycloalkylethyl, aryl halide,
19    alkyl aryl halide, 1-(N-methyl-2-piperidinyl)methyl, or
20    2-(4-morpholinyl)ethyl, whether or not further substituted
21    on the indazole ring to any extent, whether or not
22    substituted on the naphthyl ring to any extent: including,
23    but not limited to, THJ-018, THJ-2201;
24        (65) 2-(1-naphthoyl)benzimidazole with substitution
25    at the nitrogen atom of the benzimidazole ring by alkyl,
26    haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,

 

 

SB2612- 288 -LRB103 34492 JAG 64324 b

1    aryl halide, alkyl aryl halide,
2    1-(N-methyl-2-piperidinyl)methyl, or
3    2-(4-morpholinyl)ethyl, whether or not further substituted
4    on the benzimidazole ring to any extent, whether or not
5    substituted on the naphthyl ring to any extent: including,
6    but not limited to, FUBIMINA;
7        (66)
8    N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indazole-
9    3-carboxamide with substitution on the nitrogen atom of
10    the indazole ring by alkyl, haloalkyl, alkenyl,
11    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
12    halide, 1-(N-methyl-2-piperidinyl)methyl, or
13    2-(4-morpholinyl)ethyl, whether or not further substituted
14    on the indazole ring to any extent: including, but not
15    limited to, AB-PINACA, AB-FUBINACA, AB-CHMINACA;
16        (67) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
17    indazole-3-carboxamide with substitution on the nitrogen
18    atom of the indazole ring by alkyl, haloalkyl, alkenyl,
19    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
20    halide, 1-(N-methyl-2-piperidinyl)methyl, or
21    2-(4-morpholinyl)ethyl, whether or not further substituted
22    on the indazole ring to any extent: including, but not
23    limited to, ADB-PINACA, ADB-FUBINACA;
24        (68) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1H-
25    indole-3-carboxamide with substitution on the nitrogen
26    atom of the indole ring by alkyl, haloalkyl, alkenyl,

 

 

SB2612- 289 -LRB103 34492 JAG 64324 b

1    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
2    halide, 1-(N-methyl-2-piperidinyl)methyl, or
3    2-(4-morpholinyl)ethyl, whether or not further substituted
4    on the indole ring to any extent: including, but not
5    limited to, ADBICA, 5F-ADBICA;
6        (69) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1H-indole-
7    3-carboxamide with substitution on the nitrogen atom of
8    the indole ring by alkyl, haloalkyl, alkenyl,
9    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
10    halide, 1-(N-methyl-2-piperidinyl)methyl, or
11    2-(4-morpholinyl)ethyl, whether or not further substituted
12    on the indole ring to any extent: including, but not
13    limited to, ABICA, 5F-ABICA;
14        (70) Methyl 2-(1H-indazole-3-carboxamido)-3-
15    methylbutanoate with substitution on the nitrogen atom of
16    the indazole ring by alkyl, haloalkyl, alkenyl,
17    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
18    halide, 1-(N-methyl-2-piperidinyl)methyl, or
19    2-(4-morpholinyl)ethyl, whether or not further substituted
20    on the indazole ring to any extent: including, but not
21    limited to, AMB, 5F-AMB;
22        (71) Methyl 2-(1H-indazole-3-carboxamido)-3,3-
23    dimethylbutanoate with substitution on the nitrogen atom
24    of the indazole ring by alkyl, haloalkyl, alkenyl,
25    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
26    halide, 1-(N-methyl-2-piperidinyl)methyl, or

 

 

SB2612- 290 -LRB103 34492 JAG 64324 b

1    2-(4-morpholinyl)ethyl, whether or not further substituted
2    on the indazole ring to any extent: including, but not
3    limited to, 5-fluoro-MDMB-PINACA, MDMB-FUBINACA;
4        (72) Methyl 2-(1H-indole-3-carboxamido)-3-
5    methylbutanoate with substitution on the nitrogen atom of
6    the indole ring by alkyl, haloalkyl, alkenyl,
7    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
8    halide, 1-(N-methyl-2-piperidinyl)methyl, or
9    2-(4-morpholinyl)ethyl, whether or not further substituted
10    on the indazole ring to any extent: including, but not
11    limited to, MMB018, MMB2201, and AMB-CHMICA;
12        (73) Methyl 2-(1H-indole-3-carboxamido)-3,3-
13    dimethylbutanoate with substitution on the nitrogen atom
14    of the indole ring by alkyl, haloalkyl, alkenyl,
15    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
16    halide, 1-(N-methyl-2-piperidinyl)methyl, or
17    2-(4-morpholinyl)ethyl, whether or not further substituted
18    on the indazole ring to any extent: including, but not
19    limited to, MDMB-CHMICA;
20        (74) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-
21    indazole-3-carboxamide with substitution on the nitrogen
22    atom of the indazole ring by alkyl, haloalkyl, alkenyl,
23    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
24    halide, 1-(N-methyl-2-piperidinyl)methyl, or
25    2-(4-morpholinyl)ethyl, whether or not further substituted
26    on the indazole ring to any     extent: including, but not

 

 

SB2612- 291 -LRB103 34492 JAG 64324 b

1    limited to, APP-CHMINACA, 5-fluoro-APP-PINACA;
2        (75) N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1H-indole-
3    3-carboxamide with substitution on the nitrogen atom of
4    the indole ring by alkyl, haloalkyl, alkenyl,
5    cycloalkylmethyl, cycloalkylethyl, aryl halide, alkyl aryl
6    halide, 1-(N-methyl-2-piperidinyl)methyl, or
7    2-(4-morpholinyl)ethyl, whether or not further substituted
8    on the indazole ring to any extent: including, but not
9    limited to, APP-PICA and 5-fluoro-APP-PICA;
10        (76) 4-Acetoxy-N,N-dimethyltryptamine: trade name
11    4-AcO-DMT;
12        (77) 5-Methoxy-N-methyl-N-isopropyltryptamine: trade
13    name 5-MeO-MIPT;
14        (78) 4-hydroxy Diethyltryptamine (4-HO-DET);
15        (79) 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET);
16        (80) 4-hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT);
17        (81) 4-hydroxy-N-methyl-N-isopropyltryptamine
18    (4-HO-MiPT);
19        (82) Fluorophenylpiperazine;
20        (83) Methoxetamine;
21        (84) 1-(Ethylamino)-2-phenylpropan-2-one (iso-
22    ethcathinone).
23    (e) Unless specifically excepted or unless listed in
24another schedule, any material, compound, mixture, or
25preparation which contains any quantity of the following
26substances having a depressant effect on the central nervous

 

 

SB2612- 292 -LRB103 34492 JAG 64324 b

1system, including its salts, isomers, and salts of isomers
2whenever the existence of such salts, isomers, and salts of
3isomers is possible within the specific chemical designation:
4        (1) mecloqualone;
5        (2) methaqualone; and
6        (3) gamma hydroxybutyric acid.
7    (f) Unless specifically excepted or unless listed in
8another schedule, any material, compound, mixture, or
9preparation which contains any quantity of the following
10substances having a stimulant effect on the central nervous
11system, including its salts, isomers, and salts of isomers:
12        (1) Fenethylline;
13        (2) N-ethylamphetamine;
14        (3) Aminorex (some other names:
15    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
16    4-5-dihydro-5-phenyl-2-oxazolamine) and its
17    salts, optical isomers, and salts of optical isomers;
18        (4) Methcathinone (some other names:
19    2-methylamino-1-phenylpropan-1-one;
20    Ephedrone; 2-(methylamino)-propiophenone;
21    alpha-(methylamino)propiophenone; N-methylcathinone;
22    methycathinone; Monomethylpropion; UR 1431) and its
23    salts, optical isomers, and salts of optical isomers;
24        (5) Cathinone (some trade or other names:
25    2-aminopropiophenone; alpha-aminopropiophenone;
26    2-amino-1-phenyl-propanone; norephedrone);

 

 

SB2612- 293 -LRB103 34492 JAG 64324 b

1        (6) N,N-dimethylamphe
tamine (also known as:
2    N,N-alpha-trimethyl-benzeneethanamine;
3    N,N-alpha-trimethylphenethylamine);
4        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
5    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine);
6        (8) 3,4-Methylenedioxypyrovalerone (MDPV);
7        (9) Halogenated amphetamines and
8    methamphetamines - any compound derived from either
9    amphetamine or methamphetamine through the substitution
10    of a halogen on the phenyl ring, including, but not
11    limited to, 2-fluoroamphetamine, 3-
12    fluoroamphetamine and 4-fluoroamphetamine; 
13        (10) Aminopropylbenzofuran (APB):
14    including 4-(2-Aminopropyl) benzofuran, 5-
15    (2-Aminopropyl)benzofuran, 6-(2-Aminopropyl)
16    benzofuran, and 7-(2-Aminopropyl) benzofuran; 
17        (11) Aminopropyldihydrobenzofuran (APDB):
18    including 4-(2-Aminopropyl)-2,3- dihydrobenzofuran,
19    5-(2-Aminopropyl)-2, 3-dihydrobenzofuran,
20    6-(2-Aminopropyl)-2,3-dihydrobenzofuran,
21    and 7-(2-Aminopropyl)-2,3-dihydrobenzofuran; 
22        (12) Methylaminopropylbenzofuran
23    (MAPB): including 4-(2-methylaminopropyl)
24    benzofuran, 5-(2-methylaminopropyl)benzofuran,
25    6-(2-methylaminopropyl)benzofuran
26    and 7-(2-methylaminopropyl)benzofuran. 

 

 

SB2612- 294 -LRB103 34492 JAG 64324 b

1    (g) Temporary listing of substances subject to emergency
2scheduling. Any material, compound, mixture, or preparation
3that contains any quantity of the following substances:
4        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
5    (benzylfentanyl), its optical isomers, isomers, salts, and
6    salts of isomers;
7        (2) N-[1(2-thienyl) methyl-4-piperidyl]-N-
8    phenylpropanamide (thenylfentanyl), its optical isomers,
9    salts, and salts of isomers.
10    (h) Synthetic cathinones. Unless specifically excepted,
11any chemical compound which is not approved by the United
12States Food and Drug Administration or, if approved, is not
13dispensed or possessed in accordance with State or federal
14law, not including bupropion, structurally derived from
152-aminopropan-1-one by substitution at the 1-position with
16either phenyl, naphthyl, or thiophene ring systems, whether or
17not the compound is further modified in one or more of the
18following ways:
19        (1) by substitution in the ring system to any extent
20    with alkyl, alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or
21    halide substituents, whether or not further substituted in
22    the ring system by one or more other univalent
23    substituents. Examples of this class include, but are not
24    limited to, 3,4-Methylenedioxycathinone (bk-MDA);
25        (2) by substitution at the 3-position with an acyclic
26    alkyl substituent. Examples of this class include, but are

 

 

SB2612- 295 -LRB103 34492 JAG 64324 b

1    not limited to, 2-methylamino-1-phenylbutan-1-one
2    (buphedrone); or
3        (3) by substitution at the 2-amino nitrogen atom with
4    alkyl, dialkyl, benzyl, or methoxybenzyl groups, or by
5    inclusion of the 2-amino nitrogen atom in a cyclic
6    structure. Examples of this class include, but are not
7    limited to, Dimethylcathinone, Ethcathinone, and
8    a-Pyrrolidinopropiophenone (a-PPP); or
9    Any other synthetic cathinone which is not approved by the
10United States Food and Drug Administration or, if approved, is
11not dispensed or possessed in accordance with State or federal
12law.
13    (i) Synthetic cannabinoids or piperazines. Any synthetic
14cannabinoid or piperazine which is not approved by the United
15States Food and Drug Administration or, if approved, which is
16not dispensed or possessed in accordance with State and
17federal law.
18    (j) Unless specifically excepted or listed in another
19schedule, any chemical compound which is not approved by the
20United States Food and Drug Administration or, if approved, is
21not dispensed or possessed in accordance with State or federal
22law, and is derived from the following structural classes and
23their salts:
24        (1) Benzodiazepine class: A fused 1,4-diazepine and
25    benzene ring structure with a phenyl connected to the
26    1,4-diazepine ring, with any substitution(s) or

 

 

SB2612- 296 -LRB103 34492 JAG 64324 b

1    replacement(s) on the 1,4-diazepine or benzene ring, any
2    substitution(s) on the phenyl ring, or any combination
3    thereof. Examples of this class include but are not
4    limited to: Clonazolam, Flualprazolam; or
5        (2) Thienodiazepine class: A fused 1,4-diazepine and
6    thiophene ring structure with a phenyl connected to the
7    1,4-diazepine ring, with any substitution(s) or
8    replacement(s) on the 1,4-diazepine or thiophene ring, any
9    substitution(s) on the phenyl ring, or any combination
10    thereof. Examples of this class include but are not
11    limited to: Etizolam.
12(Source: P.A. 103-245, eff. 1-1-24.)
 
13    Section 995. No acceleration or delay. Where this Act
14makes changes in a statute that is represented in this Act by
15text that is not yet or no longer in effect (for example, a
16Section represented by multiple versions), the use of that
17text does not accelerate or delay the taking effect of (i) the
18changes made by this Act or (ii) provisions derived from any
19other Public Act.
 
20    Section 999. Effective date. This Act takes effect upon
21becoming law.